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Summary / Resumen 
La ciencia no sabe de países, porque el conocimiento le pertenece a la 
humanidad y es la antorcha que ilumina al mundo. La ciencia es el alma 
de la prosperidad de las naciones y la fuente de todo progreso. 
Louis Pasteur 

Summary 
Summary  
The overall objective of this PhD thesis has been the design and production of 
engineered mesoporous nanoparticles for biomedical applications. In this sense, the 
efforts during this doctoral thesis have been headed towards the development of 
nanomatrices with potential applicability in the treatment of complex diseases, such as 
bone and wound healing and cancer. 
 The initial context of this doctoral thesis was the European project “MOZART” 
(“MesopOrous matrices for localiZed pH-triggered releAse of theRapeuTic ions and 
drugs”), which included many different European partners (11) from both academic and 
industrial environments. The proposal involved the use of mesoporous materials to treat 
delayed bone healing and chronic wound healing. The objective was to load therapeutic 
agents and ions within the mesoporous framework that would be released in the affected 
areas, boosting the healing and improving the health of the patients. The use of a stimuli-
responsive gatekeeper for the pore entrances to minimize potential premature release was 
considered. In this sense, the acid pH that was expected to be found in those pathological 
scenarios was selected as stimulus to trigger the payload release.  
In addition to MOZART, much work during this PhD has been focused on developing 
smart approximations based on stimuli-responsive nanomatrices to improve current 
chemotherapeutic treatments. The administration of free drugs leads to non-selective 
distribution throughout the organism. In this sense, the encapsulation of cytotoxic 
compounds in mesoporous nanomatrices allows the preferential accumulation of the 
particles in the tumoral mass, owing to the Enhanced Permeability and Retention (EPR) 
effect. This effect has fueled the development of commercialized nanomedicines such as 
Doxil®, and it is consequence of the defective vasculature of tumoral blood vessels, 
which allows the extravasation and retention of molecules in the tumors.  
This doctoral thesis is divided in 2 general parts. The first part comprises the 
development of stimuli-responsive mesoporous nanomatrices able to achieve on-demand 
drug release under specific conditions. These smart particles find application in the 
treatment of bone and wound healing (MOZART) and cancer. The second part is focused 
on the potential treatment of cancer. In particular, this part involves the design and 
evaluation of smart approximations to overcome relevant biological barriers that 
nanocarriers may have to face when administered in vivo. 
11
Summary 
 
Graphical summary of this PhD thesis.   
As shown in the Graphical summary of the thesis, the work has focused on the use of 
mesoporous nanomatrices owing to their attractive properties, such as excellent textural 
properties or the ease of their surface functionalization with smart moieties. The use of 
Mesoporous Silica Nanoparticles (MSNs) as nanocarriers was initially devised. In 
addition, several types of nanomatrices were provided by the MOZART consortium, 
including Mesoporous Carbon Nanoparticles (MCNs) (National Center of Scientific 
Research “Demokritos”, Greece), Mesoporous Bioactive Glasses (MBGs) (Friedrich-
Alexander-Universität of Erlangen, Germany, and Politecnico di Torino, Italy) and 
alternative MSNs (Nanolith, a Swedish company). 
The first part covers the design of stimuli-responsive drug delivery systems based on 
the above-mentioned mesoporous nanomatrices. The origin of these stimuli can be 
external (applied by the clinician from outside the body) or internal (based on alterations 
of relevant biomarkers). In particular, this doctoral thesis has focused on the use of 
internal stimuli, namely pH and redox agents, to trigger the drug release.  
One of the most relevant objectives during this PhD has been the design of stimuli-
responsive moieties with smart behavior to functionalize the surface of the different 
nanomatrices here employed and prevent as much premature release as possible. In this 
sense, a type of chemistry, referred to as self-immolative chemistry, has been extensively 
employed to engineer such smart structures.  
Much of the work carried out in the first part has comprised the use of pH as trigger. 
This part devoted to pH can be divided into two more subparts: (1) nanoparticles for 
Mesoporous Nanomatrices
Stimuli-Responsive Drug Delivery
pH-Responsive
Cancer MOZART
Redox-Responsive
Cancer 
Part 1
Overcoming Biological Barriers
Target Cancer cells
Target Tumoral mass
Endosomal Escape
Part 2
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cancer treatment and (2) nanoparticles for bone and wound healing (MOZART). The 
overall approximation here has been the design of a pH-responsive self-immolative 
polyurethane, whose grafting and pH-responsivity have been evaluated in many different 
nanomatrices.  
The application of nanoparticles to cancer treatment has comprised the use of the 
above-mentioned pH-responsive polyurethane in combination with (a) Mesoporous Silica 
Nanoparticles (Section 2.2) and (b) various types of Mesoporous Carbon Nanoparticles 
(Section 2.3). The rationale behind the use of acid pH to trigger the release is the acid 
environment found in certain subcellular organelles (pH ca. 5). In this way, the drugs 
would remain within the mesopores until the particles were internalized. Then, that acid 
pH would trigger the self-immolation, opening the pores and leading to the drug release.  
The initial studies were carried out using MSNs, which were functionalized with the 
pH-responsive self-immolative polymer (SIP). The functionalized nanoparticles were 
fully characterized and their pH-responsiveness was confirmed in vial. In addition, a 
preliminary in vitro experiment with normal and tumoral cells was conducted, where it 
was shown that the SIP-coated MSNs were biocompatible.  
Once the SIP coating was shown to be functional, the next step was to translate the 
technology to the different matrices provided by the MOZART consortium. In this sense, 
the preliminary results obtained with MCNs were very satisfactory. In addition, it was 
observed that these particles showed outstanding loading capacity and, consequently, they 
were proposed as candidates for the design of an anticancer nanoplatform, instead of just 
being applied for the initial purposes considered in the proposal. This work is the result 
of a intense collaboration between our university (UCM), Demokritos (Athens, Greece), 
which provided the carbon matrices and Charité-Universitätmedizin (Berlin, Germany), 
where the in vivo experiments were carried out, producing outstanding results in terms of 
biocompatibility and performance in the animal models. The SIP-coated carbons were 
fully characterized and their pH-responsive behavior was validated in vial, in vitro and in 
vivo. In addition, the SIP-coated carbons were shown to be biocompatible in vivo and 
their ability to inhibit cell viability when loaded with a cytotoxic compound was evaluated 
in vitro, showing excellent results.  
The second subpart of the first part consisted in the application of the pH-responsive 
self-immolative technology to the different mesoporous silica-based nanomatrices 
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provided by the MOZART consortium to address bone and wound healing (Section 2.4). 
In this way, the acid environment expected in delayed bone healing and chronic wound 
healing (pH ca. 5) would trigger the release of the therapeutic agents and ions. In this 
sense, the particles were functionalized with the pH-responsive self-immolative 
polyurethane and the correct grafting was evaluated using different characterization 
techniques. Their ability to close the pore entrances was evaluated via release 
experiments.  
Further experiments carried out by members of the consortium demonstrated that the 
initial assumption of an acidic environment in delayed bone healing and chronic wound 
healing was inaccurate. In consequence, the self-immolative polyurethane previously 
employed with the MOZART nanomatrices had to be modified to be responsive to newly 
relevant pH values. In particular, it was found that pH 6.8 and 8 were the values that had 
to be addressed. In this regard, the efforts were headed towards the development of self-
immolative polyurethanes bearing alternative triggers sensitive to those pH values 
(Section 2.5). Many different approximations were attempted for the effective synthesis 
of both triggers but not fully satisfactory results could be obtained, even though a 
contingency plan considered in the proposal was activated. 
The second approach considered in the first part was the use of redox stimulus to 
trigger the drug release (Section 2.6). The rationale behind the use of this stimulus was 
the overexpression of redox species, namely glutathione, in the cytoplasm of cells 
compared to the extracellular fluids. In this way, premature release would be hampered 
until the particles were internalized, where the reductive environment would trigger the 
release. In this case, MSNs were used as nanocarrier and the innovative self-immolative 
technology was considered again as basis for the design of a redox-responsive self-
immolative molecule. This molecule could act as a diffusion barrier and provided reactive 
points for additional functionalizations. In particular, the redox-responsive particles were 
further functionalized with poly(ethylene glycol), a polymer that is known to be 
biocompatible, improve the colloidal stability and endow particles with stealth properties. 
The functionalized particles were fully characterized and the redox-responsiveness was 
validated. In addition, the ability of the self-immolative molecule to delay premature 
release was verified in vial, paving the way for future biological experiments.  
The second part involved the design of a nanocarrier able to overcome relevant 
biological barriers present in cancer scenarios. When nanoparticles are administered in 
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the bloodstream they may have to face several biological barriers. Overcoming these 
barriers is of vital importance as, otherwise, the efficacy of the treatment could be too low 
and no significant improvements could be observed despite the application of 
nanotechnology. This second part deals with 3 relevant biological barriers: (1) the lack 
of preferential particles accumulation in tumor tissues so the particles might be distributed 
throughout the organism, (2) the lack of selectivity towards cancer cells so normal cells 
could also internalize the drug-loaded particles and (3) nanoparticle sequestration in the 
endo-lysosomal pathway (pathway normally employed for the internalization of 
nanoparticles) so the payload may be degraded or multidrug resistance may be developed. 
The PEGylated MSNs functionalized with the self-immolative linker were selected as 
starting material, since delivering the redox-responsive particle to the cytoplasm to 
interact with the overexpressed glutathione is of major importance. In this sense, a 
polyvalent peptidic compound was developed and grafted to the redox-responsive 
nanoparticles (Section 3.2). This peptide-like compound combines in a single structure a 
motif able to specifically recognize tumoral cells over normal cells and a fragment able 
to induce endosomal escape. The biological performance of the carrier was evaluated in 
2D and 3D cell cultures, showing excellent results in terms of internalization and 
achievement of endosomal escape. In addition, the ability of the system to preferentially 
accumulate in the tumoral mass was validated in a pseudo-in vivo model, using tumor-
bearing chicken embryos. In addition, a preliminary experiment of tumor elimination in 
this model was also carried out. Most of the biological studies carried out for this material 
were performed in the Institute for Integrated Cell-Material Sciences (iCeMS) at Kyoto 
University, Japan, as a result of a research stay that took place during this doctoral thesis. 
In summary, all the results obtained in this PhD thesis highlight the convenience of 
using mesoporous nanomatrices to design smart drug delivery systems thanks to their 
biocompatibility and multifunctionality. In addition, it has been shown the suitability of 
using stimuli-responsive self-immolative structures to control the drug release. Finally, a 
simple but smart approximation to overcome some relevant biological barriers has been 
developed and could constitute a breakthrough to achieve more efficient drug delivery in 
complex diseases such as cancer.  
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El objetivo principal de esta tesis ha sido el diseño y la producción de nanopartículas 
mesoporosas para aplicaciones biomédicas. En este sentido, los esfuerzos durante esta 
tesis doctoral han estado dirigidos hacia el desarrollo de nanomatrices con potencial 
aplicabilidad en el tratamiento de enfermedades complejas, como pueden ser la 
reparación de fracturas crónicas graves de hueso y de heridas piel o el cáncer.  
El contexto inicial de esta tesis doctoral fue el proyecto europeo “MOZART” 
(“MesopOrous matrices for localiZed pH-triggered releAse of theRapeuTic ions and 
drugs”), que incluía diferentes miembros europeos (11) del ámbito académico e 
industrial. La proposición implicaba el uso de materiales mesoporosos para tratar 
enfermedades de hueso y piel. El objetivo era cargar agentes e iones terapéuticos en la 
matriz mesoporosa, los cuales serían liberados en las zonas de interés, fomentando la 
curación y mejorando la vida de los pacientes. El uso de compuertas estimulo-respuesta 
para cerrar los mesoporoso fue considerada. En ese sentido, el pH ácido que se esperaba 
encontrar en estas patologías fue considerado como estímulo para iniciar la liberación de 
la carga.  
Al margen del trabajo realizado para MOZART, se ha llevado a cabo el desarrollo de 
diferentes aproximaciones estímulo-respuesta para mejorar los actuales tratamientos 
quimioterapéuticos. La administración de fármacos libres da lugar a una distribución no 
selectiva a largo de todo el organismo. En este sentido, la encapsulación de citotóxicos 
en nanomatrices mesoporosas permite la acumulación preferencial de las partículas en la 
masa tumoral, debido al efecto de Retención y Permeabilidad Aumentada (efecto EPR, 
por sus siglas en inglés, Enhanced Permeability and Retention Effect). Este efecto ha 
potenciado el desarrollo de nanofármacos que ya están comercializados como el Doxil®, 
y es consecuencia de la deficiente estructura de los vasos sanguíneos tumorales, lo cual 
permite la extravasación y retención de las moléculas en los tumores. 
Esta tesis doctoral consta de 2 partes principales. La primera parte comprende el 
desarrollo de nanomatrices mesoporosas estímulo-respuesta capaces de lograr la 
liberación del fármaco bajo condiciones concretas. Estas partículas encuentran aplicación 
en el tratamiento de enfermedades de hueso y piel (MOZART) y en cáncer. La segunda 
parte está centrada en el potencial tratamiento del cáncer. En particular, esta parte 
comprende el diseño y evaluación de aproximaciones inteligentes para superar barreras 
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biológicas relevantes a las que puede que tengan que enfrentarse los nanotransportadores 
cuando son administrados in vivo.  
Resumen gráfico de esta tesis doctoral.  
Como se muestra en el resumen gráfico de la tesis, el trabajo se ha centrado en el uso 
de nanomatrices mesoporosas debido a sus excelentes propiedades texturales o la 
facilidad para funcionalizarlas con estructuras inteligentes. El uso de Nanopartículas 
Mesoporosas de Sílice (MSNs) como nanotransportadores fue inicialmente considerada. 
Además, varios tipos de nanomatrices fueron proporcionadas por el consorcio MOZART, 
incluyendo Nanopartículas Mesoporosas de Carbono (MCNs) (National Center of 
Scientific Research “Demokritos”, Grecia), Vidrios Mesoporosos Bioactivos (MBGs) 
(Friedrich-Alexander-Universität of Erlangen, Alemania, y Politecnico di Torino, Italia) 
y MSNs alternativas (Nanolith, una compañía sueca). 
La primera parte comprende el diseño de sistema de estímulo-respuesta de transporte 
de fármacos basados en las mencionadas nanomatrices mesoporosas. El origen de estos 
estímulos puede ser externo (aplicado por el sanitario) o interno (basado en alteraciones 
de biomarcadores relevantes). En particular, esta tesis doctoral se ha centrado en el uso 
de estímulos internos, pH y agentes redox, para iniciar la liberación de fármacos. 
Uno de los objetivos más relevantes durante esta tesis ha sido el diseño de estructuras 
estímulo-respuesta con comportamiento inteligente para funcionalizar la superficie de las 
distintas nanomatrices empleadas y así prevenir la liberación prematura del fármaco tanto 
como sea posible. En este sentido, la denominada química autoinmolativa ha sido 
ampliamente empleada para diseñar dichas estructuras inteligentes.   
Nanomatrices Mesoporosas
Transporte de Fármacos Estímulo-Respuesta
Sensible al pH
Cáncer MOZART
Sensible a Especies Redox
Cáncer
Parte 1
Superar Barreras Biológicas
Dirigir a Células Tumorales
Dirigir a la Masa Tumoral
Escape Endosomal
Parte 2
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Gran parte del trabajo desarrollado en la primera parte ha comprendido el uso del pH 
como estímulo. Esta parte relativa al pH puede ser a su vez divida en dos subpartes: (1) 
nanopartículas para el tratamiento del cáncer y (2) nanopartículas para curación de 
fracturas crónicas de hueso y heridas de piel (MOZART). La aproximación general aquí 
ha sido el diseño de un poliuretano autoinmolativo sensible al pH, cuyo anclaje y 
respuesta al pH han sido evaluados en diferentes nanomatrices. 
La aplicación de nanopartículas para tratamiento del cáncer ha comprendido el uso del 
mencionado poliuretano sensible al pH en combinación con (a) Nanopartículas 
Mesoporosas de Sílice (Sección 2.2) y (b) varios tipos de Nanopartículas Mesoporosas de 
Carbono (Sección 2.3). El motivo por el cual se ha utilizado pH para iniciar la liberación 
es el ambiente ácido encontrado en ciertos orgánulos subcelulares (pH ca. 5). De esta 
forma, los fármacos permanecerían en los mesoporos hasta que las partículas fueran 
internalizadas. Tras ello, ese pH ácido iniciaría la autoinmolación, abriendo los poros y 
dando lugar a la liberación del fármaco.  
Los estudios iniciales fueron realizados usando MSNs, las cuales fueron 
funcionalizadas con el polímero autoinmolativo sensible al pH (SIP). Las partículas 
funcionalizadas fueron completamente caracterizadas y su respuesta al pH fue confirmada 
in vial. Además, un experimento in vitro preliminar con células normales y tumorales fue 
llevado a cabo, donde se demostró que las MSNs funcionalizadas con el SIP eran 
biocompatibles.  
Una vez que se demostró que el recubrimiento autoinmolativo era funcional, el 
siguiente paso fue trasladar esta tecnología a las diferentes matrices proporcionadas por 
el consorcio MOZART. En este sentido, los resultados preliminares obtenidos con los 
MCNs fueron muy satisfactorios. Además, se observó que estas partículas poseían una 
extraordinaria capacidad de carga y, como consecuencia, estas matrices fueron propuestas 
como candidatas para el diseño de un nanotransportador con propósitos antitumorales, en 
lugar de ser sólo aplicadas para los propósitos iniciales considerados en el proyecto. Este 
trabajo es el resultado de una profunda colaboración entre nuestra universidad (UCM), 
Demokritos (Atenas, Grecia), que proporcionó las matrices de carbono y Charité-
Universitätmedizin (Berlín, Alemania), donde se llevaron a cabo los experimentos in vivo, 
dando lugar a excelentes resultados en términos de biocompatibilidad y actuación en los 
modelos animales. Las MCNs funcionalizadas con SIPs fueron completamente 
caracterizadas y su respuesta al pH fue evaluada in vial, in vitro e in vivo. Además, se 
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demostró que eran biocompatibles in vivo y su habilidad para inhibir la viabilidad celular 
in vitro fue evaluada cargando un antitumoral, mostrando resultados excelentes.  
La segunda subparte de la primera parte consistió en la aplicación de la tecnología 
autoinmolativa sensible al pH a las diferentes nanomatrices mesoporosas basadas en sílice 
proporcionadas por el consorcio MOZART para tratar enfermedades de hueso y piel 
(Sección 2.4). De esta forma, el ambiente ácido esperado en estos escenarios (pH ca. 5) 
iniciaría la liberación de los agentes e iones terapéuticos. En este sentido, las partículas 
fueron funcionalizadas con el poliuretano autoinmolativo sensible al pH y su correcto 
anclaje se validó a través de diferentes técnicas de caracterización. Su habilidad para 
cerrar los poros se c a través de experimentos de liberación.  
Algunos miembros del consorcio realizaron experimentos para determinar la magnitud 
del pH encontrado en estos escenarios, y se observó que la suposición de un pH ácido en 
fracturas crónicas de hueso y heridas de piel era inexacta. En consecuencia, el poliuretano 
usado previamente con las matrices mesoporosas proporcionadas por MOZART tuvo que 
ser modificado para responder a los nuevos valores de pH relevantes. En particular, se 
observó que pH 6.8 y 8 eran los pHs objetivo, respectivamente. En este sentido, los 
esfuerzos se centraron en desarrollar poliuretanos autoinmolativos sensibles a esos 
valores de pH (Sección 2.5). Se desarrollaron diferentes estrategias para la síntesis de 
ambas moléculas iniciadoras de la autoinmolación, pero no se obtuvieron resultados del 
todo satisfactorios, a pesar incluso de que el plan de contingencia considerado en el 
proyecto fue activado.  
La segunda aproximación considerada en la segunda parte fue el uso de estímulos 
redox para iniciar la liberación del fármaco (Sección 2.6). La razón de ser del uso de este 
estímulo fue la sobreexpresión de especies redox, glutatión, en el citoplasma de las células 
comparado con los fluidos extracelulares. De esta forma, la liberación prematura sería 
ralentizada hasta que las partículas fueran internalizadas, donde el ambiente reductor 
iniciaría la liberación. En este caso, las MSNs fueron utilizadas como nanotransportador 
y la innovadora tecnología autoinmolativa fue considerada de nuevo como base para el 
diseño de una molécula autoinmolativa sensible a estímulos redox. Está molécula podría 
actuar como barrera de difusión y proporcionar puntos reactivos por funcionalizaciones 
adicionales. En particular, las partículas sensibles a especies redox fueron funcionalizadas 
con polietilenglicol, un polímero que se sabe que es biocompatible, que mejora la 
estabilidad coloidal y que proporciona propiedades furtivas a las partículas. Las partículas 
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funcionalizadas fueron completamente caracterizadas y la respuesta a las especies redox 
fue validada. Además, la habilidad de la molécula autoinmolativa para retrasar la 
liberación prematura fue verificada in vial, sentando las bases para futuros experimentos 
biológicos.  
La segunda parte comprende el diseño de un nanotransportador capaz de superar 
barreras biológicas relevantes presentes en escenarios tumorales. Cuando las partículas 
son administradas en el torrente sanguíneo puede que tengan que enfrentarse a varias 
barreras biológicas. Superarlas en muy importante pues, de otro modo, la eficacia del 
tratamiento podría ser demasiado baja y no se verían mejoras en el paciente a pesar de 
usar nanotecnología. Esta segunda parte afronta 3 barreras biológicas: (1) la falta de 
acumulación preferencial de las partículas en el tumor, de modo las partículas podrían ser 
distribuidas a lo largo de todo el organismo, (2) la falta de selectividad hacia células 
cancerosas de modo que las normales también podrían internalizar las partículas y (3) el 
atrapamiento de las partículas en la ruta endo-lisosomal (ruta empleada normalmente para 
la internalización de nanopartículas) de modo que la carga podría ser degradada o podría 
desarrollarse resistencia a los fármacos.   
Las nanopartículas PEGiladas a través del linker autoinmolativo fueron seleccionadas 
como material de partida, pues transportar la partícula sensible a estímulos redox hasta el 
citoplasma para que interaccione con el glutatión allí sobreexpresado es de vital 
importancia. En este sentido, un compuesto peptídico polivalente fue desarrollado y 
anclado a las nanopartículas sensibles a redox (Sección 3.2). Este compuesto combina en 
una única estructura un fragmento capaz de reconocer específicamente células tumorales 
frente a normales y otro fragmento capaz de inducir escape endosomal. El desempeño 
biológico del sistema fue evaluado en cultivos celulares 2D y 3D, mostrando resultados 
excelentes en términos de internalización e inducción de escape endosomal. Además, la 
habilidad del sistema para acumularse preferencialmente en el tumor fue validado en un 
modelo pseudo-in vivo, usando embriones de pollo en los cuales se había crecido un 
tumor. Además, se llevó a cabo un experimento preliminar de eliminación tumoral en este 
modelo. La mayoría de los experimentos de esta parte fueron realizados en el Institute for 
Integrated Cell-Material Sciences (iCeMS), Kyoto University, Japón, como resultado de 
una estancia predoctoral de tres meses realizada durante esta tesis.  
En resumen, los resultados obtenidos en esta tesis doctoral resaltan la conveniencia de 
usar nanomatrices mesoporosas para diseñar sistemas de transporte de fármacos 
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inteligentes gracias a su biocompatibilidad y multifuncionalidad. Además, se ha 
demostrado la idoneidad de usar estructuras autoinmolativas para controlar la liberación 
del fármaco. Finalmente, se desarrolló una aproximación simple pero útil para superar 
algunas barreras biológicas relevantes que podría constituir un avance significativo para 
conseguir un transporte de fármacos más efectivo en enfermedades complejas como 
puede ser el cáncer.  
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1.1. Introduction 
As stated in 2000 by the US National Nanotechnology Initiative, “Nanotechnology is 
concerned with materials and systems whose structures and components exhibit novel 
and significantly improved physical, chemical and biological properties, phenomena and 
processes due to their nanoscale size”.1 In other words, reducing the size of some 
materials may lead to novel properties that might generate a wide variety of new potential 
applications. From a general point of view, a material can be considered as a nanomaterial 
if at least one of its dimensions belongs to the nanometric scale (1 nm=1·10-9 m).2 
In the last decades, nanotechnology has been applied to a wide variety of fields, 
ranging from the development of electronic devices to the study of biological processes.3 
In particular, the application of nanotechnology to medicine, the so-called nanomedicine, 
has attracted the attention of many researchers. The first examples of the application of 
nanotechnology to medicine were reported in the early 60’s when liposomes were first 
described as carriers.4,5 Since then, a wide number of nanomaterials have been engineered 
to achieve effective delivery of therapeutics, including organic, inorganic and hybrid 
combinations.6   
1.2. Types of Particles 
Many different nanocarriers have been applied as nanomedicines in the last decades. 
These carriers can be classified as either organic (e.g., micelles polymeric nanoparticles) 
or inorganic (e.g., metallic nanoparticles, silica nanoparticles), although several hybrid 
organic-inorganic nanocarriers have also been reported (Figure 1.1). 
 
Figure 1.1. Some representative examples of nanoparticles employed in nanomedicine. Top: Organic 
nanoparticles (polymeric micelles, liposomes and polymeric nanoparticles). Bottom: Inorganic 
nanoparticles (metal, carbon and silica-based nanoparticles).  
Polymeric nanoparticlesLiposomesPolymeric micelles
Carbon nanoparticles Silica-based nanoparticlesMetal nanoparticles
Organic nanoparticles
Inorganic nanoparticles
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1.2.1. Organic Nanoparticles 
1.2.1.1. Polymeric micelles  
Polymeric micelles are colloidal nanoparticles of ca. 5-100 nm composed by 
amphiphilic block copolymers capable of self-assembling when placed in aqueous 
medium. The copolymer is produced with a hydrophobic chain and a hydrophilic part, 
usually being the latter the well-known poly(ethylene glycol). Their hydrophobic section 
allows the loading of hydrophobic compounds to enhance their bioavailability and the 
hydrophilic content enhances the stability and biocompatibility. In addition, they can be 
loaded with gamma emitters or paramagnetic metals to carry out nuclear imaging or 
magnetic resonance imaging, respectively.7 
1.2.1.2. Liposomes 
Liposomes consist of amphiphilic lipids (natural or synthetic) that rearrange in 
aqueous environment to yield vesicles containing an aqueous compartment surrounded 
by a variable number of lipid bilayers. Thanks to that architecture, they can load both 
hydrophilic and hydrophobic drugs in the core and in the lipid bilayer, respectively.8 
Furthermore, due to their biocompatibility and biodegradability, liposomes were the first 
drug delivery nanosystems to be successfully translated into the clinic (Doxil®). Since 
then, other liposomal formulations have been approved (DaunoXome®, Ambisome®, 
DepoDur®, etc),9 paving the way for the future translation of other nanomaterials.  
1.2.1.3. Polymeric nanoparticles 
Polymeric nanoparticles can be synthesized from a wide variety of polymers which 
can be composed of monomers with many different chemical functionalities. This allows 
the design of a variety of versatile and multifunctional nanocarriers. The most common 
methods to obtain such nanoparticles are nanoprecipitation, emulsification-diffusion, 
solvent emulsion-evaporation and interfacial deposition. As polymeric source, either non-
biodegradable or biodegradable polymers can be employed, being the latter particularly 
interesting thanks to their elimination from the body (as long as the degradation by-
products are biocompatible).10 The co-polymer poly(lactic-co-glycolic acid) has already 
been approved by the Food and Drug Administration (FDA) for its use in drug delivery 
and diagnostic.11  
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1.2.2. Inorganic Nanoparticles 
1.2.2.1. Metal-based nanoparticles 
The synthesis of novel metal nanoparticles, specially gold and silver nanoparticles, and 
their application to nanomedicine have increased in the last few years.  
Gold nanoparticles are metal nanoparticles prepared from the reduction of a gold salt 
in the presence of stabilizing agents that prevent agglomeration.12 Although they have 
been applied to drug delivery technologies,13 their nonporous structure leads to poor 
storage capacity and lacks of a protective shell for the drugs. Accordingly, gold 
nanoparticles find major application as contrast agents for imaging14 or as photothermal 
therapy agents due to the surface plasmon resonance.15 Gold nanoparticles are usually 
though to be highly biocompatible due to their inertness, although their size and low 
clearance rate might affect their biocompatibility.16 
Silver nanoparticles are metal nanoparticles that can be produced by means of physical 
or chemical methods.17 They are attractive in nanomedicine due to their bactericidal 
properties.18–20 In addition, their plasmon surface resonance has been applied to the design 
of sensors17 and their anticancer activity has been validated.21,22 
1.2.2.2. Carbon nanoparticles 
Within the large family of carbon-based materials, those showing sp2 hybridation have 
attracted much attention owing to their interesting physical-chemical properties. 
Examples are fullerene or carbon nanotubes. However, their cytotoxicity is still 
controversial because factors such as the degree of surface functionalization or the shape 
seem to influence their biocompatibility.23–28 On the contrary, mesoporous carbon 
materials have received growing attention. Their unique characteristics include (1) 
excellent biocompatibility; (2) outstanding textural properties; (3) controlled drug release 
of hydrophobic and hydrophilic compounds; (4) easy surface modification; (5) 
photothermal conversion capability and (6) supramolecular π-π stacking possibilities, 
which are interesting for loading aromatic drugs.29–32 Their synthesis can be accomplished 
by either hard of soft templating approaches, being the former based on the use of pre-
synthesized organic or inorganic templates and the latter on the use of organic molecules 
that self-assemble to generate nanostructures.33 Some of their recent applications are drug 
delivery, chemo-photothermal therapy, in vivo real-time imaging or gene transfection, 
among others.34   
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1.2.2.3. Mesoporous silica nanoparticles 
Ordered mesoporous silica-based materials were first reported in the early 90’s by 
Mobil Oil Corporation researchers35 and researchers from Waseda university.36 These 
materials are characterized by (1) tunable and narrow pore size distributions (2-30 nm); 
(2) adjustable pore structures; (3) high specific surface areas (up to 1500 cm2/g); (4) high 
pores volumes (ca. 1 cm3) and (5) high silanol density on the surface that allows further 
modifications.37–41 Owing to their exquisite physical-chemical properties, mesoporous 
silica materials have been broadly applied in a number fields, including heavy metal 
adsorption42–44 or separation,45–47 catalysis,48–53 food54 or energy storage,55,56 among 
others. 
In addition, these materials find broad application within the field of biomaterials, and 
have been widely studied since Prof. Vallet-Regí and coworkers first reported their 
suitability as drug delivery systems.57 Since then, several porous silica-based nanocarriers 
have been engineered and applied to controlled drug delivery,58–62 efficient gene 
transfection,63–66 bone tissue regeneration67–72 or antibacterial treatment,73–78 among 
others applications. 
Since their discovery, several families of mesoporous silica materials have been 
developed. In particular, the MCM-n (Mobil Composition of Matter) and SBA-n (Santa 
Barbara Amorphous) series have attracted much of the attention.79 In general, the 
synthesis of mesoporous silica materials is based on the sol-gel process in the presence 
of surfactant molecules acting as template. Depending on the particular conditions of the 
synthesis, it is possible to obtain several pore structures. Examples of the MCM-n family 
are MCM-41, MCM-48 and MCM-50 materials, which present hexagonal p6mm, cubic 
Ia3d and laminar p2 arrangement of the mesopores, respectively (Figure 1.2). 
 
Figure 1.2. Spatial arrangement of the pores in a) MCM-41 (hexagonal). b) MCM-48 (cubic). c) MCM-50 
(laminar) mesoporous materials. Reproduced from Ref 79 with permission of Wiley.  
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 Synthesis of Mesoporous Silica Nanoparticles  
The synthesis of MCM-41-like Mesoporous Silica Nanoparticles (MSNs) is based on 
a modification of the method reported by Stöber to obtain micron-sized monodispersed 
silica spheres in 1968.80 With this method the solid particles were formed by means of 
the hydrolysis and subsequent condensation of alkyl silicates catalyzed by ammonia in an 
alcoholic solution.  
Mesoporous silica materials were initially produced as bulk materials, but it did not 
take very long to develop nanoparticles with the same textural properties. To obtain such 
materials, the above-mentioned Stöber method was modified and the addition of 
surfactants as structure-directing agents yielded silica nanoparticles showing 
mesoporosity rather than nonporous spheres. The morphology and dimensions of these 
surfactant-templated mesoporous silicas can be tailored by controlling the reaction 
conditions (e.g., temperature, pH, surfactant concentration or type of silica precursor, 
among others).81 The mechanism proposed for the formation of MSNs (Cooperative 
Liquid Cristal template) is depicted in Figure 1.3. 
 
Figure 1.3. Mechanism proposed for the formation of MCM-41 mesoporous materials. The surfactant 
molecules self-assembly and the silica precursors polymerize around them from the beginning, leading to 
the formation of a silica backbone with hexagonally ordered pores. Adapted from Ref 79 with permission 
of Wiley.  
The hydrolysis, condensation and polymerization of the silica precursors occur from 
the very beginning. They are deposited around individual surfactant micelles prior to their 
arrangement in a hexagonal fashion and further silica network formation.79 According to 
Hou et al,82,83 the formation of MSNs depends on the interactions among the inorganic 
precursor, the polar head of the surfactant and the ions present in the solution as a function 
of the pH of the synthesis. Depending on the pH, anionic, cationic and neutral surfactants 
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can be employed to yield mesoporous materials. The inorganic precursor is negatively 
charged and the polar head positively charged for MCM-41 mesoporous silica.  
The next step consists in removing the surfactant to obtain accessible mesopores with 
large surface areas and pore volumes. In general, the template can be removed by either 
calcination or solvent extraction, although a mixed method involving the use of solvents 
with high boiling points has also been reported.84 The solvent extraction method is usually 
preferred over calcination, since the latter may cause irreversible aggregation of the 
MSNs and limit their potential bioapplication.84–86 In addition, it preserves the functional 
organic moieties in the nanoparticles that otherwise would be thermally destroyed during 
calcination.86 However, the solvent extraction method may induce higher cytotoxicity if 
surfactant molecules are not completely removed, so several extraction steps are usually 
needed.86,87  
 Functionalization of Mesoporous Silica Nanoparticles 
One of the most attractive features of MSNs is their surface with a high density of 
silanol groups. That surface chemistry allows to anchor other chemical groups on the 
surface (i.e., functionalize the surface), which are usually introduced using organosilanes. 
The interactions between the silica matrix and the payload can be tuned depending on the 
organosilane employed.38,88 There are two approximations for an effective 
functionalization of MSNs, the so-called post-synthesis and co-condensation methods 
(Figure 1.4).79 
 
Figure 1.4. Functionalization of MSNs. a) Post-synthesis method. The functionalities are introduced after 
synthesizing the MSNs. b) Co-condensation method. The functionalities are introduced during the synthesis 
of the MSNs. Adapted from Ref 79 with permission of Wiley.  
The post-synthesis method (Figure 1.4a) consists in the modification of the surface after 
the synthesis. If this process is done before removing the surfactant template, this method 
leads to MSNs bearing different groups inside (silanol) and outside the pores. If the 
a) b)Post-synthesis Co-condensation
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functionalization is carried out after removing the template the new functional groups can 
also be found in the mesopores. An advantage of this approach is the possibility to 
introduce different functional groups at the same time (e.g. amine and thiol, amine and 
carboxylic acid, etc). The main disadvantage is that if a bulky organosilane is used, its 
anchoring might lead to the complete closure of the pores and the molecules might not be 
loaded inside.79 
The co-condensation method (Figure 1.4b) consists in the simultaneous addition of the 
silica precursor and the functional organosilane during the formation of the particle. This 
yields MSNs with functional groups homogeneously distributed throughout the silica 
backbone. Its main advantage is that it is a one step process, which might be interesting 
for industrial purposes. However, if too much functional organosilane is added the 
mesostructure may be compromised.79,89 In addition, it is also possible to co-condensate 
periodic, labile chemical groups during the synthesis, leading to biodegradable periodic 
mesoporous nanoparticles.90  
1.3. Stimuli-Responsive Mesoporous Nanoparticles 
Mesoporous nanoparticles have attracted great attention in nanomedicine due to their 
capacity to entrap molecules within their pores. Thanks to the open porous structure, it is 
very easy for the drugs to locate inside the pores but, for the same reason, they can easily 
diffuse out. When using a cytotoxic drug this phenomenon may lead to undesired side 
effects and a reduction of the efficacy of the treatment.  
A smart approximation to minimize that premature drug release would be the use of 
pore blocker structures, the so-called gatekeepers, to close the pore entrances. In addition, 
it would be desirable to open them and allow the release only under very specific 
conditions. The concept of stimuli-responsive nanocarriers arose to achieve that on-
demand drug delivery. It is based on the use of very specific stimulus, that can be 
characteristic of a particular disease or externally administered, to open the pores and 
trigger the release only in the area of interest. In the last years, several examples of 
gatekeepers controlled by either internal or external stimuli have been reported (Figure 
1.5). 
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Figure 1.5. Schematic representation of a stimuli-responsive mesoporous silica nanocarrier and the types 
of stimuli that can be applied for the on-demand delivery of drugs, including pH, redox species, magnetic 
fields or light, among others. 
1.3.1. External Stimuli-Responsive Mesoporous Nanoparticles 
In the case of externally triggered gatekeepers the stimulus comes from outside of the 
body. The main advantage of these nanocarriers is that the stimulus is provided by an 
external apparatus, and then, it might be applied on-demand by the clinician. The most 
common external stimuli employed with mesoporous nanoparticles are alternating 
magnetic fields, light and ultrasounds. 
1.3.1.1. Thermo-responsive mesoporous nanoparticles 
Heat generation can be used for two main purposes, (1) induction of hyperthermia-
mediated cell death and (2) triggering the opening of the mesopores. Researchers have 
been mainly focused on superparamagnetic iron oxide nanoparticles, which are known to 
generate heat upon application of an alternating magnetic field.91 These particles can be 
used as seeds for the growth of mesoporous silica shells to yield nanocarriers with high 
loading capacity and ability to generate heat. Several thermosensitive gatekeepers have 
been described to close the pore entrances of mesoporous nanocarriers, including β-
cyclodextrin-based diels-alder nanovalves,92 thermosensitive nucleic acid strands93 or 
thermosensitive polymers,94,95 among others.  
1.3.1.2. Light-responsive mesoporous nanoparticles 
Researchers using light as stimulus have focused on the use of ultraviolet (UV), near-
infrared and visible light. This stimulus is interesting because of the ease of its 
application, since only a lamp or laser adjusted to the target wavelength are needed.   
Stimulus
Cytotoxics
Nanogates
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UV light has the lowest penetration in tissue96 yet the highest energy which leads to 
(1) radiation-induced cell damage and (2) high ability to break bonds. Examples of these 
bonds include the cleavage of the o-nitrobenzyl97,98 or the isomerization from trans-to-cis 
of the azo-benzene group, that open the pore entrances upon UV light irradiation and 
allow the drug release.99,100 
Near-infrared light has lower energy and therefore lower scattering in the tissues than 
UV light, reaching deeper lengths while being harmless. It is useful to irradiate 
upconversion nanoparticles (transition metal-based nanoparticles that generate UV light 
in the vicinity of the carrier upon near-infrared irradiation) to break the above-mentioned 
bonds without affecting healthy tissues.101,102 In addition, it can be used to generate heat 
through many inorganic materials, such as gold nanorods103 or CuS crystals,104 among 
others. 
Visible light penetrates deeper than UV does. Despite having low energy it is still able 
to break some types of bonds without inducing cellular damage. Examples are double 
bonds105 or coordination bonds.106 In addition, visible light can mediate the formation of 
reactive oxygen species (ROS) that can be used to induce bond cleavage and subsequent 
drug release.107 
1.3.1.3. Ultrasound-responsive mesoporous nanoparticles 
The use of ultrasounds in drug delivery is attractive due to their non-invasiveness, the 
absence of ionizing radiations and their high tissue penetration depth.108 Additionally, the 
ultrasound generator is inexpensive and can easily be transported and used by the 
clinician, which might favor the translation to the clinic. Despite this stimulus has not 
been as explored as the others, it has been successfully employed to trigger the release 
from MSNs bearing ultrasound-responsive polymeric coatings109,110 or supramolecular 
nanovalves.111 In addition, ultrasounds can macroscopically increase the temperature and 
have been used to promote the cellular internalization of MSNs through the cleavage of 
thermo-responsive bonds.112 
1.3.2. Internal Stimuli-Responsive Mesoporous Nanoparticles 
Internal stimuli-responsive nanocarriers take advantage of the variations of some 
biomarkers in some diseases. Examples include variations in the concentration of 
enzymes, the value of pH or the concentration of redox species.   
 
35
Chapter 1: General Introduction to Nanomedicine 
 
 
 
 
1.3.2.1. Enzyme-responsive mesoporous nanoparticles 
The overexpression of particular enzymes is a well-stablished phenomenon in diseases 
such as cancer,113 osteoporosis114 or inflammation scenarios.115 They are interesting due 
to their ability to break certain bonds. Based on that, several enzyme-responsive 
gatekeepers have been used to block the mesopores and allow the release under very 
specific conditions.116–120 In addition, they can also be used to engineer strategies to 
reduce the off-target through the uncaging of targeting groups as a consequence of the 
enzymatic activity.121,122 
1.3.2.2. pH-responsive mesoporous nanoparticles 
The use of pH as trigger relies on its variations throughout the organism (bloodstream, 
stomach, lysosomes, etc) and during some specific diseases (cancer, osteoporosis).123,124 
In this sense, several pH-responsive gatekeepers have been successfully applied to close 
the pore entrances, including polymers,125–127 small particles128–130 or pH-labile bonds,131–
133 among others.  
1.3.2.3. Redox-responsive mesoporous nanoparticles 
Redox-responsive nanoparticles take advantage of the differences in the concentration 
of glutathione (GSH) found inside and outside the cells. Moreover, the levels of GSH are 
even higher in cancer cells, as a consequence of an enhanced production of ROS.134,135 
The main strategy consists in the use of disulfide bonds to engineer gatekeepers because 
they are easily cleaved in the presence of redox species. Examples are polymers 
conjugated via disulfide bonds136 or redox-responsive cross-linkers.137 
1.4. Nanotechnology and Cancer 
In the last few years, the efforts of many nanotechnologists have been headed towards 
the design of nanomaterials capable of diagnosing or treating the challenging area of 
cancer. In addition, nanotechnology has also been applied for the treatment of other 
diseases such as diabetes138 or those related to kidney139 or lung,140 among others.  
According to the World Health Organization, cancer is one of the leading causes of 
death worldwide.141 Most of the current cancer treatments rely on the use radiotherapy or 
chemotherapy. Additionally, patients may undergo surgery to remove certain tumors, 
although they still might have to be irradiated or go through chemotherapy, depending on 
the particularities of each patient.142  
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Radiation therapy consists in the use of ionizing radiation able to induce DNA damage 
in the cells. It is based on the fact that normal cells show faster repair of radiation damage 
than cancer cells. Depending on the particularity of the tumor the radiation can be 
administered from inside (radioactive sources introduced in the body) or outside the body 
(high energy rays: photons, protons or particle radiation). Current research efforts are 
headed towards the development of more precise equipment and the optimization of the 
algorithms applied for the planning of the treatments.143    
Chemotherapy consists in the administration of drugs able to induce cell death. 
However, these compounds do not show preferential accumulation in the tumor tissues 
and distribute throughout the entire body, leading to severe side effects.144 In this sense, 
it would be desirable to specifically deliver the chemotherapeutics only to cancer cells. A 
smart approximation would be the use of nanoparticles since they (1) can retain drugs 
until reaching the tumor; (2) allow the delivery of hydrophobic drugs that otherwise 
would not be soluble in the bloodstream; (3) provide a protective shell for the drugs so 
their degradation can be delayed and their cellular uptake enhanced; (4) allow the co-
loading of several drugs to improve the efficacy of the treatment and (5) can be modified 
with targeting moieties to specifically recognize tumoral cells over normal cells and 
improve the selectivity of the treatment.58,65,145,146  
The main rationale behind the use of nanocarriers is their passive and preferential 
accumulation into the tumors as a consequence of the Enhanced Permeability and 
Retention effect, the so-called EPR effect. The EPR effect was first reported in 1986 when 
Maeda and coworkers observed that proteins above a certain molecular weight 
spontaneously accumulated in tumoral tissues and remained there for a long time.147 Their 
research showed that solid tumors present blood vessels with abnormal architecture and 
poor lymphatic drainage as a consequence of their rapid growth. As a result, 
macromolecules larger than 40 kDa tend to leak out from the tumor vessels and 
accumulate in the tumor. This effect has not been observed in healthy tissues.148 
Unfortunately, the magnitude of the EPR effect and its ability to accumulate 
macromolecules in the tumor highly depend on the particularities of the patient and the 
tumor.149 For such reason, even when existing a significant EPR effect, nanocarriers have 
to face consecutive physical and biochemical biological barriers (Figure 1.6), including 
(1) opsonization and subsequent nanocarrier removal from the bloodstream by the 
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mononuclear phagocyte system; (2) nonspecific distribution throughout the body; (3) 
premature release of the antitumoral drugs; (4) high intratumoral pressure and dense 
collagen matrix that prevent nanoparticles from reaching deeper regions of the tumor; (5) 
low selectivity towards cancer cells or (6) entrapment of nanoparticles in the lysosomes 
so effective payload may be compromised, among others.150 
 
Figure 1.6. Sequential biological barriers that nanocarriers may have to face when administered to the 
patient, ordered from their administration in the bloodstream (1) to an eventual internalization in the cells 
(6). 
In the last few years, several approximations have been reported in order to overcome 
some of these limitations, including (1) chemical species that avoid or reduce 
opsonization of the carriers;151–153 (2) tumor-homing peptides154 or mesenchymal stem 
cells155 that spontaneously migrate to tumoral areas; (3) stimuli-responsive gatekeepers 
that hamper premature drug release until some specific event happens;156 (4) proteolytic 
enzymes that digest the collagen matrix157 or ultrasound-induced cavitation that enhance 
extravasation into the tumor;158 (5) biomolecules that specifically bind receptors only 
overexpressed on the tumoral cell membranes;146 or (6) agents able to induce endosomal 
escape,159 among others. 
However, the implementation of all these strategies in a single carrier remains elusive 
due to the complexity of the interactions between these nanomaterials and the living 
organisms. In consequence, the translation from the bench to the bed still constitutes the 
bottleneck of this field.160  
  
(1) Opsonization
(Nanocarriers may be removed from the 
bloodstream by the macrophages)
(2) Nonspecific distribution
(Nanocarriers do not accumulate 
preferentially in the tumor)
(3) Premature drug release 
(Drugs may affect healthy tissues)
(4) High intratumoral pressure 
and dense collagen matrix
(Hinder nanocarrier penetration in the 
tumor and limits the number of cells 
receiving the treatment)
(5) Low selectivity towards 
cancer cells 
(Nanocarriers may be internalized by 
normal cells)
(6) Lysosomal entrapment
(Possible payload degradation and 
chemoresistance) 
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Chapter 2 
Stimuli-Responsive Drug Delivery 
El éxito no es definitivo, el fracaso no es fatal: lo que realmente cuenta 
es el valor para continuar. 
Winston Churchill 
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2.1. Introduction 
2.1.1. Aims  
The objective of this chapter was to design and produce different stimuli-responsive 
nanocarriers based on mesoporous nanoparticles within the frame of the European Project 
“MOZART” (“MesopOrous matrices for localiZed pH-triggered releAse of theRapeuTic 
ions and drugs”). According to MOZART proposal, the objective of project can be stated 
as follows:   
“The MOZART project involves 8 different countries and 11 partners, 5 high tech 
SMEs and 6 top European Universities. The concept behind MOZART is to develop a 
library of inorganic nanomatrices to be used as smart platforms for effective, non-
invasive and highly targeted therapies to treat delayed bone healing and non-healing 
chronic skin wounds, which are both characterized by an inflammation and often 
infection. Mesoporous therapeutic glasses, doped with selected ions, will be synthesized 
and then loaded with the chosen payload. Ordered mesoporous carbons will also be 
manufactured to host a wide range of biomolecules and higher payload. As in an 
orchestra, where the integration among the different participants allows a harmonious 
symphony to be created, in MOZART the synergistic release of ions and drugs will be 
directed to achieve a radically improved therapeutic effect. Mozart aims to translate these 
new and innovative medical products into the clinic and market for the benefit of the 
patients and the industrial healthcare sector in Europe.”  
In particular, the overall objective of this project was to engineer a stimuli-responsive 
gatekeeper, graft it to different mesoporous carriers and evaluate its on-demand drug 
delivery capabilities. The proposal considered variations in pH characteristic of certain 
scenarios to trigger the release. In this way, the ions and drugs would only leave the matrix 
in the diseased site, avoiding nonspecific and premature release.  
The use of self-immolative polymers (SIPs) as gatekeepers for those nanomatrices was 
explored. These polymers are interesting because they are able to disassembly into their 
functional units upon application of a particular stimulus, such as pH. When grafted to 
the nanomatrices, they would be stable at physiological pH, hampering premature release. 
However, after a pH drop the chain would self-immolate, opening the pores and leading 
to the cargo release. Then, the first objective was to synthesize a polymeric chain 
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showing this self-immolative behavior and bearing an acid-responsive trigger to start the 
disassembling in these scenarios.   
The grafting of the self-immolative polymers to the particles was initially optimized 
for MSNs and tested at pH 5. In this sense, many pH-responsive systems reported as 
anticancer nanotechnological approximations are able to hamper the drug release at 
physiological pH and trigger it at acid pH, as this system did. Therefore, translating the 
above-mentioned self-immolative technology to the design of pH-responsive 
nanocarriers applied to cancer treatment seemed appropriate. In consequence, the second 
objective was to apply the self-immolative technology to MSNs to design a system with 
anticancer application. This study comprised the evaluation of their pH-responsive 
capabilities as well as their preliminary biological performance. 
As a result of the collaboration among some of the MOZART partners, the possibility 
of using mesoporous carbon nanomatrices to engineer a pH-responsive solution for 
cancer treatment was explored. In this sense, the third objective was to apply the self-
immolative technology to mesoporous carbon nanoparticles (MCNs). In particular, these 
materials showed outstanding textural properties and the initial task was to demonstrate 
that they could load significantly higher amounts of molecules than the well-studied 
MSNs. In this way, these nanomatrices would constitute a step ahead in the design of 
anticancer formulations. Then, the self-immolative technology was applied and their pH-
responsiveness evaluated. In view of the promising results, the materials were subjected 
to further biological experiments, including the study of their performance in vivo, as it 
will be described in this chapter. 
The proposal considered the use of acid-responsive self-immolative polymers to seal 
the pore entrances. In consequence, the fourth objective was to functionalize the 
different nanomatrices provided by the consortium with this polymeric coating and test 
their pH-responsive behavior at acid pH.     
One of the initial tasks of the MOZART consortium was to provide an accurate pH 
value for the above-mentioned scenarios (delayed bone healing and non-healing chronic 
skin wounds) using in vivo animal models. Initially, the proposal considered the use of 
acid pH as trigger. However, the in vivo experiments demonstrated the existence of 
several pHs, spanning from acid to basic values, confronting the initial hypothesis of a 
discrete pH value as trigger. Nonetheless, two pH values, 6.8 and 8, seemed to recurrently 
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be present in the diseased models. In consequence, the polymer above-described had to 
be modified, so the fifth objective was the development of alternative triggers able to 
initiate the self-immolation and trigger the release at the new target pH values.  
The possibility of using an alternative and relevant stimulus found in cancer scenarios 
to trigger the release was explored once all the requirements of MOZART were fulfilled. 
In this sense, the sixth objective was to develop a self-immolative gatekeeper sensitive 
to high concentrations of redox species, which are known to be found within tumoral 
cells. This study comprised the development of a novel redox-responsive self-immolative 
linker. Its grafting to the surface of MSNs was optimized and their redox-responsive 
behavior evaluated. 
In summary, this chapter will provide a detailed introduction to the different topics 
above-described, i.e., pH-responsive drug delivery, redox-responsive drug delivery and 
self-immolative technology. Then, the methodology and results derived from the 
application of the self-immolative technology for the design of anticancer formulations 
will be described. Finally, the results derived from the MOZART project will be presented 
and discussed.  
 
Scheme 2.1. Schematic representation of the aims of Chapter 2.  
  
Aims Chapter 2
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3
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Self-Immolative Polymer
responsive to acid pH
MSNs-SIPs responsive to 
acid pH
Mesoporous carbon-SIPs
responsive to acid pH
MSNs-SIPs responsive to 
different pHs
MSN-SIPs responsive to 
Redox environments
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2.1.2. pH-responsive mesoporous nanoparticles 
The different pHs that can be found throughout the organism provide a useful tool for 
the design of stimuli-responsive drug delivery nanocarriers. These pH-responsive systems 
are able to avoid premature drug release at the bloodstream pH while promoting it once 
in the tumoral area or inside particular organelles within the tumoral cells.  
In this section the biological rationale behind the use of the differences in pH as a 
relevant biomarker will be presented. Then, different approximations for the design of 
pH-responsive mesoporous nanoparticles will be introduced, including the use of (1) 
electrostatic interactions between the mesoporous matrix and the payload, (2) acid-labile 
bonds as linkers between the nanocarriers and the gatekeepers and (3) several 
supramolecular structures employed as pore capping agents.   
2.1.2.1. The role of pH in drug delivery 
The maintenance of the different physiological pHs along the body is of vital 
importance for the organism to keep alive. For instance, variations in pH of body fluids 
within 7.35 and 7.45 can be corrected, but greater alterations may lead to acidosis or 
alkalosis events that may even cause death. However, there are particular areas in the 
body or some diseases that present values that deviate from physiological pH. In 
particular, the pH throughout the digestive system and within some cellular compartments 
differ from that of the bloodstream. Moreover, the pH found in the extracellular tumor 
tissues is also slightly different as a consequence of the special metabolism of tumor cells. 
 Digestive system 
Due to the various conditions needed for the digestion of the different nutrients, pH is 
not kept constant throughout the organs of the gastrointestinal tract. This fact has been 
exploited for the design of oral drug delivery carriers.1,2 In particular, the pH in the 
stomach is between 1–2, and reaches pH 7–8 after leaving it. In the stomach the pH is 
lowered by the secretion of protons by the parietal cells, which can be suppressed by 
different hormones. As a protective mechanism, the epithelium secrets bicarbonate ions 
to regulate the pH. After leaving the stomach, the bile salts are responsible for increasing 
the pH up to 7-8.3 
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 Extracellular tumor microenvironment 
In presence of O2, nonproliferating healthy cells, i.e., differentiated tissue, metabolize 
glucose to CO2 through the highly efficient oxidative phosphorylation process (Figure 
2.1a, left). Under anaerobic conditions, normal cells can also produce energy through 
anaerobic glycolysis, leading to the production of lactate (Figure 2.1a, right). On the 
contrary, most cancer cells, and any proliferating cell in general, produce large amounts 
of lactate regardless of the oxygen supply through the aerobic glycolysis process (Figure 
2.1b). The generation of lactate through this process is called Warburg effect, and is 
responsible for the slight acidification of the extracellular tumoral matrix.4 
 
Figure 2.1. Schematic representation of the different mechanisms of energy production by normal 
nonproliferating cells (differentiated tissue) vs normal proliferating and cancer cells. a) Healthy 
nonproliferating cells efficiently produce energy from glucose in the presence of oxygen via oxidative 
phosphorylation (left) or less efficiently via anaerobic glycolysis when no oxygen available (right). b) 
Cancer and healthy proliferative cells almost always produce their energy via aerobic glycolysis, regardless 
of the presence of oxygen, leading to the acidification of the extracellular tumoral matrix. Adapted from 
Ref 4 with permission of AAAS. 
Those large amounts of lactate are secreted outside the cells, leading to the 
acidification of the extracellular tumoral matrix. In addition, the excess of CO2 generated 
as a by-product can also contribute to the extracellular acidification thanks to the activity 
of the carbonic anhydrase. This acidification has a major role in cancer development: (1) 
it enhances tumor cell migration and radioresistance; (2) it mediates chronic inflammation 
in tumor microenvironments by increasing interleukin production by T-cells and 
macrophages and (3) it disturbs the metabolism and function of T-cells.5 This decrease in 
the extracellular pH has been quantified to be within the range 6.5-7.6–8  
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 Intracellular pH 
There are some compartments and organelles inside all cells that show slight 
differences with respect to the near neutral pH found in the cytoplasm. Those differences 
can be used to design smart pH-responsive systems.  
Cells internalize substances through different mechanisms, being the endocytic 
pathway one of them. Briefly, the cell membrane creates a vesicle around these substances 
that is subsequently transported inside the cell. This vesicle matures from the early 
endosomes to the late endosomes and eventually to the lysosomes. The function of these 
organelles is the degradation of compounds that are no longer useful for the cell. For that 
reason, these compartments present acid pH. In particular, pH becomes more acidic as 
the substances go from the endocytic vesicles (pH 6.5) to the lysosomes (pH 4.5-5). The 
different organelles have an intrinsic capacity to buffer slight changes, which is provided 
by the weak acids and bases present there. However, this buffer is finite and there must 
be another mechanism to control the pH of each compartment. That precise regulation of 
pH is provided by the presence of proton-pumping ATPases. The injection of protons by 
these pumps together with the existence of channels capable of introducing negative ions 
lead to the final pH of each organelle.9 
These differences in pH can be employed for the design of stimuli-responsive 
mesoporous materials sensitive to pH variations. In this way, the drugs would be confined 
within the mesopores at physiological pH and they would only be released upon a change 
in the pH value. The most common approximations that can be found in the literature fall 
into three types of strategies: electrostatic host-guest interactions, acid-labile bonds and 
supramolecular capping agents.  
2.1.2.2. Host-guest interactions 
The use of the electrostatic interactions between the functional groups present in the 
mesopores and those in the payload constitutes the simplest approximation to engineer 
pH-responsive nanocarriers. In this way, at physiological pH the molecules remain 
retained inside the pores, avoiding premature release. However, when pH changes the 
electrostatic interactions weaken, leading to the drug release. 
These host-guest interactions have been employed to induce the pH-responsive release 
of several drugs, including ibuprofen, 5-fluoracil, mitoxantrone, methotrexate, 
sulfasalazine or doxorubicin.1,10–12 In particular, doxorubicin (DOX), which is a cationic 
60
Chapter 2: Stimuli-Responsive Drug Delivery 
Introduction 
 
 
drug widely used for more than 30 years to treat many types of tumors,13 has been 
recurrently loaded as model drug in mesoporous materials. 
The storage in MSNs takes place through the electrostatic interaction between DOX 
and the silanol groups of the nanoparticles. The silanol groups of MSNs are deprotonated 
at physiological pH and the amino group of DOX is positively charged, remaining 
electrostatically attracted. However, at acid pH the silanol groups protonate and, 
consequently, repulsion interactions appear, leading to the drug release (Figure 2.2).  
 
Figure 2.2. Example of DOX storage and release from the mesopores of MSNs through host-guest 
interactions. At physiological pH, DOX interacts with the deprotonated silanol groups (depicted by the 
dotted line). However, when the pH drops, silanol groups protonate and these interactions weaken, leading 
to the drug release.  
When MCNs are used, DOX is retained in the mesopores through the π-π staking 
interactions, which are non-covalent hydrophobic interactions between aromatic 
structures due to the sp2 hybridization. In this way, at neutral pH the aromatic rings of 
DOX are attracted by the aromatic framework of the carbon nanocarriers.  However, a 
decrease in pH leads to an increase in the hydrophilicity of DOX, thereby reducing the 
strength of the π-π interactions with the surface. In this way, the π-π interactions are 
disrupted, triggering the drug release.14 
2.1.2.3. Acid-labile bonds 
Labile bonds are interesting for drug delivery as they can remain stable until some 
specific event takes place. In particular, there are several types of acid-responsive bonds 
that can be used to exploit the differences in pH within the body. In this way, it is possible 
to synthesize mesoporous nanoparticles with smart pH-responsive behavior. Some 
representative examples of pH-responsive linkers are shown in Table 2.1. 
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Table 2.1. Acid-labile bonds that have been used in the design of pH-responsive mesoporous nanoparticles.  
Bond pH-Responsive Mechanism References 
Hydrazone 
 
 
 
15–22 
Acetal 
 
 
 
23–28 
Imine 
 
  29–35 
Ester-based 
 
 
 
36–45 
Citraconic 
 
 
 
46,47 
Coordination bonds 
The host-metal-guest interaction weakens at acid pH, leading 
to the release of either the drug or the metal ion and the drug 
48–54  
 Hydrazone bond 
Hydrazone bonds have been widely explored in the design of prodrugs, which are 
masked forms of active drugs that remain inactive until a particular event takes place.  In 
this way, the prodrugs would remain inactive at physiological pH, undergoing fast 
hydrolysis at pH 5.55,56 In this sense, it is possible to decorate the surface of MSNs with 
hydrazine groups to then add active drugs to these groups to yield a prodrug-like 
nanocarrier. In this way, the drugs would remain inactive at physiological pH and they 
would recover their activity at the lysosomal acid pH, leading to the drug release. 
Examples include the conjugation of cisplatin15 or doxorubicin,16,17 either on the external 
surface or within the mesopores (Figure 2.3).  
 
Figure 2.3. Example of MSNs decorated with a prodrug via hydrazone bond on the surface.  In this case, 
at neutral pH the inactive drug (represented by the orange star) remains covalently attached to the silica 
matrix. However, the acid environment of the lysosomes hydrolyzes the bond and the active drug 
(represented by the yellow star) is released.  
In addition, this approach can be used to engineer labile gatekeepers. In this way, the 
pore entrances remain closed at physiological pH. However, at acid pH the bond suffers 
hydrolysis and the gatekeeper leaves the pores open, leading to the drug release. Examples 
Acid pH
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are the use of gold nanoparticles19,20 or hyaluronic acid22 as gatekeepers via formation of 
a hydrazone bond.   
 Acetal bond 
The acetal bond is stable at physiological pH and hydrolyzes at acid pH. Similarly to 
the previous case, it is useful for the design of prodrug-functionalized mesoporous 
carriers.23 In addition, it also finds application in the design of acid-labile gatekeepers 
able to be cleaved only within the cells, leading to the drug release. Examples of 
gatekeepers grafted via acetal bond are small metal24,28 and carbon25 nanoparticles or 
polymeric coatings.26,27  
 Imine-based bond 
Imine bonds are condensation products of primary amines with carbonyl compounds 
that hydrolyze at acid pH. In particular, benzoic-imine bonds have attracted much 
attention because they hydrolyze at pH ca. 6.8 (i.e., extracellular tumor pH).57 For such 
reason, imine bonds have been applied to design mesoporous nanoparticles able to 
overcome the so-called PEG dilemma. This phenomenon is consequence of two facts: (1) 
PEGylation of nanocarriers increases their circulation time and (2) the presence of PEG 
chain difficulties the cellular uptake owing to the steric hindrance and the hydration layer 
created by the PEG chains.58 Figure 2.4 represents the behavior of these nanocarriers. The 
PEG layers are attached to the surface via benzoic imine bonds, that remain stable at 
physiological pH. However, at the acidic pH of the extracellular tumoral matrix the bond 
is cleaved and the positive charge of the nanoparticle surface is exposed, increasing the 
uptake.30,31 
 
Figure 2.4. Cleavage of a benzoic-imine bond to overcome the PEG dilemma. At neutral pH the PEG chain 
remain attached to the surface, avoiding protein adsorption. However, the slightly acidic pH found in the 
extracellular tumoral matrix cleaves the imine bond, exposing a positive charge on the nanoparticle surface 
that enhances the cellular uptake. Adapted from Ref 30 with permission of Elsevier. 
Imine bond-based compounds are also useful as cross-linking agents. For instance, it 
is possible to design pH-sensitive protective layers on the nanocarriers by reacting amine-
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containing compounds with carbonyl-containing macromolecules, such as chitosan with 
dialdehyde starch,32 dextrin with tetraethylenepentamine33 or glutaraldehyde with 
polyethyleneimine.34  
 Ester-based bond  
Ester-based pH-sensitive bonds find broad application as linkers between the 
nanocarriers and the gatekeepers, although it is possible to use polyesters as pore 
blockers.36 In particular, the most employed ester is the boronate ester bond, which is 
known to undergo reversible hydrolysis at acid pH.59 This behavior allows to design 
pulsatile systems where gatekeepers can open and close the pores upon pH changes. 
Examples of such gatekeepers are small Au or Fe3O4 nanoparticles,
38,39 lactobionic acid40 
and β-CD.44,45 
 Citraconic-based bonds 
Citraconic anhydride is usually reacted with amines to yield a pH-responsive amide. 
This bond is stable at physiological pH but undergoes rapid hydrolysis upon a drop in pH. 
In this sense, this pH-responsive bond also finds application in the design of prodrug-like 
nanocarriers, where the release would be trigger by the acid pH found in the tumors.46 In 
addition, it can be employed to mask the positive charge of cell-penetrating peptides. In 
this way, the nonspecific interactions with healthy cells are minimized. However, the acid 
pH found in the tumoral matrix cleaves the bond, exposing the positive charge of the 
peptide again to lead to enhanced nanoparticle uptake by tumoral cells.47 
 Coordination bonds 
This approach is based on loading metal ions within the mesopores. The ions can form 
stable coordination bonds with the mesoporous matrix (host) and with loaded drugs 
(guests). However, when the pH decreases there are competition events and either the 
host-metal or the metal-guest may be cleaved. In this way, it is possible to modify the 
functional groups of the nanoparticles to tune the host-metal-guest interactions (Figure 
2.5).60  
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Figure 2.5. Schematic representation of the release of guest molecules upon cleavage of coordination 
bonds. Depending of strength of the interactions, the drug (a), the metal coordinated to the drug (b) or both 
independent elements (c) can leave the mesopores. This strategy may enhance the therapeutic effect of the 
drugs due to the presence of therapeutic ions. Adapted from Ref 60 with permission of Elsevier. 
Nanoparticles are usually functionalized with amino-based groups that can coordinate 
with the metal ions, including Zn2+, Fe3+, Co+2, In3+ or Cu2+, among others.48–54 
Depending on the strength of the interactions, it is possible to deliver a simple drug 
(Figure 2.5a) or to deliver both drugs and ions (Figure 2.5c), which are known to have 
therapeutic properties.61  
2.1.2.4. Supramolecular pore-capping agents 
 Small degradable nanoparticles 
In the previous section, some examples of gatekeepers based on small nondegradable 
nanoparticles grafted to MSNs via different acid-cleavable bonds have been described. In 
addition to this approximation, it is also possible to close the pore entrances with some 
types of small nanoparticles that degrade in acidic environments. In this way, the 
gatekeepers close the pores at physiological pH, but degrade when pH decreases, opening 
the pores and leading to the drug release.  
ZnO quantum dots are known to be stable at physiological pH, but rapidly dissolve at 
pH below 5. An extended strategy is using them as gatekeepers to close the mesopores. 
At physiological pH the quantum dots are stable and keep the pore entrances closed. 
However, they rapidly degrade at lysosomal pH, leading to the drug release and the 
generation of cytotoxic Zn2+ ions as a by-product of the dissolution.62–66 In addition, MnO 
nanoparticles can also be used as gatekeepers, leading in this case to manganese ions as 
degradation by-products that can be used for imaging purposes.67,68  
 Cyclodextrins 
Cyclodextrins (CD) are water-soluble and biocompatible macromolecules obtained 
from the enzymatic degradation of starch. They have a hydrophilic outer surface and a 
a)
b)
c)
pH ↓
Release
Host carrier Functional group Metal ion Drug molecule
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hydrophobic cavity that allows the complexation of various structures inside. In 
particular, β-CD are useful in drug delivery because of their convenient cavity size, which 
is able to block the pore entrances.69 β-CD-based drug delivery systems usually present 
an amine-based stalk covalently attached to the surface of the nanoparticles that interacts 
electrostatically with the hydrophobic cavity of a β-CD. At neutral pH, the stalk and the 
cap interact tightly, preventing the drug release. However, at lower pH the affinity 
between the stalk and the cap decreases, opening the pores and allowing the cargo 
release.70,71 In addition, it is also possible to use complementary base pairs to control the 
interaction of the β-CD gates with the surface.72  
 Polyelectrolytes 
Polyelectrolytes are polymers that have ionizable groups along the polymeric chain. A 
smart approximation is to close the pore entrances with these polymers through 
electrostatic interactions with the surface of the nanoparticle. In this way, upon a change 
in pH electrostatic repulsion forces will appear, opening the pores and allowing the 
release. Cationic or anionic polymers could be used depending on the electric charge of 
the particle. Table 2.2 summarizes some of the most used polyelectrolytes employed in 
the design of pH-responsive mesoporous nanocarriers. 
Table 2.2. Polyelectrolytes most commonly used in the design of pH-responsive mesoporous nanocarriers 
through electrostatic interactions.  
Polycation Structure References 
Chitosan 
 
73–76 
Poly(allylamine hydrochloride) 
 
77–79 
Polyethyleneimine  
 
80,81 
Poly(vinyl pyridine) 
 
82 
Polyanion Structure References 
Poly(styrene sulfonate) 
 
79 
Poly(acrylic acid-co-itaconic acid) 
 
83 
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A common approach when using the polyelectrolytes depicted in Table 2.2 is their 
arrangement in multilayers. At neutral pH, the layers are close to each other, leading to a 
robust coating that prevents premature release. However, when the pH decreases, the 
interactions weaken, and the multilayer disassembles, allowing the payload release. 
Examples of such gatekeepers are the combination of chitosan with sodium alginate84,85 
or poly(allylamine hydrochloride) with poly(styrene sulfonate).77,86 
It is also possible the coating of mesoporous carriers with only one type of 
polyelectrolyte. Depending on the charge of the nanoparticle surface, a specific 
polyelectrolyte can be used. In this sense, the most representative polyelectrolyte is 
chitosan. This polymer can be used to coat the surface because it swells reversibly at acid 
pH, leading to pulsatile systems.73,74,76,87 Other representative polyelectrolytes used in this 
way are polyethyleneimine,80,81 poly(vinyl pyridine),82 poly(2-diethylamino ethyl 
methacrylate)88 or the polyanionic poly(acrylic acid-co-itaconic acid).83 
 Polymers that undergo conformational changes 
Many polymers are able to change their conformation under pH variations. In general, 
the polymeric coating is collapsed on the surface at neutral pH, blocking the pore 
entrances. However, upon a variation in pH the polymers change their hydrophobicity 
and adopt and extended conformation, allowing the drug release (Figure 2.6). 
 
Figure 2.6. Collapse-to-extended phase transition of a polymer upon changes in pH that allows the drug 
release. At physiological pH the polymeric coating is collapsed on the surface. When the pH varies, the 
polymers undergo a conformational change to an extended conformation, opening the pores and allowing 
the release. Adapted from Ref 89 with permission of The Royal Society of Chemistry. 
These polymers present ionizable groups that remain neutral at physiological pH and 
acquire net charge upon pH variations. This behavior leads to the appearance of repulsion 
forces among the chains appear, becoming hydrophilic and adopting an extended 
conformation that open the pores. Some of the polymers that behave in that way and have 
been used to engineer pH-responsive mesoporous nanocarriers are shown in Table 2.3. 
pH variation
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Table 2.3. Phase-transition polymers usually employed as gatekeepers in pH-responsive mesoporous 
nanocarriers. PMAA: poly(methacrylic acid); PAA: poly(acrylic acid); PDMAEA: poly(2-
(dimethylamino)ethyl acrylate); PPEMA: poly(2-(pentamethyleneimino)ethyl methacrylate); PDEAEMA: 
poly(2-(diethylamino)ethyl methacrylate).  
Cationic Polymers Structure Refs 
Polyamine-based -- 90–92 
PDMAEA 
 
93,94 
PPEMA 
 
95 
PDEAEMA 
 
96–99 
Anionic Polymers Structure Refs 
PMAA 
 
100–106 
PAA 
 
107–112 
Cationic polymers are composed of amine-containing monomers that remain neutral 
at physiological pH and protonate when the pH decreases below a certain value. This 
behavior can be exploited to design pH-responsive mesoporous nanoparticles that impede 
the release until the nanocarrier is internalized by the cell. Once there, the acidic 
organelles protonate the amine groups of the polymer chain, leading to an extended 
conformation that opens the pores and triggers the drug release. Examples of polymers 
showing this behavior are polyamine-based polymers/dendrimers,90–92 amino-based 
acrylates and methacrylates,96,97 poly(L-histidine)113 and poly(n-vinyl pyridine).114–116 
Anionic polymers are usually composed of monomers that contain either a carboxyl 
or a sulfonyl functional groups.117 Poly(acrylic acid) (PAA) has pKa=3 and 
poly(methacrylic acid) (PMAA) has pKa=5–6. Consequently, at neutral pH these 
polymers are expected to show an extended conformation due to repulsion forces. For 
that reason, nanocarriers functionalized with these polymers would avoid the release at 
acid pH, being good candidates for oral drug delivery.107–109 
The examples described so far involve the use of a single type of polymer. However, 
the copolymerization with other polymers provides polymeric coatings with an increased 
span of functionalities. For instance, the introduction of anionic polymers during the 
polymerization allows to tune the hydrophilic/hydrophobic behavior of the final 
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polymer.93,94 In addition, it is also possible to copolymerize monomers showing different 
responsiveness to yield multiresponsive drug carriers.118–121  
 Biological macromolecules that undergo conformational changes 
Some biological macromolecules, such as small peptides, proteins or DNA, undergo 
reversible conformational changes when exposed to heat or changes in pH, ranging from 
a more compact structure to a scattered conformation. This behavior can be used to design 
pulsatile pH-responsive gates to close the pore entrances of mesoporous nanoparticles 
(Figure 2.7). In this sense, it is possible to design pH-responsive gates that open the pores 
when the pH decreases122–125 or when the pH recovers the physiological value, being the 
latter case particularly useful for oral drug delivery.126,127 
 
Figure 2.7. Reversible pH-responsive DNA strands as gatekeepers. At neutral pH the strands remain 
hybridized. However, these strands dehybridize when the pH drops, opening the pores and leading to the 
drug release. When the pH recovers the physiological value again, the strands hybridize again and close the 
pores, hampering the drug release. 
2.1.3. Redox-responsive mesoporous nanoparticles 
Redox species are molecules able to change the oxidation state of atoms of other 
molecules. In particular, the levels of this class of compounds in the cellular cytosol are 
significantly higher than those outside the cell membrane. In addition, the concentration 
of these molecules in tumoral cells is higher than that in healthy tissues. Therefore, it is 
possible to take advantage of these variations to design highly specific stimuli-responsive 
nanocarriers.  
In this section the biological relevance of antioxidants will be stated. In addition, it 
will be described how the overexpression of those antioxidants can be employed to design 
organic and inorganic nanocarriers with redox stimuli-responsive behavior. 
2.1.3.1. The role of glutathione  
Under physiological conditions, there is a balance between the production of ROS and 
that of antioxidants inside the cells. However, in cancer cells ROS levels are significantly 
increased due to some genetic mutations, an altered metabolism and mitochondrial 
Acid pH Physiological pH
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dysfunction. To counteract that, cancer cells present elevated levels of ROS scavengers 
that prevent tumor cells from suffering apoptosis.128  
The most representative antioxidant molecule is the tripeptide GSH (γ-glutamyl-
cysteinyl-glycine). It participates in the metabolism of many molecules, being a free-
radical scavenger, playing a role in cell-cycle regulation or regulating protein function 
and gene expression, among others.129 Interestingly, it also has an important role in cancer 
development and may contribute to increase the resistance to radio- and chemotherapy.130 
It is mainly located in the cytoplasm and mitochondria, although the redox-active nature 
of the endosomal compartment has also been reported (controlled by the gamma-
interferon-inducible lysosomal thiol reductase).131 
It is particularly interesting the fact that glutathione levels in cells vary from 2-10 mM 
in the cytosol to 2-20 µM in the extracellular microenvironment.132 Moreover, the much 
higher presence of its reductive state compared to the reduced one has grabbed the 
attention of many researchers and several examples of nanocarriers sensitive to GSH have 
been reported in the last years.133   
While many pH-responsive moieties are based on protonation-deprotonation 
processes, the design of redox-responsive nanocarriers normally relies on the use of GSH-
cleavable bonds. Redox-responsive systems are usually based on disulfide, diselenide or 
carbon-selenium bonds. Besides, some oxidation-responsive agents such as boronic 
esters, ferrocene or tetrathiafulvalene can also be used to design such carriers.134 In 
particular, the low energy of diselenide and carbon-selenium bonds, compared to their 
disulfide counterpart, makes them more sensitive to both reducing and oxidation agents, 
although the disulfide bond remains the most employed.135 
2.1.3.2. Redox-responsive organic nanocarriers  
Disulfide bonds are particularly useful to synthesize block copolymers from 
hydrophobic and hydrophilic blocks. Then, these polymers can be applied to the design 
of polymeric nanocarriers. For instance, it is possible to synthesize redox-responsive 
micelles that disassemble only inside the cells due to the overexpression of GSH, leading 
to the drug release (Figure 2.8). Examples are the combination of hydrophobic poly(ε-
caprolactone) with PEG,136,137 dextran138 or poly(ethyl ethylene phosphate).139 This 
strategy is useful to design multiresponsive micelles if one of the blocks presents stimuli-
responsive behavior. For instance, the combination of poly(N-isopropylacrylamide) with 
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tetrahydropyran-protected 2-hydroxyethyl methacrylate through disulfide bonds yields 
micelles with sensitivity to heat, pH and redox species.140  
 
Figure 2.8. Schematic representation of the formation and subsequent degradation of micelles formed from 
disulfide bond-containing block copolymers. When the micelles reach the cytosol, the overexpressed GSH 
cleaves the hydrophilic PEG, leading to the disruption of the micelles and the drug release. Reproduced 
from Ref 136 with permission of Elsevier.  
Analogously, there are several examples of redox-responsive polymersomes141–144 and 
polymer capsules145,146 synthesized from disulfide-containing polymers. In this way, the 
nanocarriers show negligible drug release outside the cancer cells. However, when they 
are internalized the overexpression of GSH induces to the disruption of the particle, 
leading to the drug release.  
In addition, the use of redox-cleavable bonds is also interesting for the design of redox-
responsive prodrugs147,148 and polymer-drug conjugates.149–151 In this way, the therapeutic 
agents would become active only inside the cytoplasm of cells and the efficacy of the 
treatment would increase. Gene therapies can also benefit from this stimulus. For 
instance, the design of thiolated polyplexes that release the nucleic acids only in the 
cytoplasm avoids potential degradation and increases the therapy efficacy.152,153 
2.1.3.3. Redox-responsive inorganic nanocarriers 
Many inorganic nanoparticles have been modified with redox-sensitive bonds to 
introduce different functionalities, including magnetic154,155 and gold156,157 nanoparticles, 
quantum dots158 or mesoporous hydroxyapatite,159 among others.  
The main disadvantage of mesoporous nanoparticles is their potential premature 
release owing to their open porous structure. In this sense, the use of a stimulus that only 
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triggers the release inside the cells seems convenient. For such reason, the development 
of redox-labile gatekeepers has attracted much attention. In this way, the pore entrances 
remain closed in the bloodstream, avoiding undesired premature release. However, after 
being internalized the overexpression of GSH triggers the cleavage of the gatekeepers, 
leading to the drug release.  
Much work has been done on MSNs. In this sense, many supramolecular structures 
have been employed to seal the mesopores. The use of disulfide bonds as linkers with the 
surface allows the conjugation of macromolecules whose sizes are big enough to close 
the pores, avoiding the release. Besides, these macromolecules can provide further 
functionalities to the nanocarrier. For instance, the use of β-CD,160,161 collagen,162 PEG,163 
or peptides31,164 introduces targeting possibilities (Figure 2.9). 
 
Figure 2.9. Example of a redox-responsive mesoporous nanocarrier where the gatekeeper is conjugated via 
disulfide bonds. In this case, a peptide acts as gatekeeper and targeting agent at the same time, allowing the 
release once the bond is cleaved in the cytoplasm. Reproduce from Ref 164 with permission of The Royal 
Society of Chemistry. 
Another interesting example is the conjugation of cytochrome c to MSNs through 
disulfide bonds, since it works as gatekeeper and at the same time it generates ROS in the 
cells, triggering their death.165  
This approximation also allows the grafting of small nanoparticles such as gold166 or 
cerium nanoparticles167 to the surface of MSNs. As with micelles, it is possible to use 
disulfide bonds as cross-linking agents in MSNs. Examples are the cross-linking of 
grafted PAA168 or the design of biodegradable MSNs presenting disulfide bonds 
throughout their backbone.169 
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The field of mesoporous carbon materials is still at its early stage and less examples 
are available. Some polymers have been attached to their surface via disulfide bonds, such 
as PEG,170 pluronic171 or PAA.112 Besides, small carbon dots have been connected to the 
surface of mesoporous carbon nanoparticles to act as gatekeepers and trackers of the 
release, since their fluorescence is quenched when coupled to the carbon matrix and 
recovered when the disulfide bond is cleaved.112 
2.1.4. Self-immolative chemistry in nanomedicine 
The challenge when designing stimuli-responsive nanomedicines relies on the moiety 
employed to confer that responsiveness. An interesting approach consists of the so-called 
self-immolative systems, which are macromolecules programmed through their synthesis 
to undergo head-to-tail disassembly into their building blocks in response to certain 
events in a domino-like fashion (Figure 2.10). 
 
Figure 2.10. Schematic representation of the cleavage of a trigger on a self-immolative polymer leading to 
the head to tail disassembly into its building blocks. When the trigger is removed, the electron pair generated 
induces a cascade of electron movements that disassembles the polymer chain in a domino-like fashion.  
Doron Shabat and coworkers laid the foundations of this new chemistry in 2003, when 
they reported for the first time smart self-immolative dendrimers undergoing self-
degradation upon stimulation.172 Later on, they reported an interesting design based on a 
linear polyurethane bearing a protecting group on the terminal amine that acted as trigger. 
Once the protecting group was removed, sequential 1,6-elimination and decarboxylation 
reactions led to the original monomer precursors.173 
In general, Self-Immolative Polymers are produced through a polymerization reaction 
of the appropriate monomer to then cap the terminal head-group of the polymer with a 
specific protecting group, leading to a polymer with a trigger. Then, the selective cleavage 
pH
Light
Enzymes
Redox species
…
Trigger cleavage
Trigger
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of the protecting group would initiate the polymer sequential fragmentation into the 
original building blocks from head to tail. Therefore, the appropriate selection of the 
trigger would allow the design of many different responsive materials.  
In this section some general concepts of self-immolative chemistry will be described, 
including the main properties of self-immolative spacers. Then, the application of self-
immolative chemistry to nanomedicine will be revised, including some examples of 
prodrugs and particle-like polymeric vehicles.  
2.1.4.1. Self-immolative spacers 
The simplest self-immolative moiety is composed of a protecting group linked to a 
spacer, which is also linked to a reporter, that will eventually be released. The reporter 
can be a drug, a dye or a polymeric chain (Figure 2.11). 
 
Figure 2.11. General structure of a self-immolative spacer: A protecting group connected to a spacer which 
is linked to a reporter. The reporter can be a drug, a dye or a polymeric chain.  
The use of self-immolative spacers allows the release of a single molecule upon 
application of a certain stimulus. That stimulus cleaves the protecting group, leading to 
the generation of a free electron pair. Then, an electronic cascade starts, finally leading to 
the release of the reporter (Figure 2.12). 
 
Figure 2.12. Schematic representation of the self-immolation of a self-immolative spacer upon application 
of a stimulus. The cleavage of the trigger and the subsequent electron cascade lead to the release of an 
active reporter. 
From the chemical point of view, the self-immolation process is normally driven by a 
cooperative rise in the entropy along with the formation of thermodynamically stable 
products. Generally speaking, self-immolative spacers can be classified in two main 
SPACER Reporter
Protecting
group
Stimulus
Self-Immolation
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groups, depending on the particular disassembling process: (1) 1,4-,1,6-, or 1,8-
Elimination; or (2) Cyclization.174 Additionally, it is possible to combine both types of 
spacers to tune the degradation rates in self-immolative polymers.175 
1,4-,1,6-, or 1,8-Elimination 
These spacers are based on aromatic species that present electron donor groups in 
ortho or para positions and good leaving groups in benzylic positions. The electron donor 
group (usually amino, hydroxyl or thiol functionalities) normally leads to 1,4- or 1,6-
eliminations. The cleavage of the protecting group initiates the self-immolation, leading 
to a free electron pair. Then, the electron donor group transmits the electron pair to the 
aromatic ring, starting an electronic cascade that leads to the disassembly of the spacer 
(Figure 2.13). 
 
Figure 2.13. Spacers and elimination procedures. a) 1,4-Elimination; b) 1,6-Elimination. The protecting 
group is an electron donor group, normally amino, hydroxyl or thiol functionalities, that initiates the 
electronic cascade, leading to the reporter release.  
Interestingly, in some molecules, such as naphthalene, the 1,8-elimination does not 
lead to the release of the leaving group. Moreover, 1,10-elimination or successive do not 
lead to the release of the leaving group because the electronic cascade does not take place. 
This behavior has not been completely elucidated although some explanations have been 
given. It has been associated to the excessive energy barrier that is necessary to break 
aromaticity and to the repulsion of the ortho-hydrogens that prevents the formation of the 
planar structure necessary for good electron delocalization.174 
Cyclization 
Spacers suffering cyclization are based on lineal alkyl chains or aromatic molecules 
with substituents in ortho. Once the trigger is cleaved, a nucleophilic attack on a carbonyl 
group or an electrophilic aliphatic carbon leads to the cyclization of the spacer, which 
provokes the release of the reporter (Figure 2.14).174 
a) Ortho
b) Para
Protecting group
Leaving group
H
H
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Figure 2.14. Spacers suffering cyclization. a) Attack to carbonyl; b) Attack to aliphatic carbon. The 
protecting group is an electron donor group, normally amino, hydroxyl or thiol functionalities. The cleavage 
of the protecting group initiates the electronic cascade, leading to the reporter release. 
The applicability of the self-immolative molecule will depend on the appropriate 
election of the protecting group. A number of protecting groups useful in clinical 
scenarios have been reported. Those stimuli can be classified in three main groups: (1) 
chemical (hydrogen peroxide or pH); (2) enzymatic; and (3) luminescent (ultraviolet or 
near-infrared light). Table 2.4 summarizes the different types of stimuli-responsive 
protecting groups applied in the design of stimuli-responsive self-immolative spacers.  
Table 2.4.  Stimuli-responsive protecting groups used for the design of self-immolative spacers.  
 
2.1.4.2. Prodrugs based on self-immolative spacers 
Ideally, a prodrug would circulate throughout the body without showing therapeutic 
activity until arriving at the desired area, where it would suffer self-immolation and the 
therapeutic activity would be recovered.  It is also usual the design of prodrug-like 
precursors that are capable of releasing dye molecules. By doing that, it is possible to 
monitor different processes. In this sense, the fluorescence detection indicates that the 
molecule has self-immolated. 
Protecting group
Leaving group
a)
b)
H
COOH
 
Protecting Group Trigger Refs Protecting Group Trigger Refs Protecting Group Trigger Refs 
Chemical Stimulus Enzymatic Stimulus Light Stimulus 
 
H2O2 176–181  
Penicillin G-
Amidase 
182 
 
Ultraviolet 
178,183–
190 
 
 
Acid pH 191–194 
 
 
 
Alkaline 
Phosphatase 
195 
 
Near-
Infrared 
189,190,196 
 
Basic pH 197  Glutathione 
176,183,198–
202 
   
 
Tetrazine 203 
 
Glutathione 204 
   
   
 
Human 
carboylesterase-2 
205 
   
   
 
DT-Diaphorase 206 
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For an enzymatic reaction to happen it is necessary the formation of temporary bonds 
between the substrate and the active site of the enzyme. Then, if an enzyme is to bind a 
substrate, the latter should show adequate accessibility for the active site. In that sense, it 
has been shown that the addition of a self-immolative spacer between the trigger and the 
drug increases the accessibility of the enzyme to the specific substrate. In consequence, 
the introduction of self-immolative fragments leads to higher rates of bioconversion and, 
then, higher therapeutic activity.207  
There are several examples of enzymes that have been utilized in the design of this 
kind of molecules. Cathepsin B is a cysteine protease which is involved in many 
pathologies and oncogenic processes in humans.208 In particular, it is overexpressed in 
the lysosomes of many cancer cells. The self-immolative spacer p-aminobenzyl alcohol 
has been used in combination with various of dipeptides to provide sensitivity to this 
enzyme. For instance, the dipeptides Phe-Lys and Lys-Lys have been used in the design 
of selective prodrug-inspired probes capable of releasing a fluorogenic peptide.209 
Besides, the Phe-Lys combination has shown great efficacy both in vitro and in vivo, 
showing much less toxicity in healthy areas than its active counterpart.210 In order to 
monitor endogenous alkaline phosphatase in living cells, p-hydroxybenzyl alcohol has 
been used as spacer between a phosphate moiety (enzyme substrate) and the dye 
resorufin.195 DT-diaphorase, an enzyme that is overexpressed in some malignant tumors, 
has also been used as enzymatic trigger through self-immolative linkers. In particular, the 
use of a quinone propionic acid-based moiety allows to incorporate two camptothecin 
drug molecules at a time on each prodrug.206 Furthermore, there is an enzyme (human 
carboxyl-esterase-2) that has proved its efficacy in the cleavage of a self-immolative ester 
to provide the active form of the potent anticancer drug platinum-acridine.205 
With regard to self-immolative prodrugs undergoing chemical activation, most of the 
examples involve a conversion mechanism based on the action of GSH, although designs 
sensitive to hydrogen peroxide have also been reported.176 Besides, conjugation of self-
immolative prodrugs with gold nanoparticles has also been described, leading to a system 
with dual drug capability and targeting ability.199 In order to verify the effective drug 
cleavage due to the action of GSH, a dendritic system bearing one molecule of 
camptothecin and one of an inactive dye was reported. When GSH cleaves the trigger, 
both drug and dye are released in their active form, thereby obtaining a light signal only 
if the drug has been released.204 
77
Chapter 2: Stimuli-Responsive Drug Delivery 
Introduction 
 
 
2.1.4.3. Nanocarriers based on self-immolative moieties 
It is very frequent the use of single self-immolative units in order to design prodrug-
like molecules, as it has been mentioned above. Nonetheless, their use is not limited to 
the already mentioned examples, since it is also possible to synthesize several types of 
nanovehicles by using self-immolative fragments in combination with other 
macromolecular structures.  
 Polymer capsules 
In the last few years a number of techniques to synthesize particles or capsules out of 
self-immolative elements have been developed.211 In that sense, the synthesis of self-
immolative microcapsules composed of self-immolative polymers was accomplished in 
2010 for the first time (Figure 2.15).194 
 
Figure 2.15. Microcapsule synthesized from self-immolative polymers. The cleavage of the trigger initiates 
the self-immolation, inducing the disruption of the wall and leading to the drug release. Reproduced from 
Ref 194 with permission of American Chemical Society.  
The presence of triggering units throughout the wall led to the disruption of the carrier 
and the release of the cargo upon application of the triggering conditions. Afterward, other 
design of self-immolative polymer was formulated as nanoparticles. In this case, the 
nanocarrier was sensitive to both ultraviolet and near-infrared light (instead of to strong 
acid or base, as in the first example) and then, the applicability of these nanocarriers in 
biological scenarios was evaluated.212 Furthermore, more examples comprising other 
designs of self-immolative polymers sensitive to various wavelengths have also been 
reported.188–190 The introduction of aryl boronic esters within the polymer chain has led 
to multiple designs of hydrogen peroxide responsive polymer nanoparticles.180,181,213 
Moreover, dual stimuli-responsive polymer nanoparticles have also been published, 
including pH and light192,193 or hydrogen peroxide and pH.179 Finally, heat-responsive 
polymer nanoparticles have been recently reported. Upon heating, the carrier undergoes 
a retro-Diels Alder reaction that leads to a furfuril carbamate that suffers elimination, thus 
inducing the degradation of the carrier.214  
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 Polymeric micelles and polymersomes 
Self-immolative chemistry finds broad application in the synthesis of polymeric 
micelles and polymersomes. These nanocarriers self-assemble spontaneously from linear 
structures to three dimensional polymeric particles. In this sense, many self-immolative 
molecules have been used to synthesize block copolymers. The polymers rearrange in 
water and are stable until some stimulus is applied. When that happens the self-
immolation starts, leading to the disassembly of the block copolymer and subsequent drug 
release. The use of self-immolative moieties facilitates the destabilization of the 
polymeric carrier because, ideally, a single event may lead to the degradation of a large 
self-immolative block. 
There several approximations to construct self-immolative polymeric micelles. The 
general design normally comprises two polyethylene glycol blocks with a self-immolative 
fragment within them. It is common the use of a self-immolative block containing 
multiple triggering points along the chain. In that sense, disulfide containing 
polycarbonates186 as well as hydrogen peroxide-responsive poly(amino ester)s187 have 
been used as building blocks for the hydrophobic component (Figure 2.16). It is also 
possible to have just one triggering point. For instance, such design can be found in 
micelles formed from amphiphilic polymers containing a poly(ethyl glyoxylate) 
undergoing head-to-tail depolymerization.178 
 
Figure 2.16. Redox-responsive polymeric micelle. The hydrophobic block contains periodic disulfides 
bonds that are cleaved by the overexpressed GSH in the cells, leading to the disassembly and the drug 
release. Reproduce from Ref 186 with permission of American Chemical Society. 
The use of pendant self-immolative groups185 or linear self-immolative 
polycarbamates183 within the hydrophilic segments allows to synthesize light-responsive 
polymersomes. In addition to light, enzymes have been used to trigger the disassembly of 
self-immolative polymeric vesicles capable of addressing antimicrobial resistance in 
vitro.182 
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 Nucleic acid-based nanoparticles 
There are particular three-dimensional arrangements of nucleic acids with improved 
properties that their linear or circular counterparts do not show, such as better cell 
internalization or stability against enzyme degradation. In this sense, it is possible to 
engineer amphiphilic blocks composed of hydrophilic DNA and a hydrophobic fragment 
containing hydrophobic drugs connected through a self-immolative linker. In this way, 
the DNA-drug complex rearranges in water and forms a micelle. The self-immolative 
linker is cleaved in the tumoral cells, leading to the self-immolation and subsequent drug 
release (Figure 2.17). Examples are the use of light-184 and reductive-202 responsive self-
immolative moieties to synthesize the amphiphilic block. 
 
Figure 2.17. Micelle formed from a DNA block (hydrophilic) conjugated to the drug camptothecin 
(hydrophobic). The complex rearrange in water and disassembles when the stimulus is applied, leading to 
the self-immolation and subsequent drug release. Adapted from Ref 184 with permission of American 
Chemical Society.  
Moreover, it is also possible the combination of miRNA with polymeric prodrugs201 
or polymer chains bearing pendant prodrugs200 to yield particle-like polyplexes. The main 
advantage is that it is possible to transport drugs, in their active or inactive form, that, 
once the stimulus is applied, are released in combination with different nucleic acids, 
which also show therapeutic efficacy and biocompatibility. 
2.1.5. Conclusions 
This section has introduced several examples of nanoparticles responsive to either pH 
or GSH, which are known to be relevant biomarkers found in tumoral scenarios. Besides, 
it has been shown that self-immolative chemistry constitutes a powerful tool for the 
design of structures sensitive to either internal or external stimuli with application in 
nanomedicine. In this sense, the main purpose of this PhD thesis has been the design of 
Stimulus
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self-immolative structures and their application to mesoporous nanoparticles. In this 
manner, the combination of the excellent physical-chemical properties mesoporous 
nanocarriers with the tunability of self-immolative chemistry has led to the development 
of various nanocarriers with potential applicability to various diseases, such as cancer.  
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2.2. Self-Immolative Polymers as Novel pH-Responsive 
gatekeepers for Mesoporous Silica Nanoparticles 
2.2.1. Introduction 
This first piece of research consisted in developing a smart stimuli-responsive drug 
delivery system using mesoporous silica nanoparticles as carriers and a polymeric coating 
as gatekeeper. 
Mesoporous silica nanoparticles were synthesized following a modification of the 
well-known Stöber method and their successful synthesis was verified through several 
characterization techniques. 
Regarding the responsive behavior, pH was selected as trigger owing to the differences 
found through the organism. Then, the gatekeeper should be able to change its 
conformation upon variations in pH. In this sense, the possibility of using a self-
immolative polymer to obtain such behavior was explored. The idea was to use a polymer 
that would maintain its integrity at physiological pH, and when exposed to an acid 
environment it would disassemble into its functional units. 
The synthesis of the here employed self-immolative polymer involved many 
modifications of a previously reported method. The monomer was easily synthesized but 
the polymerization required several attempts. During this process, two main interrelated 
challenges were found: (1) being able to introduce a significant amount of pH-responsive 
trigger into the polymeric chain and (2) being able to synthesize a polymeric chain long 
enough to close the mesopores. For such reason, three different protocols were developed 
and, finally, a synthetic pathway that yielded ca. 100% of the chains bearing the trigger 
was obtained.  
The surface coating was performed in two steps. First, the surface of the particles was 
modified with a chloro alkoxysilane that would act as a linker. Then, the polymer was 
added and the final material was characterized through different techniques.  
A summary of the synthetic work carried out here and the hypothesized pH-responsive 
behavior is depicted in Scheme 2.2. 
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Scheme 2.2. Schematic representation of the synthesis of the polymer-coated nanoparticles and their pH-
responsive evaluation. The nanoparticles were synthesized using the sol-gel method. The template was 
removed to yield hollow mesopores. Then, the surface was modified with a linker and the particles were 
loaded with a model fluorophore to then graft the polymer on the surface. Finally, the pH-responsiveness 
was evaluated at two representative pH values.  
Once synthesized, the particles were loaded with a ruthenium complex and an in vial 
release experiment was carried out to test the pH-responsiveness. The experiment was 
performed at two pH values, 7.4 (physiological pH) and 5 (lysosomal pH). 
Finally, some preliminary biological experiments were carried out. The behavior of 
the system with healthy cells was evaluated to determine the potential intrinsic 
cytotoxicity of the material. Then, their ability to be internalized by tumoral cells was 
evaluated using prostate cancer cells.   
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2.2.2. Materials and Methods 
The following compounds were purchased from Sigma-Aldrich Inc.: Tetraethyl 
orthosilicate (TEOS); Ammonium nitrate; Cetyltrimethylammonium bromide (CTAB); 
Fluorescein isothiocyanate isomer I (FITC); 3-(Aminopropyl)triethoxysilane (APTES); 
4-Aminobenzyl alcohol (ABA); Phenyl chloroformate; N,N-Diisopropylethylamine 
(DIPEA); Dibutyltin dilaurate (DBTL); tert-butanol (tBuOH); 4-Dimethylaminopyridine 
(DMAP); Tris(2,2’-bipyridyl)dichlororuthenium(II) hexahydrate (Ru) ; (3-
chloropropyl)triethoxysilane; Di-tert-butyl dicarbonate (BOC2O); Dimethyl sulfoxide 
(DMSO); N,N-Dimethylformamide (DMF); Tetrahydrofuran (THF); Dichloromethane 
(DCM). The rest of the chemicals (ethanol, heptane, etc) were of the best quality and were 
employed as received. 
2.2.2.1. Mesoporous Silica Nanoparticles 
Mesoporous silica nanoparticles were synthesized following a modification of the 
Stöber method.1 Briefly, to a 1L flask containing CTAB (1 g, 2.74 mmol), H2O (480 mL) 
and NaOH (3.5 mL) were added and the solution was stirred until the surfactant was 
dissolved. Then, the solution was heated to 80ºC and TEOS (5 mL, 22.39 mmol) was 
added dropwise over 20 minutes. Afterward, the solution was heated for further 2 hours 
at 80ºC under magnetic stirring. Finally, the precipitate was centrifuged and washed twice 
with water and once with ethanol.  
The surfactant was removed by ionic exchange using 500 mL of a solution of 10 
mg/mL of NH4NO3 in ethanol (95%) at 75C for 2 hours. The process was repeated two 
more times. Finally, the nanoparticles were centrifuged, washed twice with water and 
once with ethanol and subsequently stored in absolute ethanol.  
To synthesize fluorescein-labeled MSNs (MSN-F), FITC (1 mg, 0.002 mmol) was 
reacted with APTES (2.2 μL, 0.009 mmol) in ethanol (40 µL) for 2 hours. Then, TEOS 
was added and the whole solution was gently shaken. After that, the procedure was carried 
out as previously described. 
The as-produced particles were characterized in terms of X-Ray Diffraction (XRD), 
Fourier Transformed Infrared (FTIR) spectroscopy, Thermogravimetric Analysis (TGA 
analysis) N2 adsorption analysis, Scanning Electron Microscopy (SEM), Transmission 
Electron Microscopy (TEM), Dynamic Light Scattering (DLS) and Zeta potential. 
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2.2.2.2. pH-Responsive Self-Immolative Polymers 
 Phenyl(4-(hydroxymethyl)phenyl)carbamate (1) 
To a N2-purged flask containing ABA (1 g, 8.12 mmol), dry DMF (15 mL) and dry 
DIPEA (1.7 mL, 9.76 mmol) were added and the solution was magnetically stirred until 
the powder was completely dissolved. Then, the flask was placed in an ice bath and 
phenyl chloroformate (1.12 mL, 8.83 mmol) was added dropwise. After 15 minutes the 
ice bath was removed and the reaction was controlled to completion by thin layer 
chromatography. Afterward, the organic phase was extracted in ethyl acetate, washed 
with saturated ammonium chloride solution and finally dried over sodium sulfate. Finally, 
the solvent was partially removed and the resultant solution was precipitated in cold 
heptane and centrifuged twice to yield compound 1 as a whitish solid that was dried under 
vacuum. The product was characterized by 1H-NMR. 
 Tert-butyl(4-(hydroxymethyl)phenyl)carbamate (2) 
To a N2-purged flask containing ABA (1 g, 8.12 mmol) and BOC2O (1.8 g, 8.12 
mmol), dry THF (80 mL) and dry DIPEA (1.4 mL, 8.12 mmol) were added and the 
solution was stirred until the powder was completely dissolved. Then, the mixture was 
refluxed overnight and subsequently evaporated to yield a yellow oil. The oil was 
dissolved in a small amount of ethyl acetate and precipitated in cold heptane to yield 
compound 2 as a whitish solid, which was filtered off and dried under vacuum. The 
product was characterized by 1H-NMR. 
 Poly(phenyl(4-(hydroxymethyl)phenyl)carbamate) (3) 
The synthesis of compound 3 was attempted through various synthetic pathways based 
on a previously reported method.2 Protocol A and B were carried out for 150 mg of 
monomer while protocol C was adapted to 1 g of starting material.  
Protocol A: To a N2-purged vial containing compound 1 (0.15 g, 0.618 mmol), dry 
DMSO (0.5 mL) was added and the solution was heated to 80ºC under magnetic stirring. 
Then, DBTL (13% mol with respect to 1) was added and the reaction mixture was 
subsequently stirred for 90 minutes at 80ºC. Then, dry DMSO (1.5 mL) and tBuOH (1.5 
mL, 18 mmol) were mixed in a N2-purged vial and the mixture was added in 6 times (0.5 
mL of the mixture each time). Afterward, the reaction was further stirred for 2 hours and 
finally allowed to cool down to room temperature (rt). After that, the mixture was 
precipitated in cold methanol, centrifuged and washed 3 times with methanol to yield 
compound 3 as a dark yellow solid that was dried under vacuum.  
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Protocol B: To a N2-purged vial containing compound 1 (0.15 g, 0.618 mmol), dry 
DMSO (0.5 mL) was added and the solution was heated to 80ºC with stirring. Then, 
DBTL (5% mol) was added and the reaction mixture was subsequently stirred for 90 
minutes at 80ºC. Then, to a N2-purged vial containing different amounts DMAP and dry 
DMSO (1 mL), different amounts of tBuOH were added.  This vial was added to the 
initial reaction mixture in several steps. Afterward, the reaction was further stirred for 2 
hours and, finally, it was allowed to cool down to rt. After that, the mixture was 
precipitated in cold methanol, centrifuged and washed 3 times with methanol to yield 
compound 3 as a dark yellow solid that was dried under vacuum. 
Protocol C: To a N2-purged vial containing compound 1 (1 g, 4.12 mmol), dry DMSO 
(1.62 mL) was added and the solution was heated to 85ºC with stirring. Then, DBTL (5% 
mol) was added and the reaction mixture was subsequently stirred for 2h 30 minutes at 
85ºC. After that, compound 2 (223 mg, 1 mmol) in dry DMSO (0.5 mL) was injected and 
the solution was heated for further 2 hours. Finally, the crude reaction mixture was 
precipitated in cold methanol, centrifuged and washed 3 times with methanol to yield 
compound 3 as a yellowish solid that was dried under vacuum.   
The compounds obtained through the different approximations were all characterized 
by 1H-NMR. 
2.2.2.3. SIP-Coated Mesoporous Silica Nanoparticles 
 Mesoporous Silica Nanoparticles Functionalized with (3-chloropropyl) triethoxysilane (MSN-
CS) 
First, to a N2-purged flask containing MSNs (175 mg), dry toluene (30 mL) was added 
and the solution was sonicated until no aggregates could be observed. Then, (3-
chloropropyl)triethoxysilane (100 µL, 0.04 mmol) was added and the mixture was 
refluxed overnight. After that, the particles were centrifuged, washed with toluene and 
ethanol and dried under vacuum.  
 SIP-Coated Mesoporous Silica Nanoparticles (MSN-CS-SIP) 
First, to a N2-purged flask containing MSN-CS (175 mg), dry DMSO (25 mL) was 
added and the particles were dispersed with the aid of an ultrasonicator. Separately, to a 
N2-purged flask containing compound 3 (0.33 g, 0.1 mmol), dry DMSO (2.5 mL) and dry 
DIPEA (25.6 µL, 0.15 mmol) were added and the solution was stirred for 2 hours for 
alcohol activation. After that, the latter solution was added dropwise to the nanoparticles 
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solution and the mixture was heated to 80ºC. Afterward, a second vial containing 
compound 3 in DMSO was activated for 2 hours with dry DIPEA and subsequently added 
to the nanoparticles solution. Finally, a third vial containing compound 3 in DMSO was 
activated with dry DIPEA and added to the nanoparticles solution. After the third addition 
of activated compound 3, the whole reaction mixture was allowed to react overnight at 
80ºC. Finally, the product was centrifuged, thoroughly washed with DMSO, water and 
ethanol and dried under vacuum. 
Both materials were characterized in terms of XRD, FTIR spectroscopy, TGA analysis 
N2 adsorption analysis, DLS and Zeta potential. 
2.2.2.4. Release Experiment from MSN-CS-SIP 
 MSN-CS-SIP Loaded with Ru (MSN-CS-SIP-Ru) 
First, to a N2-purged flask containing MSN-CS (175 mg), a solution of Ru (260 mg, 
0.33 mmol) in dry DMSO (25 mL) was added and the solution was stirred overnight at 
rt. After that, the functionalization with the SIP was carried out as described in Section 
2.2.2.3. A control group without SIP coating was prepared soaking MSNs in a saturated 
solution containing the Ru dye (MSNs-Ru). 
 Release Experiments 
The pH-responsive capabilities of MSNs-Ru and MSN-CS-SIP-Ru were tested in vial 
using Transwells® and at two different pH values: 7.4 (0.01 M phosphate buffer) and 5 
(0.01 M acetate buffer). The general protocol was carried out as follows. A vial containing 
10 mg of the corresponding group of particles was prepared for each pH (two vials of 10 
mg for either MSNs-Ru or MSN-CS-SIP-Ru). Then, 1.8 mL of phosphate buffer (pH 7.4) 
were added to each vial. After that, 0.5 mL of nanoparticles suspension (ca. 3 mg of 
particles) were placed on a Transwell® permeable support with 0.4 µm of polycarbonate 
membrane. Three Transwell® support were prepared from each vial (6 Transwell® in 
total for either MSNs-Ru or MSN-CS-SIP-Ru). The external well was filled with 1.5 mL 
of phosphate buffer (pH 7.4) and the suspension was kept under orbital shaking at 100 
rpm and 37oC for all the experiment. After 2 hours, the phosphate buffer (pH 7.4) of three 
of the Transwell® was replaced by the acetate buffer (pH 5). The group at pH 5 received 
this solution for the rest of the experiment. At every time point evaluated, the solution 
from the external well of the Transwell® was taken out, measured by fluorescence 
spectrometry to determine the amount of Ru released and replaced with the corresponding 
fresh medium 
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2.2.2.5. Cell Experiments 
 Cell Cultures 
Cell culture tests were performed using the well-characterized mouse osteoblastic cell 
line MC3T3-E1 (subclone 4, CRL-2593) and an androgen-sensitive LNCaP cells, a 
human prostate cancer cell line (CRL-1740; ATCC). MC3T3-E1 and LNCaP cells were 
then plated at a density of 20,000 cells cm2 in 1 mL of alfa-minimum essential medium 
or Dulbecco’s modified Eagle’s medium (DMEM, Sigma Chemical Company), 
respectively, containing 10% of heat-inactivated fetal bovine serum (FBS, Thermo Fisher 
Scientific) and 1% penicillin–streptomycin (BioWhittaker Europe) at 37ºC in a 
humidified atmosphere of 5% CO2. Then, nanoparticles were placed at different 
concentrations and incubated for different periods of time.  
 Cell Viability  
Cell proliferation was determined by addition of Alamar Blue solution (AbD Serotec) 
at 10% (v/v) to the cell culture at 24, 48 and 72 hours, following manufacturer 
instructions. After 4 hours, 200 µL aliquots were added to 96-well plates, and the 
absorbance intensity was measured using excitation emission wavelengths of 570 and 600 
nm, respectively, in a Unicam UV-500 UV–visible spectrophotometer. 
 Internalization studies 
For the fluorescence microscopy, LNCaP cells were incubated with the nanoparticles 
(100 µg/mL) for 2h in serum-free culture medium. Then, the medium was withdrawn and 
cells were washed with phosphate buffered saline (PBS) three times. Cells were fixed 
with ethanol for 2 min and stained with DAPI. Fluorescence microscopy was carried out 
in order to evaluate nanoparticle uptake. Green channel was used for nanoparticles and 
blue for cell nucleus, in a Evos FL Cell Imaging System equipped with tree Led Lights 
Cubes (lEX (nm); lEM (nm)): DAPI (357/44; 447/60), GFP (470/22; 525/50), RFP 
(531/40; 593/40) from AMG (Advance Microscopy Group). 
2.2.3. Results and Discussion 
2.2.3.1. Synthesis of Mesoporous Silica Nanoparticles  
The synthesis of MSNs was accomplished through a modification of the Stöber 
method.1 In particular, MSNs were synthesized using the sol-gel method under basic and 
very diluted conditions, employing CTAB as structure directing agent and TEOS as silica 
precursor. The template was removed by solvent extraction to obtain empty pores 
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(Scheme 2.3). The as-produced nanoparticles were characterized through TGA, XRD, 
FTIR spectroscopy, N2 adsorption analysis, SEM, TEM, DLS and Zeta potential.  
 
Scheme 2.3. Schematic representation of the synthesis of mesoporous silica nanoparticles. The silica 
precursor was added to the self-assembled surfactant molecules to form the silica backbone. Then, the 
template was removed using a solvent extraction to yield mesoporous silica nanoparticles with empty pores.  
The produced nanoparticles were analyzed through TGA analysis to ensure the correct 
removal of the surfactant and to determine the amount of residual surfactant present 
within the pores after the extraction (Figure 2.18).  
 
Figure 2.18. TGA measurement of MSNs and MSN-CTAB. The as-produced (MSN-CTAB) showed ca. 
40% of weight loss associated to the presence of the template. The successive extraction steps yielded 
nanoparticles showing ca. 3% of weight loss, confirming the correct template removal.  
Figure 2.18 shows ca. 40% of weight loss in the as-produced nanoparticles, indicating 
the presence of the surfactant template filling the pores. However, after carrying out 
several extraction steps, only ca. 3% of weight loss could be observed, confirming the 
successful extraction and yielding nanoparticles with empty pores.   
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The correct removal of the template as well as the proper formation of the silica 
backbone was determined through FTIR spectroscopy measurements (Figure 2.19).  
 
Figure 2.19. FTIR spectroscopy before and after the template removal. The presence of the C-H band in 
MSN-CTAB indicated the presence of the organic template. The indicated bands in MSNs demonstrated 
the proper hydrolysis, condensation and polymerization processes of the silica precursor and the presence 
of silanol groups on the surface. The disappearance of the C-H vibration bands confirmed the template 
removal. 
Figure 2.19 shows the representative stretching (δ) and bending (ν) bands of the as-
produced material. The presence of the C-H vibration bands in MSN-CTAB indicated the 
presence of the organic template within the pores. However, after carrying out several 
extraction steps, that bands disappeared in MSNs, confirming again the successful 
template removal. Furthermore, the Si-O-Si vibration bands confirmed the proper 
hydrolysis, condensation and subsequent polymerization of the silica precursors during 
the synthesis, leading to a network of Si-O-Si bonds as backbone. In addition, the Si-OH 
bands confirmed the expected presence of silanol groups on surface of MSNs. 
The structure of the MSNs was determined through XRD measurements. These 
materials are composed of amorphous silica. This means that they are amorphous on an 
atomic level.  However, their porosity present certain symmetry and this is why the XRD 
are carried out at low angle (Figure 2.20). 
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Figure 2.20. XRD diffractogram of MSNs. The maxima obtained demonstrated the hexagonal pore 
symmetry, as expected in a MCM-41-like material.  
The maxima shown in the diffractogram, ([100], [110] and [200]), confirmed the 
hexagonally ordered pore distribution with p6mm spatial group typical of MCM-41-like 
materials.3,4  
MSNs were subjected to N2 adsorption analysis to determine the textural properties, 
including the morphology and size of the above-confirmed honeycomb-patterned pores. 
(Figure 2.21). 
 
Figure 2.21. N2 adsorption analysis of MSNs. The type-IV isotherm confirmed the presence of cylindrical 
mesopores with a diameter of ca. 2.7 nm.  
The N2 adsorption analysis confirmed the excellent textural properties of this kind of 
material, showing a surface area of ca. 1000 m2/g and pore width and volume of 2.74 nm 
and 1.05 cm3/g, respectively. The pore size would allow the loading of therapeutic 
compounds, such as the typical anticancer drugs.5 The shape of the isotherm provides 
structural information about the material. According to the IUPAC classification, Figure 
2.21 showed the type-IV isotherm typical of mesoporous materials,6 although some 
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authors consider this type of isotherm where hysteresis can barely be observed as type-
IVc isotherm.7 In addition, MSNs mainly presented a highly ordered distribution of 
cylindrical mesopores (2 nm < pore size < 50 nm).8,9  
The morphology of MSNs was observed through different electron microscopy 
techniques (Figure 2.22). 
 
Figure 2.22. Micrographs of MSNs. a) SEM. b) TEM. The observations under the electronic microscopes 
demonstrated the nearly spherical homogeneous shape and the porosity of MSNs. 
The observation of the MSNs through the SEM and TEM microscopes confirmed the 
almost spherical and homogeneous shape of the particles with size of ca. 160-190 nm. In 
addition, it could be observed that the particles were well dispersed. Moreover, the 
analysis through the TEM microscope demonstrated the presence of porosity in the as-
synthesized nanoparticles.  
The surface charge of MSNs was analyzed through Zeta potential measurements. 
Silanol groups on the surface of MSNs are deprotonated at neutral pH, so a negative value 
for surface charge was expected. In this sense, the measurements on MSNs yielded a 
value of -35.3 mV, confirming the chemical nature of this material.  
The size distribution of MSNs in aqueous solution was analyzed through DLS 
measurements (Figure 2.23). 
 
Figure 2.23. DLS measurements of MSNs. The analysis showed a homogenous distribution centered at 
220 nm and well dispersed, in agreement with the electronic micrographs.  
a) b)
MSNs
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As observed in Figure 2.23, the distribution was centered at ca. 220 nm. The DLS 
technique provides the hydrodynamic size of the particles because the water molecules 
bind their surface. In consequence, the size distribution was centered at slightly higher 
values than the observed in the electronic micrographs. In addition, there were no 
aggregates, confirming the suitability of the particles for their biological application.   
2.2.3.2. Synthesis of pH-Responsive Self-Immolative Polymers  
The synthesis of the SIPs was based on the use of ABA as building block. This 
molecule has been widely explored in the design of prodrugs owing to their self-
immolative properties.10–12 The synthesis of compound 1 was accomplished 
straightforwardly through the reaction of ABA with phenyl chloroformate. The 
compound was characterized through 1H-NMR (Figure 2.24). 
 
Figure 2.24. The presence of the expected signals confirmed the correct synthesis of compound 1. (250 
MHz, DMSO) δ 10.20 (s, 1H), 7.25-7,45 (m, 9H), 5.12 (t, 1H), 4.45 (d, 2H). 
The synthesis of the polymer was accomplished through modifications of a previously 
reported method.2 The polymerization was based on the addition of the alcohol group of 
one monomer to the carbamate of another monomer. This process was catalyzed by 
DBTL, which is a catalyst widely used in the synthesis of polyurethanes.13  
Different experimental conditions in terms of monomer and catalyst concentrations 
were evaluated to produce polymer chains with different lengths. Additionally, different 
solvents were also evaluated, such as N,N-dimethylformamide and dimethyl sulfoxide. 
When using the former, the polymer tended to precipitate during the reaction, leaving the 
latter as best candidate.  
It was observed that for a fixed monomer concentration, the higher the amount of 
catalyst, the lower the molecular weight of the polymer. The reason for that was that a 
high catalyst concentration would lead to several polymer chains starting at the same time. 
1
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In consequence, less single monomers would be available to be sequentially incorporated 
into each polymer chain, and the molecular weight would be lower.  
Moreover, it was observed that there was a lower limit for the catalyst concentration, 
below which the polymer could not be synthesized regardless of the temperature or the 
reaction time. This was ascribed to a too low amount of monomers activated as a 
consequence of a too low presence of the catalyst in the medium. 
The incorporation of the pH-responsive trigger was explored through three different 
approximations (Scheme 2.4).  
 
Scheme 2.4. Strategies for the incorporation of the pH-responsive trigger. Left: Direct addition of tert-
butanol (protocol A); Center: Activation of tBuOH with DMAP (protocol B); Right: Triggering monomer 
(protocol C). 
The initial approach (Protocol A) consisted in following the previously reported 
method,2 which was based on the direct addition of tBuOH to end-cap the preformed 
polymeric chain. Despite several experimental conditions were explored, such as adding 
the trigger in several steps or increasing the total amount of tBuOH, the maximum amount 
of the molecule that could be incorporated was 15%. This value was determined using 
1H-NMR (Figure 2.25).  
1. DBTL and Polymerization
+
2. Trigger incorporation
3
1
2
Protocol A Protocol B Protocol C
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Figure 2.25. 1H-NMR of compound 3 synthesized through protocol A. (250 MHz, DMSO) δ 9.82 (s, 10H), 
7.56-7.15 (m, 49H), 5.15(s, 23H), 4.43 (d, 2H), 1.48 (s, 1H). The ratio between integrals of peaks 2 and 1 
provided the number of monomers in the chain. Signal 4 integral provided the amount of trigger 
incorporated. 
The low percentage of trigger grafting might be ascribed to the low reactivity of the 
alcohol group from tBuOH. Hence, the possibility of pre-activating it with a base prior to 
the addition was explored (Protocol B). Different amounts of DMAP and tBuOH were 
employed, increasing the trigger presence up to 40% (Figure 2.26).  
 
Figure 2.26. 1H-NMR of compound 3 synthesized through protocol B. (250 MHz, DMSO) δ 9.82 (s, 13H), 
7.56-7.15 (m, 63H), 5.15(s, 30H), 4.43 (d, 2H), 1.48 (s, 4H). The amount of trigger incorporated was 
calculated in a similar way than in Figure 2.25. 
In view of this results, the next approach (Protocol C) consisted in producing an analog 
of compound 1 with the trigger already incorporated. Compound 2 was obtained through 
the reaction of ABA with BOC2O and the product was characterized by 
1H-NMR, 
confirming the successful synthesis of the monomer with the trigger already incorporated 
(Figure 2.27).  
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Figure 2.27. The presence of the expected signals verified the success of the synthesis of compound 2. (250 
MHz, DMSO) δ 9,29 (s, 1H), 7.17-7,41 (m, 4H), 5.05 (t, 1H), 4.40 (d, 2H), 1,48 (s, 9H). 
In this way, the trigger and the monomers would show the same reactivity and it would 
be more easily introduced as end-cap for the polymer chains. This approximation yielded 
self-immolative chains with ca. 100% of the chains bearing the pH-responsive moiety 
(Figure 2.28). 
 
Figure 2.28. 1H-NMR of compound 3 synthesized through protocol C. (250 MHz, DMSO) δ 9.82 (s, 19H), 
7.56-7.15 (m, 96H), 5.15(s, 41H), 4.43 (d, 2H), 1.48 (s, 9H).  
The molecular weight was calculated from the 1H-NMR spectrum. The number of 
monomer units per polymer chain was determined through the ratio “benzylic hydrogens 
at the molecule tail vs those in the polymeric chain”. An average synthesis led to SIPs 
with ca. 20 units, which translated into a molecular weight of ca. 3,300 g/mol. 
It was found that when the SIPs produced using Protocol C presented more than 20-
25 units before the addition of compound 2, the process of end-capping reduced the final 
number of monomers to ca. 20 units (Figure 2.29). 
1
2
3
3
12
DMSO
H2O
Aromatics
4
4
H2O DMSO
1
2
3
4
112
Chapter 2: Stimuli-Responsive Drug Delivery 
Self-Immolative Polymers as Novel pH-Responsive Gatekeepers for Mesoporous Silica Nanoparticles 
 
 
Figure 2.29. Effect of the addition of compound 2 (Protocol C) on chains presenting n > 20-25 units. It was 
observed that for this sizes, the addition of the trigger decreased the final molecular weight of the polymer.  
The reason for that might be that for a longer polymer chain, it would be more difficult 
for the trigger to react at the end of the chain, being easier the attack somewhere along 
the chain, leading to two separated chains, some of the bearing the pH-responsive 
fragment. Consequently, it was possible to cap all the polymer chains with a pH-
responsive moiety, although those chains were not particularly large. 
In a final step, the as-produced SIP was exposed to trifluoroacetic acid, which is known 
to cleave BOC-protected amines, to evaluate its response to acid environment. Figure 
2.30 shows the 1H-NMR of the SIP before and after acid treatment.  
 
Figure 2.30. Verification of the pH-sensitivity of compound 3. a) 1H-NMR of compound 3. b) 1H-NMR of 
compound 3 treated with trifluoroacetic acid (TFA). The acid environment induced the degradation of the 
polymer and the signals observed for the SIPs were lost.  
As observed in Figure 2.30, the structure of the polymer was completely lost after few 
drops of trifluoroacetic acid, which could be ascribed to the expected self-immolation 
process. This observation confirmed the responsive behavior to acid pH of the self-
immolative chain here produced. 
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2.2.3.3. Synthesis of SIP-Coated Mesoporous Silica Nanoparticles 
The functionalization of the MSNs with the pH-responsive self-immolative coating 
was carried out following a two-step synthetic strategy based on activating the surface of 
the MSNs and then anchoring the SIPs (Scheme 2.5). 
 
Scheme 2.5. Schematic representation of the two-step process for the coating of the MSNs with the SIPs. 
First, the nanoparticles surface was modified with a chloro alkoxysilane (MSN-CS) to then graft the SIP, 
leading SIP-coated MSNs (MSN-CS-SIP).  
First, a chloro alkoxysilane linker was anchored to the surface to activate the surface 
of MSNs. Once verified its successful grafting, the alcohol group of the polymer was 
activated with DIPEA, added to the nanoparticles and allowed to react to accomplish a 
Williamson etherification.14 Both processes, MSNs activation to produce MSN-CS and 
SIP grafting to obtain MSN-CS-SIP, were confirmed through different characterization 
techniques. 
The effect of the successive functionalization steps on the ordered mesostructure was 
evaluated through XRD measurements (Figure 2.31). 
 
Figure 2.31. XRD diffractogram of MSNs, MSN-CS and MSN-CS-SIP. The typical diffraction pattern of 
a MCM-41-like material could be observed in MSN-CS and MSN-CS-SIP, indicating the preservation of 
the ordered porosity after the subsequent functionalization steps.  
As shown in Figure 2.31, the diffraction pattern obtained for MSNs was still 
observable in the functionalized samples. This indicated that the mild synthetic protocols 
employed for the subsequent functionalization maintained the hexagonally ordered 
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porosity of the starting material. Moreover, the maxima intensity decreased as the degree 
of functionalization increased. This could be ascribed to the partial filling of the pores 
owing to the grafting of the chloro alkoxysilane and the SIPs within them.15 
All materials were subjected to TGA analysis to determine the amount of additional 
organic matter incorporated in the samples after the different modification steps (Figure 
2.32).  
 
Figure 2.32. TGA analysis of MSNs, MSN-CS and MSN-CS-SIP. The functionalization of MSNs with the 
alkoxysilane introduced an additional 9% of organic matter. The modification with the SIPs increased the 
weight loss up to 15%, confirming the success of the functionalization steps.  
Figure 2.32 shows that the modification of MSNs with the alkoxysilane led to an 
increment of ca. 9% in the weight loss. The subsequent addition of the self-immolative 
coating increased the weight loss up to ca. 15%, compared to their pristine counterpart. 
These observations confirmed the presence of additional organic matter on the surface 
that was ascribed to the presence of the SIPs. The presence of organic matter was further 
analyzed through elemental analysis. The amount of N in MSN-CS-SIP was found to be 
0.53%, which was significantly higher than that observed in the MSNs (0.06%), 
confirming the presence of the polymeric coating. The samples were analyzed through 
FTIR spectroscopy to evaluate whether the successive functionalization steps introduced 
new functional groups in the nanoparticles (Figure 2.33). 
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Figure 2.33. FTIR spectroscopy of MSNs, MSN-CS and MSN-CS-SIP. The presence of C-H vibration 
bands at 2900 cm-1 confirmed the successful grafting of the alkoxysilane. The incorporation of the polymer 
was validated through the presence of the C-O stretching vibration at 1650 cm-1, ascribed to the carbamates 
from the polymer chain.  
The successful preparation of MSN-CS was confirmed by the presence of the 
stretching band C-H at 2900 cm-1 associated to the CH2 groups of the organosilane. The 
subsequent functionalization of MSN-CS with the polymer was confirmed by the 
presence of the C-O stretching vibration at 1650 cm-1, ascribed to the carbamate groups 
of the polymeric chain. 
The effect of the surface modification with the organosilane and the subsequent SIP 
grafting on the textural properties of the samples was determined through N2 adsorption 
(Figure 2.34). 
 
Figure 2.34. N2 adsorption analysis of MSNs, MSN-CS and MSN-CS-SIP. Inset: Pore size distribution. 
Both functionalization steps decreased the specific surface area, especially after grafting the SIPs, which 
was ca. 40%. The pore size also decreased as the functionalization was carried out, as expected.   
The shape of the isotherms displayed in Figure 2.34 confirmed that the samples 
maintained their cylindrical mesopores after the functionalization steps. This observation, 
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together with maintenance of the hexagonally ordered mesostructure, confirmed that the 
integrity of the mesoporous silica matrix remained unaffected by the successive 
functionalization steps. The values obtained from the N2 adsorption analysis are 
summarized in Table 2.5.  
Table 2.5. Summary of the values obtained from the N2 adsorption analysis of MSNs, MSN-CS and MSN-
CS-SIP. The significant variations in MSN-CS-SIP confirmed the successful functionalization of MSNs 
with the SIPs. 
 MSNs MSN-CS MSN-CS-SIP 
Surface area (m2/g) 1053 914 671 
Pore volume (cm3/g) 1.05 1.02 0.60 
Pore diameter (nm) 2.74 2.66 2.19 
The addition of the organosilane barely modified the textural properties. The slight 
changes in the pore width and volume were ascribed to residual organosilane molecules 
grafted within the pores, in agreement with the XRD pattern. On the contrary, the 
functionalization with the self-immolative coating induced a significant reduction in most 
of the textural properties. The specific surface area decreased ca. 40% after the SIP 
grafting, clearly indicating the presence of the polymer. In addition, the reduction of the 
pore width and volume would confirm the partial filling of the mesopores with the SIP 
chains, in agreement with XRD pattern. This is another confirmation of the successful 
functionalization of MSNs with self-immolative polymers. 
Finally, the size distribution and the surface charge of the samples were analyzed 
through DLS and Zeta potential measurements. The size of MSN-CS and MSN-CS-SIP 
remained unaffected after the successive functionalization steps, probably due to the low 
molecular weight of the polymers. Nevertheless, the changes in the zeta potential as the 
linker and the polymer were incorporated (-29.0 mV and -23.8 mV, respectively, vs -35.3 
mV of MSNs) confirmed the successful functionalization.  
In conclusion, the different characterization techniques confirmed the correct 
functionalization of the mesoporous silica nanoparticles with the previously produced 
self-immolative polymers. 
2.2.3.4. Release Experiments 
In a first approach, different MSNs:SIP ratios were explored to determine the amount 
of SIP able to effectively close the pore entrances. Each MSN-CS-SIP and MSNs were 
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loaded with a model ruthenium fluorophore and an in vial release experiment at 
physiological pH was carried out (Figure 2.35). 
 
Figure 2.35. % Dye Released at physiological pH after 100 hours for MSNs, MSN-CS-SIP (1:2), MSN-
CS-SIP (1:5). The experiment demonstrated that a ratio 1:5 was able to effectively seal the mesopores, 
leading to only 25% of release. 
As shown in Figure 2.35, the percentage of dye released by MSN-CS-SIP (1:2) was 
almost the same as that of MSNs, indicating that a ratio 1:2 was unable to close the pore 
entrances, which leaded to the cargo release. However, the ratio 1:5 only released ca. 25% 
of the dye after 100 hours of experiment, demonstrating a more effective sealing of the 
mesopores.   
After achieving an adequate closing of the mesopores at physiological pH, the next 
step was to evaluate the pH-responsiveness of the self-immolative polymeric coating at 
acid pH. For such purpose, two solutions at pH 7.4 and pH 5 were used to mimic the pH 
of the bloodstream and that of the lysosomes, respectively. As a control, a release 
experiment of naked mesoporous silica nanoparticles was performed (Figure 2.36). 
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Figure 2.36. Release experiment of Ru-loaded MSNs at pH 7.4 and pH 5. The group at pH 5 released a 
slightly higher amount of dye, which was ascribed to the effect of pH on the host-guest interactions. 
As shown in Figure 2.36, the amount of dye released at acid pH from MSNs was 
slightly higher than that at pH 7.4. The reason for this small difference was the effect that 
pH has on the interactions between the silica matrix and the guest molecules. Silanol 
groups protonate at acid pH and the strength of the interaction with the Ru dye weaken, 
leading to an enhanced release. In this case, the cargo was released independently of the 
pH, demonstrating the need for gatekeepers to avoid premature release. 
The pH-responsiveness of MSN-CS-SIP was evaluated at physiological and acid pH, 
as it can be observed in Figure 2.37. In this experiment both groups were initially soaked 
at physiological pH to then change one of them to pH 5. 
 
Figure 2.37. Release experiment of Ru-loaded MSN-CS-SIP at pH 7.4 and pH 5. The SIPs could close 
the pore entrances at pH 7.4. However, at pH 5 the release was significantly higher, demonstrating the 
pH-responsivity of the carrier.  
As shown in Figure 2.37, the carrier at physiological pH released less than 10% of the 
cargo within the first couple of days, demonstrating the efficiency of the SIP to close the 
pore entrances. The residual release could be ascribed to the cargo molecules entrapped 
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within the polymer network. The carrier at acid pH showed a five-fold difference in the 
release compared to pH 7.4, demonstrating the sensitivity of the designed nanocarrier to 
acid pH.   
2.2.3.5. Cell Experiments 
Having confirmed the successful functionalization with the SIPs and the pH-
responsive behavior, the next step was to evaluate the biocompatibility with cells. To 
assess that, the pre-osteoblastic MC3T3-E1 cell line was exposed to different 
concentrations of MSN-CS-SIP to evaluate their potential cytotoxicity in case of 
interaction with healthy cells on their way to the tumor (Figure 2.38). 
 
Figure 2.38. MC3T3-E1 cell viability upon exposure with different concentrations of MSN-CS-SIP at 24, 
48 and 72 hours. *p < 0.05 vs. control. The material was biocompatible for all concentrations except for the 
highest one, which was used as positive death control.  
As shown in figure 2.38, the material did not induce any significant cytotoxicity for 
any of the concentrations, except for 300 µg/mL, which was intentionally used as positive 
death control. This results clearly indicated that, regardless of the concentration, neither 
the SIP-coated nanoparticles nor the self-immolation by-products were cytotoxic, which 
is of vital importance for the final application of the nanocarrier.  
Finally, an internalization study was carried out to test the behavior of the SIP-coated 
nanoparticles with cancer cells. For this purpose, MSN-CS-SIP were incubated with 
LNCaP prostate cancer cells, and then, after thoroughly washing the non-internalized 
nanoparticles, the samples were observed through fluorescence microscopy (Figure 2.39).  
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Figure 2.39. Internalization of MSN-CS-SIP in LNCaP cells after incubation for 2 hours. a) MSN-CS-SIP; 
b) MSN-CS-SIP + Bright field (Nanoparticles labelled with FITC and nuclei stained with DAPI). The 
hybrid nanoparticles were located within the cytoplasm, confirming their proper internalization in tumoral 
cells.  
As observed in Figure 2.39, MSN-CS-SIP distributed along the cytoplasm of tumoral 
cells, indicating that they could be passively engulfed by the tumoral cells. This confirmed 
that the functionalization of the MSNs with a self-immolative polymer had no effects on 
their ability to be internalized. The successful uptake by cancer cells together with all the 
data here shown indicated the suitability of the SIPs as gatekeepers for mesoporous 
nanocarriers.  
2.2.4. Conclusions 
The objective of this first work was to develop a stimuli-responsive system with 
potential applicability in cancer therapy. Taking advantage of the difference in pH 
between the bloodstream (pH 7.4) and the lysosomes (pH 5), a system based on 
mesoporous silica nanoparticles and pH-responsive self-immolative polymers acting as 
gatekeepers was devised.  
The MSNs were synthesized following a modification of the Stöber method, yielding 
nearly spherical homogenous mesoporous nanoparticles with convenient size for their 
application in a biological scenario.  
The SIPs were synthesized through progressive modifications of a previously reported 
method. These improvements made possible the development of a synthetic method that 
yielded polymers with an average molecular weight of ca. 3300 g/mol. In addition, the 
amount of trigger incorporated into the polymer chains increased from barely 1-2% to 
100 µm
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100%. This was made possible through the synthesis of a triggering monomer that 
polymerized in the same way as the monomers.  
A synthetic method to graft the SIPs on the MSNs was developed and optimized. Two 
ratios MSNs:SIP (1:2 and 1:5) were explored to determine the amount of polymer able to 
close the pore entrances. In a first approach, both MSN-CS-SIP batches and naked MSNs 
were loaded with a model molecule and subjected to a release experiment at physiological 
pH, demonstrating that only the ratio 1:5 was able to close the mesopores. Then, a release 
experiment at physiological and acid pH was carried out on MSNs and MSN-CS-SIP 
(1:5), clearly showing that only the SIP-coated nanoparticles were able to hamper the 
release at pH 7.4 and trigger it at pH 5. 
Finally, some preliminary cellular experiments were performed. The biocompatibility 
of MSN-CS-SIP was evaluated using healthy cells, showing no cytotoxic effect except 
for the higher concentration used as positive death control. Then, their ability to be 
internalized by cancer cells was evaluated using LNCaP prostate cancer cells. This 
experiment showed that the SIP-coated nanoparticles could be effectively engulfed by 
this cells, laying the foundations for future and more complex biological experiments.   
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2.3. Engineered pH-Responsive Mesoporous Carbon 
Nanoparticles for Drug Delivery 
2.3.1. Introduction  
The field of mesoporous carbon is still at its early stage in comparison with the widely 
studied MSNs. In consequence, the possibilities that they might offer have not been 
explored in detail so far. Some properties, such as their textural properties, stand out over 
those of their silica counterpart. While conventional MSNs exhibit a specific surface area 
of ca. 1,000 m2/g and an average pore volume of ca. 1 cm3/g, mesoporous carbons can 
reach values of up to 2,000 m2/g and 1.5 cm3/g, respectively. In addition, mesoporous 
carbons show excellent biocompatibility, allow significant loading of poorly soluble 
and/or hydrophobic drugs, produce heat upon near-infrared irradiation and provide 
potential supramolecular π-π stacking possibilities, which may be particularly beneficial 
for aromatic drugs, as many therapeutics are.1–5   
The synthesis of this type of nanomatrices is based on the use of a silica template, 
produced through the sol-gel method, and the subsequent deposition and carbonization of 
an organic precursor. Then, the inorganic template is removed to yield carbon 
nanoparticles with empty pores. Interestingly, the pore network structure of these carbon 
materials is the negative of that from the silica template (Scheme 2.6). 
 
Scheme 2.6. Schematic representation of the pore structure of carbon particles synthesized from 
mesoporous silica templates. The carbon nanoparticles represent the negative of the mesoporous silica, 
showing porosity where there was silica in the template.  
Representative examples of mesoporous carbons are CMK-1 type and CMK-3 type, 
which are synthesized using MCM-48 and SBA-15 silica particles as templates, 
respectively (Scheme 2.7).  
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Scheme 2.7. Representative examples of mesoporous carbons. CMK-1 is synthesized using MCM-48 silica 
as template, while CMK-3 is synthesized from SBA-15 mesoporous silica. Adapted from Ref 6 with 
permission of Taylor & Francis Online. 
Nonetheless, their open porous structure presents similar drawbacks as that of 
mesoporous silica, i.e., premature and nonspecific drug release. Therefore, it is necessary 
to close the pore entrances with responsive gates to control the cargo release. Based on 
our previous experience, the different pH values found in the organism were employed 
as stimulus and the previously employed self-immolative technology was adapted to the 
carbon carriers. In this sense, the synthesis of pH-responsive self-immolative polymers 
was optimized and a grafting protocol to mesoporous carbons was developed. In this way, 
the mesoporous carbons would have a self-immolative polymeric layer on the surface that 
would disassembly upon a drop in the pH, opening the pores and triggering the drug 
release. 
In particular, two types of mesoporous carbons, CMK-3 and CMK-1, have been 
synthesized. Their loading capacity has been evaluated and compared to that of 
mesoporous silica nanoparticles. Then, a method for the SIP coating has been developed 
and the pH-responsive behavior has been explored using in vial, in vitro and in vivo set-
ups.  
In addition, the biocompatibility of these materials has been studied in vitro and in 
vivo. Furthermore, the carriers have been loaded with a cytotoxic compound and their 
biological performance has been evaluated.  
A summary of the synthetic work carried out here and the hypothesized pH-responsive 
behavior is depicted in Scheme 2.8.  
 
Silica template Carbon replica
MCM-48 CMK-1
SBA-15 CMK-3
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Scheme 2.8. Schematic representation of the synthesis of mesoporous carbons coated with a pH-responsive 
self-immolative polymer. First, a silica template is synthesized with a silica precursor using the sol-gel 
method. After surfactant removal, the mold is impregnated with a organic precursor that is subsequently 
carbonized. After that the silica template is removed, yielding the mesoporous carbon matrix. Then, these 
particles are loaded and subsequently coated with the SIPs. Finally, it is hypothesized that the release would 
only be triggered at acid pH. 
2.3.2. Materials and methods  
The following compounds were purchased from Sigma-Aldrich Inc.: TEOS; CTAB; 
Pluronic P123 (Ethylene oxide20 Propylene oxide70 Ethylene oxide20, EO20PO70EO20); 
Pluronic F127 (Ethylene oxide106 Propylene oxide70 Ethylene oxide106, EO106PO70EO106); 
ABA; Phenyl chloroformate; DIPEA; DBTL; Ru; BOC2O; THF; DMSO; DMF; DCM. 
The rest of the chemicals (ethanol, heptane, etc) were of the best quality and were 
employed as received. 
2.3.2.1. Mesoporous Carbon Nanoparticles 
 CMK-3 type ordered mesoporous carbon nanoparticles (C3) 
The CMK-3-type ordered mesoporous carbon was prepared following a nanocasting 
procedure, using sucrose as carbon source and SBA-15 mesoporous silica as template. 
SBA-15 was synthesized using TEOS as silica source and triblock copolymer Pluronic 
P123 as template.7–9 Then, the carbon replica was obtained by infiltration of SBA-15 with 
an acidic sucrose solution and subsequent carbonization of the composite material at 
900ºC. Then, the silica template was removed using hydrofluoric acid to yield a carbon 
replica with empty pores.  
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 CMK-1 type ordered mesoporous carbon nanospheres (C1Sph) 
The CMK-1-type mesoporous carbons were synthesized following a similar 
procedure, using sucrose as carbon source and MCM-48 mesoporous silica as template. 
The MCM-48 spheres were prepared following a modified Stöber method, using a 
mixture of surfactants in a H2O/NH3/ethanol solution at rt and static conditions. The 
cationic surfactant CTAB was used as template and a nonionic surfactant (triblock 
copolymer Pluronic F127) as suppressant of the grain growth of the silica particles. TEOS 
was used as silica source.3 The carbon replica was obtained through infiltration of the 
silica template with an acidic sucrose solution, followed by thermopolymerization and 
carbonization at high temperatures. Finally, the silica template was removed using 
hydrofluoric acid.  
2.3.2.2. Determination of the Loading Capacity 
Each nanocarrier (15 mg) was dispersed in a saturated solution of Ru (34 mg, 0.04 
mmol) in ethanol (2 mL) and subsequently stirred for 24 hours. After that, each batch of 
particles was filtered, rinsed with 40 mL of ethanol and dried under vacuum. The loading 
capacity was determined by comparing the thermogravimetric analysis of the Ru-loaded 
samples with their respective unloaded counterpart.  
2.3.2.3. pH-responsive Self-Immolative Polymers 
 Phenyl(4-(hydroxymethyl)phenyl) carbamate (1) 
Compound 1 was synthesized following a previously reported method with slight 
modifications.10 Briefly, to a flask containing 4-aminobenzyl alcohol (6 g, 48.7 mmol), a 
2:2:1 mixture of THF/saturated aqueous sodium bicarbonate/water (240 mL) was added. 
Then, phenyl chloroformate (7 mL, 55.8 mmol) was added dropwise at rt under magnetic 
stirring and the reaction was controlled to completion by thin layer chromatography. 
Afterward, the organic phase was extracted in ethyl acetate, washed twice with saturated 
aqueous sodium bicarbonate and dried over sodium sulfate. Finally, the solvent was 
evaporated under reduced pressure and subsequently subjected to recrystallization in 
chloroform, yielding compound 1 as a white powder. The product was characterized by 
1H-NMR. 
 Tert-butyl(4-(hydroxymethyl)phenyl) carbamate (2) 
Compound 2  was synthesized following a previously reported method.11 Briefly, to a 
flask containing 4-aminobenzyl alcohol (1 g, 8.12 mmol), dichloromethane (14 mL) was 
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added. Then, di-tert-butyl dicarbonate (1.94 g, 8.75 mmol) in dichloromethane (3 mL) 
was added and the mixture was left to react overnight at rt. After that, the solvent was 
removed under reduced pressure and the product was purified in a silica column (ethyl 
acetate/heptane, 1:1) to give compound 2 as an orange powder. The product was 
characterized by 1H-NMR. 
 Poly(phenyl(4-(hydroxymethyl)phenyl) carbamate) (3) 
Compound 3 was synthesized following a previously reported method with 
modifications.12 To a N2-purged vial containing compound 1 (1 g, 4.12 mmol), dry 
DMSO (2.1 mL) was added and the solution was heated to 85ºC under magnetic stirring. 
Then, DBTL (3% mol) was added and the reaction mixture was subsequently stirred for 
2 hours at 85ºC. After that, the reaction mixture was cooled down to 40ºC and compound 
2 (223 mg, 1 mmol) dissolved in dry DMSO (0.5 mL) was added dropwise over 5 minutes. 
After being stirred at 40ºC for 15 minutes, the mixture was heated at 85ºC again for further 
2 hours. Finally, the crude reaction mixture was precipitated in cold methanol, centrifuged 
and washed twice with methanol to obtain compound 3 as a yellowish solid that was dried 
under vacuum and characterized by 1H-NMR. 
2.3.2.4. SIP-Coated Carbon Nanoparticles  
First, to a N2-purged vial containing 30 mg of each type of particles (C3 and C1Sph) 
dry DMF (3 mL) was added. Meanwhile, in a separated N2-purged vial containing 
compound 3 (300 mg, 0.09 mmol), dry DMF (2 mL) and dry DIPEA (31 µL, 0.17 mmol) 
were added and stirred at rt for 30 minutes. After that, that solution was added to each 
batch of particles and subsequently stirred at 80ºC for 24 hours. Then, the produced hybrid 
carbons were filtered, washed with DMF, water and ethanol and finally dried under 
vacuum. Both materials were characterized by means of TGA analysis, N2 adsorption 
analysis, X-ray Photoelectron Spectroscopy (XPS) and TEM microscopy. 
2.3.2.5. Release Experiments from SIP-Coated Carbon Nanoparticles 
 SIP-coated carbon nanoparticles loaded with Ru 
To a N2-purged vial containing each type of particles (30 mg), a saturated solution of 
Ru (40 mg, 0.05 mmol) in dry DMF (3 mL) was added and stirred for 24 hours at rt. After 
that, the grafting protocol for the SIP coating described in Section 2.3.2.4 was carried out 
on the loaded materials.  
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 Release experiments 
The pH-responsive responsiveness of both hybrid carbons was tested in vial using the 
same protocol previously described in Section 2.2.2.4 for SIP-coated MSNs. Briefly, the 
particles were dispersed in a solution either at physiological or acid pH and placed in 
Tranwell® at 37ºC with orbital stirring. The media were removed every time point and 
measured in a fluorimeter to determine the amount of Ru released. Fresh medium at the 
corresponding pH was added and the procedure was repeated for every time point.  
2.3.2.6. Cell Experiments 
 Cell Cultures 
Cell culture tests were performed using HOS cells derived from a human osteosarcoma 
(CRL-1543; ATCC). HOS cells were then plated at a density of 20,000 cells cm2 in 1 mL 
of Dulbecco’s modified Eagle’s medium (DMEM, Sigma Chemical Company) 
containing 10% of heat-inactivated fetal bovine serum (FBS, Thermo Fisher Scientific) 
and 1% penicillin–streptomycin (BioWhittaker Europe) at 37ºC in a humidified 
atmosphere of 5% CO2. Then, hybrid carbon nanoparticles were placed at different 
concentrations and incubated for different periods of time.  
 Cell Viability  
Cell proliferation was determined by addition of Alamar Blue solution following the 
protocol described in Section 2.2.2.5. 
2.3.2.7. Short-Term Release Experiments from C1Sph-SIP 
In view of a subsequent in vivo experiment, a second validation of the pH-responsive 
behavior was carried out on Ru-loaded C1Sph-SIP. In this case, the material was 
dispersed in a physiological solution (Sterofundin®), whose pH was adjusted to 4 or 7.4, 
respectively. Then, the particles were incubated at 37°C for 30 minutes or 24 hours at pH 
4 or for 24 hours at pH 7.4. After each triggering period, the particles were centrifuged 
and the supernatant was collected and re-centrifuged to remove residual particles. The 
particles were imaged using the IVIS® Lumina (Caliper LifeSciences, MA; ex/em filter: 
465 nm/ Cy5.5) and the supernatants measured in a plate reader (Tecan Infinite Pro 200, 
ex/em 450/620 nm). All the precipitated particles were re-suspended in pH 7.4 solution 
and incubated for an additional 24 hours at 37°C. Afterward, centrifugation, supernatant 
imaging and quantification was carried out as previously described. 
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2.3.2.8. In Vivo Study 
 pH-responsive Ru release from Ru-loaded C1Sph-SIP  
The in vivo study was performed in Germany, in accordance with the German Animal 
Welfare Act and was approved by the local animal protection authorities (LaGeSo; permit 
numbers: G 0293/17).  During the procedures, animals were anesthetized by inhalation 
of Isoflurane (2%). 
C57BL/6 mice received Ru-loaded C1Sph-SIP hybrid systems at a concentration of 3 
mg/200 µl via subcutaneous injection through a 20 G needle (Sterican) or dwelling canula 
(Vasofix®), respectively. The mice were shaved before the administration to prevent 
interference of the hair with the imaging system. The animals received an injection of 
physiological solution with either pH 4 or 7.4 (Sterofundin® adjusted with NaOH or 
HCl). Prior to the treatment, the animals received 0.015 mg/kg of buprenorphine solution 
(Temgesic®) as analgesic. 
The imaging was performed using an IVIS® Lumina (Caliper LifeSciences) in 
conjunction with Living Image® 3.1 software. All images shown were generated with 
excitation/ emission filters of 465 nm and Cy5.5, respectively. Exposure time was 15 s. 
Images shown are overlay images of bright field and fluorescent images. The final 
imaging was performed in deep anesthesia achieved by injection of medetomidine and 
ketamine (medetomidine 1 mg/kg BW (Cepetor®, CP-Pharma) and ketamin 75 mg/kg 
BW (Inresa Arzneimittel). Animals were sacrificed afterward and the injections site were 
harvested for further analysis.  
 Histological analysis of injection sites from mice  
The explanted injection sites were sewed onto histological embedding cassettes 
(Tissue-Tec, Sacura Finetec) to prevent rolling up of the tissue. Fixation was performed 
in paraformaldehyde (4%) for 24 hours. Afterward, the tissue was dehydrated and 
embedded in paraffin. Then, 5 µm thick tissue sections were stained with hematoxylin 
and eosin to visualize the tissue and the injected hybrid systems. Images were taken at 
given magnifications (10x and 40x) under bright field conditions.  
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2.3.3. Results and Discussion 
2.3.3.1. Synthesis of Mesoporous Carbon Nanoparticles 
The synthesis of C3 and C1Sph mesoporous carbons was accomplished through a 
nanocasting procedure, i.e., the use of a template and its subsequent filling with another 
material.13 In particular, SBA-15 and MCM-48 silica nanoparticles were used as 
templates, respectively. The silica molds were synthesized through the sol-gel method 
using a surfactant as structure directing agent and the calcination approach to remove the 
surfactant. Then, both samples were infiltrated with an organic carbon source that was 
subsequently polymerized/carbonized. Finally, the carbonized materials were treated with 
hydrofluoric acid to remove the silica template, yielding mesostructured carbon 
nanoparticles (Scheme 2.9).  
 
Scheme 2.9. Representative example of the synthesis of mesoporous carbons (C1Sph) through nanocasting. 
The MCM-48 silica template was synthesized using the sol-gel method and the surfactant was removed 
through calcination. The obtained silica mold was impregnated with a sucrose solution as organic precursor 
which was subsequently carbonized. Finally, the silica template was removed using hydrofluoric acid to 
yield mesostructured carbon nanoparticles.  
MCM-48 was used because it presents a cubic phase structure that assures the 
connectivity of the cavity networks after carbonization. SBA-15 was used owing to their 
large mesopores connected through micropores, which also assures the homogeneous 
carbonization. In this sense, MCM-41 presents isolated hexagonal symmetry, which 
prevents their use as template for mesoporous carbons.6  
The as-produced carbon materials were characterized by means of XRD, N2 adsorption 
analysis and SEM microscopy. 
The structure of the carbon nanoparticles was analyzed through XRD measurements. 
As it happened for the MSNs, these materials are amorphous at the atomic level. 
Therefore, the maxima observed in the diffractogram are related to the symmetry of the 
pores (Figure 2.40).  
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Figure 2.40. XRD diffractograms. a) C3. b) C1Sph. The maxima obtained demonstrated the hexagonal 
pore symmetry of C3 and 3D cubic structure of C1Sph, as expected for these materials.   
The x-ray pattern of C3 (Figure 2.40a) shows three maxima that can be ascribed to the 
[10], [11], and [20] reflections typical of a 2-D hexagonal ordered arrangement (p6mm 
space group), in agreement with SBA-15 materials.14,15 On the other hand, figure 2.40b 
shows the x-ray pattern of C1Sph, where the maxima [110] and [211] can be observed. 
This would be in agreement with the 3D cubic structure (I4132 space group), as 
expected.16 
The textural properties of the as-produced mesoporous carbons were determined 
through N2 adsorption analysis (Figure 2.41). 
 
Figure 2.41. N2 adsorption analysis. a) C3. b) C1Sph. C3 showed a type-IV isotherm typical of CMK-3 
materials showing mesoporosity. C1Sph showed a stepwise behavior typical of CMK-1 materials with 
mesopores.    
The adsorption analysis of C3 (Figure 2.41a) showed a type-IV isotherm with H2 
hysteresis loop, typical of CMK-3-type mesoporous materials with uniform cylindrical 
mesopores of ca. 4.5 nm.14,15 On the other hand, the isotherm of C1Sph (Figure 2.41b) 
exhibited a stepwise behavior, typical of CMK-1-type mesoporous materials with narrow 
mesopores of ca. 3.2 nm disposed as a helical structure of two interweaved worm-like 
pore systems.16–18 The textural properties are summarized in table 2.6. 
a) b)
C3 C1Sph
[10]
[20]
[11]
[211]
[110]
a) b)
C3 C1Sph
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Table 2.6. Summary of the textural properties of C3 and C1Sph. Both materials showed greater textural 
properties than the MSNs (Specific surface area ca. 1,000 m2/g and pore volume ca. 1 cm3/g).  
 
Specific surface area  
(m2/g) 
Pore volume  
(cm3/g) 
Pore width  
(nm) 
C3 1,340 1.4 4.5 
C1Sph 1,650 1.2 3.2 
As observed in Table 2.7, both mesoporous carbons showed improved textural 
properties compared to the well-studied MSNs, which usually show values of specific 
surface area ca. 1,000 m2/g and pore volume ca. 1 cm3/g. The morphology of C3 and 
C1sph was evaluated in the SEM microscope (Figure 2.42). 
 
Figure 2.42. SEM. a) C3 (Inset: zoom). b) C1Sph. C3 exhibited a rod-like elongated morphology with 
dimensions 0.2-0.3 x 0.5-1 µm. C1 consisted of well-defined spheres with size ca. 150 nm. 
C3 consisted of agglomerated rod-like elongated carbon particles (Figure 2.42a), 
typical of CMK-3 type carbons,19 with diameter of 0.2-0.3 µm and length of 0.5-1 µm. 
On the other hand, the C1Sph nanoparticles exhibited a well-defined spherical 
morphology with a mean particle size of ca. 150 nm (Figure 2.42b).  
2.3.3.2. Determination of the Loading Capacity 
The next step was to evaluate the loading capacity of these carriers and find out if they 
could load higher amounts of molecules than their mesoporous silica nanoparticles 
counterparts. In this sense, C3, C1Sph and MSNs were loaded with the Ru dye and 
subjected to thermogravimetric analysis to measure the organic content, which translated 
into the amount of cargo loaded (Figure 2.43). 
 
a) b)
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Figure 2.43. Surface Area and Loading Capacity of MSNs vs mesoporous carbon matrices (C3 and C1Sph). 
Both carbon nanoparticles showed greater loading capacity, specially C1Sph, which triplicated the silica 
loading capacity.  
As shown in Figure 2.43, both carbons performed better than MSNs. It should be 
highlighted that C1Sph showed remarkable loading capacity, triplicating the amount of 
cargo loaded by the MSNs. These results would confirm (1) that the adsorption capacity 
is related to the surface area and (2) that the π-π stacking could be useful for the loading 
of aromatic molecules, as many therapeutic drugs are. 
2.3.3.3. Synthesis of pH-Responsive Self-Immolative Polymers 
Once the initial hypothesis of the higher loading capacity was confirmed, the next step 
was to provide C3 and C1Sph with smart stimuli-responsive behavior. An interesting 
approximation to obtain such on-demand release would be the translation of the 
previously described self-immolative technology to these carbon materials.  
In view of a potential scale-up of this technology within the frame of MOZART, the 
next steps were headed towards the optimization of the SIP synthesis. In this sense, new 
synthetic approximations for the synthesis of compounds 1 and 2 were carried out and the 
synthesis of compound 3 was optimized to obtain higher yields. 
The synthesis of compound 1 was adapted from a previously reported method and 
scaled up to 6 g of starting ABA.10 In addition, the purification was changed to a fast 
crystallization in chloroform that provided excellent results. The synthesis of compound 
2 was reproduced from a reported method,11 avoiding the use of refluxing temperatures 
and providing better yields.   
C3
S
u
rf
a
c
e
 A
re
a
(m
2
/g
)
L
o
a
d
in
g
C
a
p
a
c
it
y
(%
)
C1SphMSNs
0
500
1000
1500
2000
0
1
2
3
Surface Area
Loading Capacity
135
Chapter 2: Stimuli-Responsive Drug Delivery 
Engineered pH-Responsive Mesoporous Carbon Nanoparticles for Drug Delivery 
 
 
 
 
The method for the synthesis of compound 3 described in section 2.2.2.2 was 
thoroughly modified to improve the yield of the SIP synthesis. First, different 
experimental conditions such as catalyst and reactant concentrations were explored to 
maximize the molecular weight of the polymer (Table 2.7). The trigger was not added 
until the highest molecular weight possible was achieved. 
Table 2.7. Optimization of the SIP molecular weight as a function of the catalyst and monomer 
concentration. *Referred to compound 1.  
% DBTL* Molarity* Number of monomers Reaction conditions 
5 1 10 
2.5 hours 
 
85ºC 
4 1 12 
3 1 14 
3 1.5 17 
2 1.5 18 
2 2 12 
3 2 20-40 
The best results in terms of number of units and, consequently, molecular weight were 
obtained with the condition: 3% DBTL, 2M, 85ºC, 2.5 hours. An average synthesis using 
these conditions led to SIPs with ca. 20 units, although polymers with up to 40 units were 
obtained, as shown in Table 2.7. 
Then, the next step was to introduce the trigger to provide the chain with pH-
responsive stimuli-responsive behavior. It was observed that the addition of compound 2 
at the reaction temperature (85ºC) led to the degradation of the preformed polymeric 
chains synthesized as stated in table 2.7. A possible explanation might be that compound 
2 would be too reactive at such temperature and might react throughout the polymer chain, 
rather than at its end. For that reason, the possibility of reducing the temperature to add 
the trigger and then increase it again was explored. In this way, the temperature 
progressively increased and compound 2 would react in a milder way. This approach 
provided SIPs composed of ca. 20 units and ca. 70-80% of incorporation of the pH-
responsive trigger (Figure 2.44). Regardless of temperature, the behavior shown in Figure 
2.30 (polymer degradation upon trigger addition if size > 20-25 units) was also observed. 
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Figure 2.44. 1H-NMR of compound 3 synthesized through the protocol described in section 2.3.2.3. (250 
MHz, DMSO) δ 9.82 (s, 20H), 7.56-7.15 (m, 87H), 5.15(s, 41H), 4.43 (d, 2H), 1.48 (s, 7H). 
As shown in Figure 2.44, the SIP could be effectively synthesized, achieving the 
maximum molecular weight possible and the incorporation of a significant amount of 
trigger. Overall, the optimization of the SIP synthesis led to SIPs with molecular weight 
ca. 3,300 g/mol and average yield ca. 90%, which was much greater than that obtained 
using the protocol described in Section 2.2.2.2 (ca. 30%).  
2.3.3.4. Synthesis of SIP-Coated Carbon Nanoparticles 
The carbons were characterized by XPS to unravel the chemical groups on the surface 
and design a synthetic protocol to graft the self-immolative coating (Figure 2.45). 
 
Figure 2.45. Top: XPS analysis; Bottom: Survey spectrum. a) XPS analysis of C3. b) XPS analysis of 
C1Sph. c) Survey spectrum of C3. d) Survey spectrum of C1Sph. The XPS analysis demonstrated the 
presence of hydroxyl, carboxylic acid and epoxy groups on the surface.  
Water
DMSO
a) b)
c) d)
C3 C1Sph
C3 C1Sph
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The spectrum of C3 (figure 2.45a) can be decomposed into six peaks: 284.8 eV, 286.0 
eV, 287.3 eV, 288.6 eV, 290.0 eV and 291.6 eV. The carbon-carbon bonds are located at 
284.8 eV. The second peak is associated to the C-O bonds. The peak at 287.3 eV can be 
ascribed to the epoxy/ether and carbonyl groups. Finally, the last two peaks may be 
related to the π-π* (HOMO-LUMO) transition of the turbostratic structure of the carbon 
backbone.20 However, it should be mentioned that signals at 290.0 eV have been also 
related in the literature to C bonded as CO3
2- (surface carbonates)21–23 Additionally, a 
residual rests of the etching agent (HF) employed to remove the silica template were 
detected in the survey of C1Sph (Figure 2.45d). 
The spectrum of C1Sph (Figure 2.45b) can be decomposed again into six peaks located 
at 284.8 eV, 286.0 eV, 287.2 eV, 288.7 eV, 290.1 eV and 291.7 eV. The first peak can be 
ascribed to the aliphatic C-C and/or C-H bonds of the main sp3 carbon frame. The peak 
at 286 eV represents the C-OH bonds on the surface of the plain carbon. The peak at 287.2 
eV represents the contribution of C-O-C epoxy/ether and C=O carbonyl groups present 
on the surface (the instrumental resolution does not allow the distinction of these 
groups).24 The peak at 288.7 eV represent the carboxylic acid groups present on the 
surface of C1Sph. Finally, the peaks at 290.1 and 291.7 eV may be ascribed to the π-π* 
features of the carbon matrix.20,22,24,25 
In view of the results, the most abundant functional groups in the samples were 
hydroxyl (OH), carboxylic acid (COOH) and epoxy (C-O-C) groups. In consequence, the 
direct addition of the hydroxyl functionality of the SIPs to form C-O-C ether groups with 
the epoxy groups of the surface was explored. The correct grafting of the SIPs on the 
surface of C3 and C1Sph was characterized in terms of TGA, N2 adsorption analysis, XPS 
measurements and TEM microscopy.  
The samples were subjected to TGA analysis to determine the amount of additional 
organic matter present in the samples after the SIP coating (Figure 2.46). 
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Figure 2.46. TGA analysis. a) C3 vs C3-SIP. b) C1Sph vs C1Sph-SIP. In both cases, the addition of the 
SIP led to ca. 15% of weight loss, confirming the presence of the SIP.  
The TGA analysis of the SIP-coated samples showed a difference of ca. 15% in the 
weight loss for each SIP-coated material, measured in the range 150-450ºC. This organic 
content could be ascribed to the presence of the polymer, confirming the functionalization 
the carbons surface. 
The effect of the functionalization with the pH-responsive polymer on the textural 
properties of the samples was determined through N2 adsorption analysis (Figure 2.47). 
 
Figure 2.47. N2 adsorption analysis. (Inset: Pore size distribution). a) C3 vs C3-SIP. b) C1Sph vs C1Sph-
SIP. The SIP coating of C3 and C1Sph led to a decrease of ca. 55% and ca. 65% in the specific surface 
area, respectively, confirming the successful grafting of the polymer.  
The functionalization of C3 with the SIPs led to a reduction of ca. 55% in the specific 
surface area (Figure 2.47a), while inducing a decrease of ca. 65% in the specific surface 
area of C1Sph. These results confirmed the successful functionalization of both 
mesoporous carbons with the self-immolative polymeric coating. In addition, the shape 
of the isotherms of the SIP-coated mesoporous carbons remained after the 
functionalization, indicating that the mesostructure was unaffected by the selected 
synthetic protocol. The results derived from the TGA and the N2 adsorption analysis are 
summarized in Table 2.8. 
a) b)
C3
C3-SIP
C1Sph
C1Sph-SIP
a) b)
C3
C3-SIP
C1Sph
C1Sph-SIP
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Table 2.8. Summary of the TGA analysis and the textural properties of the mesoporous carbon materials. 
The differences between the coated and non-coated materials (increase of weight loss and decrease of 
textural properties) confirm the successful functionalization. *Weight loss with respect to the pristine 
materials. 
  Specific surface area 
(m2/g) 
Pore volume 
(cm3/g) 
Pore width  
(nm) 
% Weight loss 
C3 1340 1.4 4.5 - 
C3-SIP 620 0.6 4.1 14.8* 
C1Sph 1650 1.2 3.2 - 
C1Sph-SIP 560 0.4 3.0 14.9* 
As shown in Table 2.8, the SIP grafting induced a reduction of the pore volume, as it 
happened for MSN-CS-SIP (Table 2.5). This would be ascribed again to the partial filling 
of the mesopores with the SIPs.  
The SIP-coated samples were analyzed through XPS to determine if the functional 
groups of the polymer were present (Figure 2.48).     
 
Figure 2.48. a) XPS analysis of C3-SIP. b) XPS analysis of C1Sph-SIP. c) XPS carbamate signal of C3-
SIP. d) XPS carbamate signal of C1Sph-SIP. e) Survey spectrum of C3-SIP. f) Survey spectrum of C1Sph-
SIP. The appearance of signals associated to the carbamates of the SIPs confirmed the successful synthesis 
of the SIP-coated carbons. 
a) b)
c) d)
e)
f)
C3-SIP C1Sph-SIP
f)
C3-SIP C1Sph-SIP
C3-SIP C1Sph-SIP
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In more detail, after the functionalization the percentage of C-C/C-H peaks decreased 
whereas the peaks that may be ascribed to C-N bonds (amines at 286.0 eV,22–28 and 
carbamates at 290.1 eV24,27), increased in general. An additional confirmation of the 
successful functionalization was the appearance of the N1s photoelectron peak at 400.5 
eV22,26–28 for both C1Sph-SIP and C3-SIP (figures 2.48c and d), which would be 
attributed to the carbamate groups of the polymer. A detailed summary of the XPS 
measurements is shown in table 2.9. 
Table 2.9. Analysis of the XPS measurements of unmodified and SIP-coated samples. 
Peak 
Assignment 
Binding Energy 
(eV) 
C1sph 
(at. %) 
C1sph-SIP 
(at. %) 
C3 
(at. %) 
C3-SIP 
(at. %) 
C-C / C-H 284.8 63.0 61.7 66.4 59.5 
C-O / C-N 286.0 17.6 18.5 14.8 17.9 
C-O-C / C=O 287.2  8.5 8.5 8.3 10.2 
O-C=O / N-C=O 288.7  4.8 5.1 4.3 6.4 
CO32- / π-π* / 
NH-C(=O)-O 
290.1  3.8 4.0 3.8 4.1 
π - π* / CF2 291.7  2.3 2.2 2.4 1.9 
The correct SIP coating of the carbons was confirmed through the increment of the 
peaks ascribed to the presence of nitrogen in Table 2.9, such as N-C=O and NH-C(=O)-
O, which would be ascribed to the carbamate of the SIPs. 
One of the main drawbacks of the nanocasting procedure is the difficulty to obtain 
hydrophilic samples.13 In this sense, the aqueous dispersibility of the samples improved 
after grafting the SIP, probably due to the presence of the carbamate groups. The 
experimental evidence was that when the pristine carbons were added to an aqueous 
solution they remained on the top of the surface, as a consequence of the highly 
hydrophobic nature of the samples (a slight degree of dispersion after sonication could be 
observed). On the contrary, when doing the same experiment with the SIP-coated 
nanocarriers, they could be properly dispersed after a short period of sonication. Indeed, 
the hybrids remained dispersed for longer periods of time after sonication (Figure 2.49). 
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Figure 2.49. Representative example of the aqueous dispersibility of the carbons before and after 
functionalization. a) Right after sonicating the samples. b) After two days. In general, the SIP-coated 
materials were better dispersed than their pristine counterparts. 
Finally, TEM analysis was carried out to evaluate whether there was presence of 
organic matter on the surface of the SIP-coated carbons. For that purpose, the pristine and 
modified materials were stained with phosphotungstic acid and observed under the 
microscope (Figure 2.50).  
 
Figure 2.50. TEM visualization of samples stained with phosphotungstic acid. a) C1Sph. b) C1Sph-SIP. c) 
C3. d) C3-SIP. The blurrier surface in the SIP-coated samples was indicative of the presence of organic 
matter on the surface, as a consequence of a successful SIP grafting.  
Phosphotungstic acid binds to the organic matter present in a sample and allows its 
visualization under the electronic microscope.29 In this sense, the SIP-coated samples 
(Figures 2.50b and d) showed a blurry shade on the surface, typical of functionalizations 
with organic compounds, confirming the successful grafting of self-immolative 
polymeric coating.  
Just sonicated After 2 days
C1Sph-SIPC1Sph-SIP C1SphC1Sph
b)a)
a) b)
c) d)
C1Sph C1Sph-SIP
C3 C3-SIP
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2.3.3.5. Release Experiments from SIP-Coated Carbon Nanoparticles 
Mesoporous carbons were loaded with a model fluorophore prior to the SIP coating. 
The release experiments were carried out in Transwells® at pH 7.4 and 5 to mimic the 
pH of the bloodstream and the lysosomes, respectively (Figure 2.51).  
 
Figure 2.51. Release experiments at physiological and acid pH. a) C3-SIP; b) C1Sph-SIP. At physiological 
pH, the SIPs blocked the pore entrances, hampering the release. However, at acid pH the SIPs degraded, 
opening the pores and inducing the release.  
Overall, both release experiments clearly showed that the SIPs maintained their 
integrity at physiological pH, blocking the mesopores and hampering the release, as 
initially hypothesized. However, at acid pH the polymeric gatekeeper self-immolated, 
opening the pores and leading to the release.   
In more detail, the release experiment of C3-SIP (Figure 2.51a) showed residual 
release of dye (ca. 28%) at physiological pH after 50 hours, which was partially ascribed 
to dye molecules entrapped within the polymeric network. However, a more than four-
fold release at acid pH was observed, confirming the sensitivity of the polymer to acid 
environments. The release kinetics for C1Sph-SIP (Figure 2.51b) showed a similar trend. 
In this case, only 20% of dye was released at physiological pH, indicating better 
performance of the polymeric coating. This could probably be ascribed to (1) the smaller 
pore size of C1Sph that would be easier to cap with the SIPs and (2) the smaller size of 
C1Sph that might lead to more homogenous SIP coating. On the other hand, the sample 
at acid pH showed a five-fold release, clearly indicating the pH-responsiveness of the 
coating. 
2.3.3.6. Cell Experiments 
The in vitro biocompatibility and cytotoxicity of the SIP-coated mesoporous carbon 
materials were assessed on human osteosarcoma (HOS) cells. Three concentrations (25, 
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50 and 100 µg/mL) and two time points (24 and 48 hours) were studied. The 
biocompatibility was tested using unloaded SIP-coated carbons (C3-SIP and C1Sph-SIP). 
To assess the cytotoxicity, the two carbons were loaded with doxorubicin (C3-DOX-SIP 
and C1Sph-DOX-SIP) before the SIP coating. DOX was selected because it is currently 
used for the treatment of osteosarcoma in the clinic.30 In order to verify that the SIP 
coating actually degrades upon acid pH and behaves as responsive and effective 
gatekeeper, another series of samples were prepared by loading the two carbons with 
doxorubicin and then coating them with the same polymer backbone but without the pH-
responsive trigger (C3-DOX-NOBOC and C1Sph-DOX-NOBOC). The results are 
depicted in figure 2.52.  
 
Figure 2.52. Cytotoxicity assay in HOS cells. a) C3-SIP and derivatives at 24 hours. b) C3-SIP and 
derivatives at 48 hours. c) C1Sph-SIP and derivatives at 24 hours. d) C1Sph-SIP and derivatives at 48 
hours. Data are mean ± SEM of 3 independent experiments performed in duplicate. *p<0.05 vs. 
corresponding SIP-coated carbon and control. None of the unloaded carriers induced toxicity for any of the 
times or concentrations. The highest cytotoxic effects were observed for C1Sph-DOX-SIP, while only the 
higher concentrations of C3-DOX-SIP inhibited the cell viability when using this material. None of the 
groups bearing the non-sensitive SIPs exerted cytotoxic effects, demonstrating the pH-sensitivity of the 
SIPs. 
Overall, neither C3-SIP nor C1Sph-SIP induced any cytotoxic effect to the cells, 
regardless of the time point or concentration. Interestingly, for lower concentrations of 
C1Sph-SIP, in particular 50 µg/mL, a significant increase of cell proliferation at 24 hours 
a) b)
c) d)24 h 48 h
24 h 48 h
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was observed due to the presence of the material (Figure 2.52c). This behavior has been 
previously reported in the literature for carbon nanotubes on several cell lines.31,32 In the 
case of C3-SIP particles a slightly positive effect (but still not significant) on the 
proliferation of the cells was found at 24 hours when using a concentration of 25 and 50 
µg/mL (Figure 2.52a). In addition, and what is more important for the present work, this 
confirmed that the polymeric coating and their degradation by-products, generated as a 
consequence of the acid pH in the lysosomes, were biocompatible. 
The drug-loaded C1Sph-DOX-SIP was able to induce significant cytotoxicity at 24 
and 48 hours, which appeared to be more pronounced at 24 hours. However, the overall 
cytotoxicity effect of C3-SIP was much lower than that of C1Sph-SIP. A reasonable 
hypothesis would be that, in general, small nanoparticles (C1Sph-SIP) are engulfed more 
easily than the bigger ones (C3-SIP). This would lead to a lower total amount of released 
drug and then a lower effect on cell viability. At 24 hours only the 100 µg/mL condition 
was able to reduce the cell viability while at 48 hours the particles at 50 µg/mL showed 
the first cytotoxic effect. Aside from the size, the fact that C1Sph shows higher release 
capacity than C3 might also be a reason for the enhanced cytotoxicity of the C1Sph 
materials. 
Once the biocompatibility and cytotoxicity of the SIP-coated nanocarriers was 
confirmed, the next step was to verify the responsivity to acid pH in vitro. For that 
purpose, a polymer with the same backbone without the pH-responsive trigger was 
synthesized (same protocol but without the addition of compound 2) and further grafted 
on the doxorubicin-loaded mesoporous carbons. As observed in figure 2.52, any of these 
groups (C3-DOX-NOBOC and C1Sph-DOX-NOBOC) induced any cytotoxic effects on 
the cells for any concentration or time point. This is a confirmation of the need of a pH-
responsive trigger to initiate the self-immolation and, consequently, trigger the drug 
release. This means that the polymeric coating maintained its integrity, closing the pore 
entrances of the non-responsive mesoporous carbons and avoiding the drug release.    
2.3.3.7. Short-Term Release Experiments from C1Sph-SIP  
The promising in vial and in vitro experiments called for an in vivo proof of concept 
validation of the system. C1Sph-SIP was chosen for such experiments because it was 
observed to be the best candidate in terms of textural properties, responsive release profile 
and cytotoxic effects. The experiments were carried out in mice exposed to either acid or 
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neutral solution in a pocket under the skin. During these experiments, a pH 4 solution was 
employed to delay pH homeostasis that could interfere with our responsive carrier. 
Prior to the in vivo experiments, the responsiveness of the Ru-loaded C1Sph-SIP to 
short-term pH-triggering was evaluated in vial (Figure 2.53). 
 
Figure 2.53. Short-term pH-triggering in vial release experiment of Ru-loaded C1Sph-SIP. The samples 
were exposed to pH 4 (red) or 7.4 (black) and the supernatants were measured in the IVIS®. Then, all the 
samples were dispersed in a 7.4 solution and measured again after 24 hours. The experiment demonstrated 
that only the particles previously exposed to acid pH were able to induce significant and continuous release. 
Images at the top are representative IVIS® images per condition. Color bar is shown on the right. Data are 
mean ± SD of n=3 (for 24 h trigger n=2). Statistics: unpaired, two-tailed t-test, p*≤ 0.05, conditions always 
compared to control per time point.  
 As shown in Figure 2.53, only the samples soaked at pH 4 (red), for either 30 minutes 
or 24 hours, resulted in substantial Ru release. This meant that 30 minutes was long 
enough to trigger the cargo release, highlighting the fast responsive behavior of the 
designed system. In consequence, C1Sph-SIP should be unaffected by any potential in 
vivo homeostasis and the triggering could be performed in vivo. 
After that experiment, the above-mentioned samples were dispersed in a 7.4 pH 
solution for further 24 hours and the supernatants were measured again, observing that 
only the previously triggered groups kept releasing the cargo. On the other hand, carriers 
at physiological pH showed negligible release, which confirms the pore blocking stability 
and highlights the unquestionable pH-responsiveness of the here designed nanocarrier. 
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2.3.3.8. In Vivo Study: pH-Responsive Ru Release and Biocompatibility of C1Sph-
SIP 
This in vivo study was conceived to provide answers to three questions: (1) despite 
both release experiments (I and II) seemed to indicate that the SIP coating maintained its 
integrity at physiological pH, would it survive when placed in a more realistic scenario 
with mice? (2) despite not being cytotoxic in vitro, would C1Sph-SIP induce an immune 
response when administered under the skin to the mice? and (3) would it be possible to 
open the pores despite the effects of the potential immune response? 
Ru-loaded C1Sph-SIP particles were administered subcutaneously to the mice in a 
physiological solution at pH 7.4 and then, the animals were imaged longitudinally in the 
IVIS® prior and just after the injection, and 24, 48 and 96 hours post injection (Figure 
2.54).    
 
Figure 2.54. Longitudinal IVIS® imaging of the dorsal site of two mice. Left: Before and just after 
injection; Right: 24, 48 and 96 h post injection. Even after 96 hours the SIPs on the surface remain 
unaffected since almost no fluorescence can be detected. 
As shown in figure 2.54, only a small amount of fluorophore could be detected after 
96 hours. This clearly demonstrated that the SIP coating could survive at physiological 
pH inside an animal. In consequence, the pores would remain closed during a potential 
systemic administration, thus avoiding premature release and confirming the pH-
sensitivity of the coating.  
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To study the general biocompatibility of C1Sph-SIP the animals were visually 
inspected on a daily basis for irritations in the injection site, overall appearance and 
behavior. After imaging at 96 h, the animals were sacrificed, the injection site was 
explanted and prepared for histology (hematoxylin and eosin staining, H&E). (Figure 
2.55). 
 
Figure 2.55. H&E-stained sections of paraffin-embedded skin tissue. a) Injected mouse; b) Non-injected 
mouse. I (administered nanoparticles), II (injection site) and III (control tissue) represent areas of a) and b) 
with higher magnification. Black: C1Sph-SIP; Purple: Nuclei; Light pink: Cytoplasm and connective tissue; 
Dark pink: Muscle tissue. The SIP-coated carriers did not induce a significant immune response, and a 
similar aspect as that of the non-injected tissue could be observed.  
As shown in figure 2.55a, none of the injected animals exhibited adverse reactions to 
the carbon material. The organism reacted to the injection of C1Sph-SIP by moderate 
formation of a capsule around the particles and only minor infiltration of immune cells 
(figure 2.55a.I) compared to the non-injected skin (figure 2.55b.III). This clearly 
demonstrated the high biocompatibility of C1Sph-SIP and its potential to be translated to 
the clinic. 
Once the absence of adverse immune reaction in vivo was demonstrated, the next 
objective was to evaluate whether the self-immolation could be triggered in vivo by the 
application of an exogenous pH trigger (pH 4). As a control, physiological pH solution 
a)
b)
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was evaluated. The animals were imaged with the IVIS® before, during and after the 
triggering period, and again at 24 and 72 hours post triggering. (Figure 2.56) 
 
Figure 2.56. Longitudinal IVIS® imaging over 72 h (from 10 min after injection up to 72 h). Top: pH 4; 
Bottom: pH 7.4. The animals were sacrificed, the injection sites harvested, inverted and imaged again 
(zoom in the right). Only the animals receiving the solution at acid pH showed significant levels of 
fluorescence.  
As shown in Figure 2.56, only the animals receiving the acid solution (top) showed a 
significant Ru release. After the initial triggering, the fluorescence signal could be 
consistently detected during the entire testing period for the group at pH 4 while only a 
low signal could be detected under pH 7.4 conditions.  
After 72 hours, the animals were euthanized and the injection site explanted, inverted 
and imaged. In this case, only the group receiving the pH 4 solution showed a strong 
fluorescent signal, while only minor signals were detected for the animals treated with 
the pH 7.4 solution.  
This results confirmed that (1) the polymeric coating maintained its integrity at 
physiological pH and (2) only the acid environment was able to trigger the degradation 
of the polymers and the subsequent dye release, clearly demonstrating the feasibility of 
triggering the release in an in vivo scenario. 
2.3.4. Conclusions 
The objective of this work was to develop smart stimuli-responsive nanocarriers based 
on mesoporous carbons for cancer treatment. For that purpose, the differences in pH 
found in the organism were selected again as stimulus to trigger the release from the 
mesopores. In this sense, the pH-responsive self-immolative technology developed in the 
previous work was adapted to these materials. 
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Since mesoporous carbons showed even better textural properties than MSNs, the 
loading capacity of these materials was determined to find out if larger specific surface 
areas translated into greater loading capacities. In this sense, both carbon materials 
outperformed the MSNs, in particular C1Sph which triplicated the silica storage capacity, 
demonstrating the influence of the specific surface area on the loading ability.  
In view of a future scale-up within the MOZART framework, the synthetic protocols 
reported in the previous work for the synthesis of compounds 1, 2 and 3 were optimized, 
leading to higher yields. Additionally, a synthetic method for the grafting of the SIPs on 
the carbons was developed, based on the analysis of the chemical groups present on the 
surface of the carbon materials.  
The pH-responsiveness was validated in vial, in vitro and in vivo, showing 
unequivocally that the polymeric coating could maintain its integrity at physiological pH 
and undergo self-immolation at acid pH, thus opening the pores and triggering the drug 
release.  
The in vial release experiments showed that the C1Sph-SIP could close more 
effectively the pore entrances at physiological pH, which translated in lower premature 
release. The in vitro experiment was carried out using doxorubicin-loaded carbons with 
a non-responsive self-immolative-like polymeric coating. In this case, the viability of the 
cells in contact with these materials was unaffected, clearly showing the need of the pH-
responsive trigger as end-cap for the polymeric backbone. The pH-responsive in vivo 
experiment demonstrated (1) that the self-immolative polymers maintained their integrity 
at physiological pH inside an animal and (2) the induction of an acidic environment within 
the animals could trigger the release, thus confirming the pH-responsive nature of the 
SIP-coated carbon materials within an animal. 
The biocompatibility of the SIP-coated mesoporous carbons was evaluated in vitro and 
in vivo. The in vitro experiments showed that the unloaded SIP-coated materials did not 
exert any cytotoxic effect on the cells. Moreover, the doxorubicin-loaded mesoporous 
carbons were able to inhibit the cell viability. In particular, C1Sph-SIP could exert a much 
higher cytotoxic effect. The in vivo biocompatibility was carried out in mice, where it 
could clearly be observed that the administration of the SIP-coated carbons induced only 
minor immune response, clearly demonstrating the potential applicability of these 
mesoporous carbons in further in vivo experiments.   
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2.4. Design of pH-Responsive Mesoporous Silica and 
Mesoporous Bioactive Glasses 
2.4.1. Introduction  
The work here presented consisted in applying the pH-responsive self-immolative 
technology to different MOZART mesoporous nanomatrices. The particles would be 
coated with the pH-responsive moieties and the payload release would be triggered by 
the acid pH found in the scenarios considered in the proposal, namely delayed bone 
healing and chronic wound healing. 
 Briefly, bone healing can be postponed for different reasons, including delayed 
revascularization and appearance of infection. Clinically, a lessened revascularization 
would prolong the initial phase of acid pH values in the fracture area due to a persisting 
anaerobic metabolism.1 In addition, acid pH is also present during the inflammatory phase 
of bone healing.2 In this sense, the idea was to use acid pH to trigger the release of pro-
angiogenic factors and therapeutic ions from the mesopores of the carriers, which would 
act synergistically, boosting revascularization  and addressing infection, and leading to 
enhanced bone healing.  
On the other hand, while acute wounds usually heal in an efficient manner, chronic 
wounds persist in a state of chronic inflammation, consequently leading to acid 
environment, as it happens for bone healing.3 In this regard, the acid pH would trigger the 
release of therapeutic and pro-angiogenic ions from the mesopores of the nanocarriers to 
improve the wound healing process. 
The pH-responsive polymeric coating based on self-immolative polymers was 
produced following the technology developed in Section 2.3.2.3, which was based on a 
previously reported article.4 Then, the SIPs were grafted to the different mesoporous 
nanoparticles, which were provided by the MOZART consortium. A Swedish company, 
named Nanolith, provided SBA-15 nanomatrices.5 The Friedrich-Alexander-Universität 
of Erlangen provided mesoporous bioactive glasses. The Politecnico di Torino provided 
two types of mesoporous bioactive glasses, one synthesized by an ultrasound-assisted 
method (US)6 and another one by a spry-drying method (SD).7 These nanocarriers will 
be denoted hereafter as Nanolith, FAU and Polito-X (X being US or SD), respectively. 
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One of the key points of MOZART was the incorporation of therapeutic ions within 
the silica framework. However, the two-step synthetic protocol described in Section 
2.2.2.3 for the synthesis of SIP-coated MSNs might induce a significant loss of ions 
during the synthesis and subsequent washing steps. In consequence, the methodology had 
to be changed from a two-step to a one-pot procedure. In this way, the SIP was first 
attached to an organosilane and then added to the particles, thus minimizing ion leakage. 
The chloro organosilane employed in Section 2.2 was discarded because the SIP had to 
be attached at 80ºC and, consequently, that temperature might lead to self-condensation 
of the organosilane prior to the addition, reducing the yield of the grafting. In this sense, 
2 alternative organosilanes bearing either isocyanate or carboxylic acid functionalities 
were explored. In this manner, the coupling should proceed at lower temperature and 
organosilane self-condensation would be avoided. In addition, the proposal considered 
the in vivo application of the nanoformulations here developed. For that reason, some 
nanomatrices were labelled with an in vivo fluorophore and further functionalized with 
the SIP coating. 
Finally, the effective sealing of the mesopores as well as the pH-responsive behavior 
of the carriers were evaluated through release experiments, using physiological and acid 
pH environments to mimic the conditions that would be found in bone and wound healing 
scenarios. A summary of the work carried out in this chapter is depicted in Scheme 2.10.  
 
Scheme 2.10. Schematic representation of the work carried out in Section 2.5. The two-step method used 
for the synthesis of SIP-coated MSNs was changed to a one-pot protocol to minimize potential premature 
ion leakage. Different organosilanes bearing either isocyanate or carboxylic acid moieties were explored to 
graft the SIPs to the particles. Finally, the effectiveness of the pore capping was evaluated performing 
release experiments at acid and physiological pH.  
R = NCO or COOH
= Carbamate or Ester
Acid pHPhysiological pH
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2.4.2. Materials and Methods 
The following compounds were purchased from Sigma-Aldrich Inc.: ABA; Phenyl 
chloroformate; DIPEA; DBTL; Ru; BOC2O; APTES; Succinic anhydride; N,N’-
Dicyclohexylcarbodiimide (DCC); DMAP; THF; DMSO; DMF; DCM; Acetonitrile 
(AcN). The rest of the chemicals (ethanol, heptane, etc) were of the best quality and were 
employed as received. 
2.4.2.1. pH-Responsive Self-Immolative Polymers  
The SIPs employed for the functionalization of the MOZART nanomatrices were 
synthesized using the protocol reported in Section 2.3.2.3. Briefly, ABA was employed 
as starting material for the synthesis of the monomer (compound 1) and the trigger 
(compound 2). Then, the monomer was polymerized using DBTL as catalyst and, once 
the polymeric chain preformed, the trigger was added as end-cap, leading to the final pH-
responsive polymer (compound 3). All compounds were characterized by 1H-NMR. 
2.4.2.2. SIP-Coated MOZART Nanomatrices 
 Synthesis of SIP-Coated MOZART nanomatrices Using an Isocyanate-Based Linker      
(Protocol A) 
First, to a N2-purged flask containing 30 mg of the corresponding batch of particles 
(SBA-15, FAU, Polito-US or Polito-SD), dry DMF (3 mL) was added and the solution 
was sonicated to disperse the potential aggregates (solution A). Then, to a N2-purged vial 
containing compound 3 (0.450 g, 0.14 mmol), dry DMF (2.5 mL) and dry DIPEA (47.5 
µL, 0.27 mmol) were added and the solution was stirred for 4 hours at 50ºC (solution B). 
After that, 0.8 mL of this mixture (solution B) were added dropwise to the initial 
dispersion of particles (solution A) and the reaction was stirred at 80ºC for 2 hours. Then, 
another 0.8 mL of solution B were added to Solution A. Finally, after 2 further hours, the 
rest of solution B was added. Afterward, the whole reaction mixture was magnetically 
stirred overnight at 80ºC. Finally, the product was centrifuged, thoroughly washed with 
DMF and ethanol and dried under vacuum. The SIP-coated nanomatrices were 
characterized by means of TGA analysis and FTIR spectroscopy.  
 Synthesis of SIP-Coated MOZART Nanomatrices Using a Carboxylic Acid-Based Linker 
(Protocol B) 
 4-oxo-4-((3-(triethoxysilyl)propyl)amino) butanoic acid (4) 
To a N2-purged vial containing succinic anhydride (0.1 g, 1 mmol), dry THF (3 mL) 
and APTES (234 µL, 1 mmol) were added and the reaction stirred overnight at rt. Then, 
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the solvent was removed under reduced pressure to yield compound 4 as a colorless oil. 
The compound was characterized through 1H-NMR. 
 SIP-coating on MOZART nanomatrices using a carboxylic acid-based linker 
To a N2-purged vial containing compound 4 (0.019 g, 0.06 mmol), DMAP (1.9·10
-3 g, 
0.015 mmol) and DCC (0.013 g, 0.064 mmol), dry DMF (1.2 mL) was added and stirred 
for 30 minutes. After that, compound 3 (0.2 g, 0.06 mmol) in dry DMF (2 mL) was added 
dropwise and the reaction was stirred at rt overnight (solution A). Separately, to a N2-
purged flask containing the corresponding particles (30 mg), dry DMF (3 mL) was added 
and the solution was sonicated to disperse the potential aggregates (solution B). Then, 1 
mL of solution A was slowly added to the particles and the reaction was heated at 80ºC 
for 2 hours. Afterward, 1 additional mL of solution A was added to solution B. After 2 
further hours, the rest of solution A was injected and reaction mixture was stirred 
overnight at 80ºC. Finally, the product was centrifuged, thoroughly washed with DMF 
and ethanol and dried under vacuum. The SIP-coated nanomatrices were characterized by 
means of TGA and FTIR. 
2.4.2.3. SIP-Coated Labelled MOZART Nanomatrices for Future In vivo 
Experiments 
FAU and Polito-US nanomatrices were labelled with a dye appropriate for in vivo 
observation (IRDye® 680RD) in view of a future in vivo application of the particles. In 
addition, Polito-US was also labelled with FITC for the initial grafting tests. The particles 
(FAU@in vivo, Polito@in vivo-US and Polito@FITC-US) were labelled by FAU and 
Polito researchers, respectively, before sending them for the subsequent SIP coating.  
FAU@in vivo and Polito@FITC-US nanomatrices were functionalized with the 
polymer using compound 4 as linker and DMF as solvent, as previously described in 
Section 2.4.2.2 (Protocol B). On the other hand, Polito@in vivo-US could not be properly 
dispersed in DMF. Instead, the particles were dispersed in a mixture of DMF and AcN. 
Except for that, the protocol was carried out as previously described.  
Polito-FITC-US nanomatrices were characterized by means of TGA analysis and 
FTIR spectroscopy. The samples labelled with the in vivo dye were characterized through 
FTIR spectroscopy (non-destructive characterization technique) to save as much sample 
as possible for a future in vivo experiment. 
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2.4.2.4. Release Experiments from SIP-Coated MOZART Nanomatrices 
 SIP-Coated MOZART nanomatrices loaded with Ru  
First, to a N2-purged flask containing the corresponding batch of nanoparticles (30 
mg), a solution of Ru (12 mg, 0.015 mmol) in dry DMF (3 mL) was added and the solution 
was stirred overnight at rt. After that, the functionalization with the SIP was carried out 
as previously described.  
 Release Experiments 
The pH-responsive behavior of the SIP-coated MOZART nanomatrices was evaluated 
in vial following the protocol described in Section 2.2.2.4 for SIP-coated MSNs. Briefly, 
the particles were dispersed in a solution either at physiological or acid pH and placed in 
Tranwell® at 37ºC with orbital stirring. The media were removed every time point and 
measured in a fluorimeter to quantify the amount of Ru released. Fresh medium at the 
corresponding pH was added every time the old media was removed.  
2.4.3. Results and Discussion 
2.4.3.1. Synthesis of pH-Responsive Self-Immolative Polymers  
The polymeric coating was synthesized following the optimized protocol described in 
Section 2.3.2.3, using compounds 1 and 2 as monomer and end-cap, respectively, and 
DBTL as catalyst. All compounds were accordingly characterized, obtaining analogous 
results. The average molecular weight of the SIPs was ca. 3,300 g/mol. As it will be 
discussed in the following subsections, the pore size of the nanomatrices greatly affected 
the efficiency of the SIPS in sealing the mesopores. In this sense, the above-mentioned 
average molecular weight was the highest that could be obtained. In consequence, the 
consortium agreed to synthesize an alternative pH-responsive polymer that will be 
described in Section 2.5.  
2.4.3.2. Synthesis of SIP-Coated MOZART Nanomatrices  
The synthetic protocol for the functionalization of the MOZART nanomatrices was 
modified to minimize the potential ion leakage during the reaction and subsequent 
washing steps. First, the SIPs were reacted with an organosilane and then that mixture 
was added to the corresponding nanoparticles, as depicted in Scheme 2.10. 
Two different organosilanes were used, one bearing an isocyanate and another one 
bearing a carboxylic acid. The reason for substituting the chloro organosilane previously 
employed for the synthesis of SIP-coated MSNs (Section 2.2.2.3) relied on the high 
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temperature that was needed for its coupling with the polymeric chain. Then, in order to 
avoid any temperature-induced self-condensation events prior to the addition on the 
nanoparticles, the functionality of the linker was initially changed to an isocyanate (mild 
reaction temperature) and finally to a carboxylic acid (reaction at rt). 
 Synthesis of SIP-Coated MOZART Nanomatrices Using an Isocyanate-Based Linker  
(Protocol A) 
In a first approach, the isocyanate linker was attached to the self-immolative chain and 
then this mixture was added to Nanolith and Polito-US nanomatrices. A ratio 1:6 
(nanomatrices:SIP) was initially employed. However, the yield was almost negligible and 
the polymer percentage was increased to 1:15. The SIP-coated Nanolith carriers were 
characterized by TGA analysis and FTIR spectroscopy to confirm the presence of the 
polymer (Figure 2.57).  
 
Figure 2.57. a) TGA analysis of Nanolith vs Nanolith-SIP. b) FTIR spectroscopy of Nanolith vs Nanolith-
SIP. The increase in the weight loss and the appearance of vibration bands associated to the carbamates 
confirmed the presence of the polymer.  
The TGA analysis (Figure 2.57a) showed a weight loss of 4.2% after the SIP coating, 
which was calculated between 150ºC and 450ºC. In addition, the FTIR spectroscopy 
(Figure 2.57b) showed evidences of vibration bands ascribed to the carbamates of the 
polymer. The combination of both results confirmed the presence of the polymer coating 
the surface of the particles.  
Polito-US samples were also functionalized with the self-immolative polymeric 
coating using the isocyanate linker and the output of the grafting was characterized 
through TGA analysis and FTIR spectroscopy (Figure 2.58).  
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Figure 2.58. a) TGA analysis of Polito-US vs Polito-US-SIP. b) FTIR spectroscopy of Polito-US vs Polito-
US-SIP. The increase in the weight loss and the appearance of the vibration bands associated to the 
carbamates confirmed the presence of the polymer.  
In this case, the TGA analysis (Figure 2.58a) showed ca. 6.5% of additional weight 
loss after the functionalization. In addition, presence of vibration bands ascribed to the 
carbamate could be observed in the FTIR spectrum of Polito-US-SIP (Figure 2.58b). In 
consequence, the maximum amount of organic matter that could be incorporated using a 
ratio nanomatrices:SIP 1:15 was ca. 6.5%, which seemed quite low for such amount of 
initial polymer. The main reason would be that the addition of the SIP to the isocyanate 
in DMF was less effective as it is in other solvents, such as dichloromethane. However, 
the SIP was insoluble in such solvents and a new linker bearing a different functionality 
was synthesized.  
 Synthesis of SIP-Coated MOZART Nanomatrices Using a Carboxylic Acid-Based Linker 
(Protocol B) 
The linker containing the carboxylic acid functionality was straightforwardly 
synthesized from APTES and succinic anhydride and its correct synthesis was verified 
by 1H-NMR (Figure 2.59). 
 
Figure 2.59. 1H-NMR of compound 4. (250 MHz, DMSO) δ 7.86 (t, 1H), 3.74 (q, 6H), 3.86–3.66 (m, 2H), 
2.41 (t, 2H), 2.29 (t, 2H), 1.53–1.31 (m, 2H), 1.15 (t, 9H), 0.63–0.45 (m, 2H). 
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The linker was attached to the SIP via carbodiimide chemistry, using catalytic DMAP 
to create a good leaving group that the alcohol could easily displace under mild 
conditions.8 Then, the silylated polymer was added to the particles to yield SIP-coated 
nanomatrices. In this sense, FAU nanomatrices were employed to evaluate the 
convenience of using compound 4 to silylate the SIPs. The correct grafting of the 
polymeric coating was verified through TGA analysis and FTIR spectroscopy (Figure 
2.60).  
 
Figure 2.60. a) TGA analysis of FAU vs FAU-SIP. b) FTIR spectroscopy of FAU vs FAU-SIP. The 
presence of the SIP was confirmed by the great % weight loss and the evident vibration bands associated 
to the carbamates from the SIP.  
The TGA analysis (Figure 2.60a) showed additional ca. 40% of weight loss, which 
was ascribed to the presence of the polymeric coating on the particles. In addition, the 
functionalization process led to the appearance of vibration bands typical of the SIP in 
the FTIR spectrum (Figure 2.60b). These results confirmed the presence of a significant 
amount of polymeric coating in the particles, highlighting the suitability of using 
compound 4 as silylating agent (Protocol B) rather than the organosilane bearing an 
isocyanate (Protocol A). 
Once a reliable grafting method was developed, the next step was to evaluate if the 
polymeric coating could close the pore entrances. For such purpose, the MOZART 
nanomatrices were loaded with the Ru dye prior to the SIP grafting. The presence of the 
polymer on the Ru-loaded FAU samples was evaluated using TGA analysis and FTIR 
spectroscopy (Figure 2.61). 
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Figure 2.61. a) TGA analysis of FAU vs FAU-Ru-SIP. b) FTIR spectroscopy of FAU vs FAU-Ru-SIP. The 
amount of organic matter incorporated after the functionalization was lower when the Ru dye was present 
(ca. 40% for FAU-SIP vs ca. 11% for FAU-Ru-SIP). The FTIR spectra showed vibration bands ascribed to 
the polymer. The differences might be ascribed to the presence of Ru molecules in the solutions that would 
interact with the silanol groups of the particles, decreasing the efficiency of the grafting. 
As shown in Figure 2.61a, the amount of additional organic matter present in the 
sample was significantly lower when the grafting was carried out after loading the 
nanomatrices with the dye (ca. 40% for FAU-SIP vs ca.11% for FAU-Ru-SIP). The FTIR 
spectrum (Figure 2.61b) showed vibration bands associated to the carbamates, confirming 
the presence of the SIP. From this results, it could be concluded that the presence of Ru 
molecules influenced the efficiency of the SIP grafting. This might be ascribed to the fact 
that Ru molecules could also interact with the silanol groups of the particles, decreasing 
the total amount of reactive points for the silylated SIP, and then, the total amount of 
organic matter on the sample.  
Ru-loaded Polito samples coated with the SIPs were also produced. For that purpose, 
the particles were initially loaded with the dye and subsequently functionalized with the 
self-immolative polymeric coating. The success of the SIP coating on Polito-US 
nanomatrices was evaluated through TGA analysis and FTIR spectroscopy (Figure 2.62). 
 
Figure 2.62. a) TGA of Polito-US vs Polito-US-Ru-SIP. b) FTIR spectroscopy of Polito-US vs Polito-US-
Ru-SIP. The ca. 9% of weight loss and the appearance of vibration bands associated with the carbamate 
confirmed the successful functionalization.  
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The TGA analysis (Figure 2.62a) showed an increase in the % weight loss of ca. 9%, 
compared to the pristine sample. The FTIR spectroscopy (Figure 2.62b) revealed the 
presence of vibration bands associated to the SIP carbamates, confirming the presence of 
the coating in the functionalized samples. The same techniques were applied for the 
characterization of the SIP-coated Polito-SD nanomatrices (Figure 2.63). 
 
Figure 2.63. a) TGA of Polito-SD vs Polito-SD-Ru-SIP. b) FTIR spectroscopy of Polito-SD vs Polito-SD-
Ru-SIP. The weight loss and the appearance of the vibration bands associated with the carbamate confirmed 
the successful functionalization. 
In this case, the grafting of the polymer induced ca. 7.5% of additional weight loss 
(Figure 2.63a). Besides, the FTIR spectrum of SIP-coated Polito-SD loaded with Ru 
demonstrated the presence of vibration bands ascribed to the polymer. Both results 
confirmed the correct functionalization with the self-immolative polymeric coating.  
2.4.3.3. Synthesis of SIP-Coated Labelled MOZART Nanomatrices for Future In 
vivo Experiments 
Some nanomatrices (FAU and Polito-US) were labelled with a silylated fluorophore 
in view of future in vivo administration. The labelling was carried out post-synthesis 
because, otherwise, the calcination process employed to remove the surfactant employed 
as template during the synthesis of the particles would destroy the organic dye. 
Calcination was employed for these nanomatrices because the use of solvent extraction 
would likely remove the calcium from the particles, leading to their degration. 
The first step was to find out if the presence of the fluorophore would affect the SIP 
coating. The efficiency of the grafting was initially evaluated using Polito-US 
nanomatrices labelled with a readily available dye, namely FITC. The functionalization 
was characterized through TGA analysis and FTIR spectroscopy (Figure 2.64). 
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Figure 2.64. a) TGA analysis of Polito@FITC-US vs Polito@FITC-US-SIP. b) FTIR spectroscopy of 
Polito@FITC-US vs Polito@FITC-US-SIP. The great increase in % weight loss and the appearance of 
vibration bands ascribed to the carbamate confirmed the successful functionalization with the polymer.  
As shown in Figure 2.64a, the SIP grafting was unaffected by the presence of the dye, 
leading to an increase in the weight loss of ca. 40%. In addition, the FTIR spectroscopy 
(Figure 2.64b) revealed the appearance of vibrations bands associated to the carbamates. 
These 2 results were in agreement with those in Figure 2.60, clearly indicating that (1) 
the polymer could be grafted to the nanoparticles regardless of the presence of the 
covalently attached dye and (2) attempting the functionalization without the Ru dye in 
the medium yielded better results. Once the feasibility of grafting the SIP on the labelled 
samples was verified, the next step was to functionalize FAU and Polito-US nanocarriers 
labelled with the in vivo dye.  
The presence of the in vivo dye somehow affected the dispersibility of Polito@in vivo-
US nanomatrices in DMF and, consequently, the conditions described in Section 2.4.2.2 
(Protocol B) could not be applied. A very diluted mixture of DMF and AcN was employed 
as an alternative. The mixture was adjusted so that (1) the particles could be properly 
dispersed and (2) the SIP, which was insoluble in AcN, could be added to the particles 
without precipitating. The output of the reaction was evaluated by FTIR spectroscopy 
(Figure 2.65). 
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Figure 2.65. FTIR spectroscopy of Polito@in vivo-US vs Polito@in vivo-US-SIP. It could be concluded 
from comparison between both spectra that the reaction did not proceed. 
The vibration bands typical of SIP could not be observed in the FTIR spectrum (Figure 
2.65), indicating that the grafting was ineffective, most probably as a consequence of the 
very diluted conditions employed. 
On the other hand, the dispersibility of the FAU nanomatrices after the attachment of 
the dye remained unaffected. In consequence, the functionalization was carried out 
following the protocol described in Section 2.4.2.2 (Protocol B, carboxylic acid) and 
characterized through FTIR spectroscopy (Figure 2.66). 
 
Figure 2.66. FTIR spectroscopy of FAU@in vivo vs FAU@in vivo-SIP. The appearance of the vibration 
bands associated with the carbamates confirmed the successful functionalization. 
The appearance of vibration bands ascribed to the carbamates in Figure 2.66 confirmed 
the proper SIP grafting. The results were in agreement with those in Figure 2.60 and 2.64, 
confirming the feasibility of grafting the SIPs on previously labelled nanomatrices.  
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2.4.3.4. Release experiments 
Once verified the presence of the polymer on the nanoparticles, the effective sealing 
of the pores was evaluated via release experiments at physiological and acid pH to mimic 
the acid environment that was expected to be found in delayed bone healing and chronic 
wound healing. The release experiment for FAU-SIP is shown in Figure 2.67. 
 
Figure 2.67. Release experiment of Ru-loaded FAU-SIP at pH 7.4 and 5. The pore size (ca. 4 nm) was too 
big to close the pore entrances with the SIPs, although the sample at acid pH released more dye, in 
agreement with the results shown in Sections 2.2 and 2.3.  
The release experiment depicted in Figure 2.67 shown that ca. 75% of the dye was 
released at physiological pH, indicating that the SIP coating was ineffective in closing the 
pore entrances. This was ascribed to the pore size (ca. 4 nm), which was too big to be 
sealed with the here produced polymer chain (3,300 g/mol). Interestingly, the samples at 
acid pH could still release more amount of dye, in agreement with the pH-responsive 
behavior previously observed in Sections 2.2 and 2.3. The release experiment for Polito-
US-SIP nanomatrices is depicted in Figure 2.68. 
 
Figure 2.68. Release experiment of Polito-US-SIP at pH 7.4 and 5. In this case, the sealing of the mesopores 
was more efficient, and promising kinetics were obtained.  
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As shown in Figure 2.68, the SIP coating sealed more efficiently the pore entrances 
and significantly higher amount of dye was released at acid pH (two times the dye 
measured at pH 7.4). In addition, this further confirmed the pH-responsive behavior of 
the SIPs. The more effective capping was ascribed to a smaller pore size, ca. 3 nm, closer 
to MSNs. Finally, the effectiveness of the pore sealing in Polito-SD-SIP was evaluated 
(Figure 2.69). 
 
Figure 2.69. Release experiment of Polito-SD-SIP at pH 7.4 and 5. In this case, the SIPs coating was 
ineffective and significant premature release could be observed, probably due to the large pore size (ca. 7 
nm). 
The release experiment of Polito-SD-SIP (Figure 2.69) showed similar kinetics than 
that of FAU-SIP, showing significant premature release (more than 60% after 12 hours) 
as a consequence of the ineffective pore capping. This experiment confirmed the 
hypothesis of the pore size (ca. 7 nm in this case), i.e., the higher the pore size, the lower 
the effectiveness of pore sealing (Figure 2.70). 
 
Figure 2.70. Premature release at 12 hours. The pore size, polymer length and amount of premature release 
were interrelated. For the same SIP molecular weight, the lowest premature release was obtained for Polito-
US-SIP, which showed the smallest pore size.  
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As shown in Figure 2.70, the pore size directly influenced the effectiveness of the 
capping. In this sense, the use of SIPs with higher molecular weights could not be 
explored because, as it was demonstrated in Table 2.7, there was an upper limit for the 
molecular weight of the polymers. Therefore, for a fixed molecular weight, the lower the 
pore size the more effective the sealing of the mesopores and, consequently, the lower 
premature release. As an alternative, the MOZART consortium agreed to synthesize a 
new polymer coating that would provide higher molecular weights, which will be 
addressed in Section 2.5.  
2.4.4. Conclusions 
The objective of the work here presented was to adapt the self-immolative technology 
to the different silica-based nanomatrices provided by the MOZART consortium. One of 
the key points of the proposal was the loading of therapeutic ions within the silica 
framework to achieve synergistic effects with a variety of co-loaded compounds. In this 
sense, the two-step grafting protocol described for the synthesis of SIP-coated MSNs was 
modified to minimize the premature ion leakage as a consequence of the multiple reaction 
and washing steps. Instead, a one-pot protocol was developed and two alkoxysilanes were 
explored to effectively attach the SIPs to the nanomatrices, being the carboxylic acid-
based (Protocol B) the one that yielded best results.    
The experimental evidence showed that the SIP grafting was less efficient when the 
different nanomatrices were previously soaked in a saturated solution of a model payload. 
The most probable reason would be that Ru molecules would interact with the silanol 
groups of the particle, decreasing the reacting points for the silylated SIP and, 
consequently, the total amount of polymer grafted.  
The degree of functionalization was unaffected by the presence of covalently attached 
fluorescent molecules on the particles. Polito@FITC-US and FAU@in vivo nanomatrices 
provided excellent results in terms of amount of SIP incorporated, although Polito@in 
vivo-US nanomatrices could not be functionalized due to their poor dispersibility, even 
though much diluted mixture of solvents was employed. 
The release experiments carried out for FAU-SIP and Polito-SD-SIP showed 
significant premature release at physiological pH, clearly indicating the ineffective 
capping of the pore entrances. This was ascribed to the large pore sizes found in both 
nanomatrices (ca. 4 and 7 nm, respectively), which would be difficult to seal with a 
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polymer of this molecular weight (ca. 3,300 g/mol), which was the maximum molecular 
weight that could be obtained and, as a contingency plan, the consortium agreed to 
proceed with a different type of polymer (Section 2.5). On the contrary, the results 
obtained for Polito-US-SIP nanomatrices (pore size ca. 3 nm) were much promising and 
significant differences were observed, as a consequence of a more effective sealing. 
Overall, all samples showed higher release at acid pH, which was in agreement with the 
pH-responsive behavior of SIPs previously discussed in this thesis.   
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2.5. Design of Self-Immolative Polymers Responsive to 
Alternative pH Values 
2.5.1. Introduction 
Initially, the MOZART proposal devised a scenario where acid pH could be a relevant 
biomarker for delayed bone healing and chronic wound healing. One of the first tasks of 
the consortium was the determination of an accurate pH value using in vivo models. This 
value was thought to be close to pH 5 and, in consequence, the acid-responsive self-
immolative polymer described in the first the first sections of this thesis was designed as 
gatekeeper. However, the experimental in vivo evidence showed that several pH values, 
including acid and basic pH, were found in those scenarios.  
The pH value in chronic wound healing was studied by members of the MOZART 
consortium from Sheffield University using a skin tissue model.1 Skin has an upper 
protective acid barrier at pH 5.5, value that increases up to 7-8 beneath this boundary. 
Raman spectroscopy was employed to evaluate the effect that bacterial infection might 
have on the pH of that skin model. The protonation state of the phosphate groups present 
throughout the epithelium was analyzed to determine the pH value (Figure 2.71).  
 
Figure 2.71. Measurement of pH in bacterially infected skin. H&E sections (A, C, & E) and pH plots (B, 
E, & F) of control skin (A & B), S. aureus infected skin (C & D), and P. aeruginosa infected skin (E & F). 
Reproduced from Ref 1 with permission of Taylor & Francis Online. 
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It was found that normal skin tissue essentially possessed pH ca. 7.5 (Figure 2.71B). 
However, the analysis of bacterially infected tissue demonstrated the presence of both 
acid and basic pH values (Figures 2.71D and F). The acid values were ascribed to the 
presence of biofilm-related microenvironment. The authors speculated that the basic 
values might be ascribed to the presence of alkaline phosphatase, which functions 
optimally between pH 8 at 11. The most recurrent value was found to be pH ca. 8 
The pH value in bone healing processes was evaluated by members of the MOZART 
consortium from the Julius Wolff Institut, Charité-Universitätsmedizin Berlin 
(unpublished results). In this work, rat and sheep animal models were employed for the 
study of pH in bone injury and muscle trauma, respectively. The pH during the first steps 
of bone healing was recurrently found to be ca. 6.8. A profound comparative between 
healthy and injured tissues concluded that during musculoskeletal lesions the tricarboxyl 
acid cycle stagnates and the energy is obtained through anaerobic metabolism, thus 
leading to the slight tissue acidification. 
In view of the above-mentioned results, the consortium agreed to explore the synthesis 
of self-immolative polymers sensitive to pH 8 or 6.8 to trigger the release from the 
mesoporous matrices in wound and bone healing scenarios, respectively. The polymer 
backbone was similar to that developed in Sections 2.2 and 2.3, so the main task here was 
to design acid and basic-responsive self-immolative triggers. These two molecules were 
designed following an approach similar to that of compound 2, i.e., that of the pH 5-
responsive self-immolative trigger (Scheme 2.11). 
 
Scheme 2.11. Schematic representation of the design of the self-immolative triggers synthesized in this 
doctoral thesis. Compound 1 is used as monomer for the polymerization. The triggers are designed so that 
they show a nucleophilic area that resembles that of compound 1 (in blue). The second part of the trigger 
(in orange) is tuned so that it can be cleaved by the specific stimulus (pH 5, 8 or 6.8, respectively).  
pH 5
pH 8
pH 6.8
5
15
1
Nucleophilic part of the self-immolative trigger (resembles compound 1)
2
Triggering part of the self-immolative trigger
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The triggers responsive to pH 8 (Scheme 2.11, compound 5) and 6.8 (Scheme 2.11, 
compound 15) were designed so that they showed a nucleophilic part with similar 
reactivity as that of compound 1 (Scheme 2.11, blue). In this way, as it happened with 
compound 2, these new triggers would be easily introduced as end-cap to the preformed 
polymeric chain. The second part (Scheme 2.11, orange) would endow the molecules with 
specific responsiveness to either pH 8 or 6.8, so that the trigger could be cleaved in those 
particular scenarios.  
The starting point for the synthesis of the basic-sensitive trigger was a previous article 
that showed that 4-hydroxybenzyl alcohol undergoes self-immolation at pH 8.2 The 
trigger synthesis was attempted through three different approaches involving synthetic 
strategies based on (1) the use of isocyanates, (2) the employment of alcohol-amine 
coupling agents and (3) the use of alcohol protecting groups.  
The use of a benzoic imine bond was explored for the design of the acid-responsive 
trigger, since it is known to be hydrolyzed at pH 6.8.3 As it will be shown in this section, 
the incorporation of the trigger into the polymeric chain was unsuccessful and the 
synthesis of a different polymer with a totally different release mechanism was attempted 
as a contingency plan. 
2.5.2. Materials and Methods 
The following compounds were purchased from Sigma-Aldrich Inc.: APTES; ABA; 
DIPEA; 1,1’-Carbonyldiimidizole (CDI); 4-Hydroxybenzyl alcohol (HBA); tert-
Butyldimethylsilyl chloride (TBDMS-Cl); 4-hydroxybenzaldehyde (HBDA); p-
Toluenesulfonic acid (TsOH); 3,4-dihydropyran; DBTL; DMAP; Ru; BOC2O; 2-
Piperidinoethanol; Methacryloyl chloride; Hydroquinone; 4,4’-azobis (4-cyanovaleric 
acid); DMF; THF; DCM; AcN. The rest of the chemicals (ethanol, heptane, etc) were of 
the best quality and were employed as received. All compounds were characterized 
through 1H-NMR.  
2.5.2.1. Self-Immolative Polymer Sensitive to pH 8  
 Protocol A: Amine to isocyanate 
The conversion of the amino group of ABA to an isocyanate was carried out following 
a previously reported method with some modifications.4 To a vial containing BOC2O 
(0.62 g, 2.84 mmol) in AcN (2 mL), a solution of DMAP (0.024 g, 0.02 mmol) in AcN 
(0.5 mL) and ABA (0.25 g, 2.03 mmol) in AcN (2 mL) were successively added. Right 
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after the addition of the amine a white solid precipitated out of the solution, which was 
filtered and dried under vacuum.  
 Protocol B: Coupling agent 
To a N2-purged vial containing HBA (0.25 g, 2.01 mmol), dry THF (10 mL) was 
added. Then, CDI (0.33 g, 2.01 mmol) was added dropwise and the mixture was stirred 
for 2 hours at rt. After that, ABA (0.496 g, 4.02 mmol) in the minimum amount of dry 
THF was added and the reaction was stirred overnight. Afterward, the solvent was 
removed under vacuum.  
 Protocol C: Protection of alcohol groups  
 phenyl (4-(((tert-butyldimethylsilyl)oxy)methyl)phenyl)carbamate (6) 
For the synthesis of compound 6, a previously reported method with slightly 
modifications was followed.5 Compound 1 was synthesized as previously described in 
Section 2.3.2.3. Then, to a vial containing compound 1 (1 g, 4.2 mmol) and imidazole 
(0.31 g, 4.52 mmol), DCM (20 mL) was added. After that, TBDMS-Cl (0.75 g, 5 mmol) 
was added dropwise and the mixture was stirred overnight at rt. Afterward, the resulting 
imidazole salts were removed by filtration and the solvent was evaporated under reduced 
pressure. Finally, the product was purified on a silica column (DCM) to yield compound 
6 as a white solid.  
 4-(tert-butoxy)benzyl (4-(((tert-butyldimethylsilyl)oxy)methyl)phenyl)carbamate (8) 
 tert-butyl (4-(hydroxymethyl)phenyl) carbonate (7) 
To a vial containing HBA (0.5 g, 4.03 mmol) and BOC2O (0.88 g, 4.03 mmol), THF 
(15 mL) and DIPEA (0.70 mL, 4.03 mmol) were added. Then, the mixture was refluxed 
overnight and subsequently evaporated under vacuum, leading to compound 7 as 
colorless oil. 
 4-(tert-butoxy)benzyl (4-(((tert-butyldimethylsilyl)oxy)methyl)phenyl)carbamate (8) 
To a vial containing compound 6 (0.5 g, 1.39 mmol) and compound 7 (0.38 g, 1.67 
mmol), toluene (10 mL) was added. Then, DBTL (20% mol) was added and the mixture 
was refluxed for 3 hours. After that, the solvent was removed under vacuum and the 
product was purified in a silica column (ethyl acetate/heptane, 1:9) to yield compound 8 
as a colorless oil. 
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 4-((tert-butyldimethylsilyl)oxy)benzyl (4-(((tert-butyldimethylsilyl)oxy)methyl)phenyl)carbamate (11) 
 4-((tert-butyldimethylsilyl)oxy)benzaldehyde (9) 
To a vial containing HBDA (1 g, 8.2 mmol) and imidazole (0.61 g, 9 mmol), DCM 
(25 mL) was added. Then, TBDMS-Cl (1.23 g, 8.2 mmol) in DCM (5 mL) was added 
dropwise and the mixture was stirred overnight at rt. After that, the imidazole salts were 
filtered off and solvent was removed under reduced pressure. Finally, the product was 
purified in a silica column (ethyl acetate/heptane, 1:3) to yield compound 9 as a colorless 
oily product.  
 (4-((tert-butyldimethylsilyl)oxy)phenyl)methanol (10) 
To a vial containing compound 9 (1.2 g, 5.1 mmol), methanol (20 mL) was added. 
Then, NaBH4 (0.23 g, 6.12 mmol) was slowly added and the reaction was stirred for 30 
minutes. After that, diluted HCl was added and the product was extracted in DCM. The 
organic layer was washed with a saturated solution of NaCl, dried over sodium sulfate 
and evaporated under reduced pressure, leading to compound 10 as a yellow oil.   
 4-((tert-butyldimethylsilyl)oxy)benzyl (4-(((tert-butyldimethylsilyl)oxy)methyl)phenyl)carbamate (11) 
To a vial containing compound 6 (1 g, 2.79 mmol) and compound 10 (0.8 g, 3.36 
mmol), toluene (45 mL) was added. Then, DBTL (20% mol) was added and the mixture 
was refluxed for 3 hours. After that the solvent was removed and the product was purified 
in silica column (ethyl acetate/heptane, 1:10) to yield compound 11 as a colorless oil.  
 4-((tetrahydro-2H-pyran-2-yl)oxy)benzyl (4-(((tert-butyldimethylsilyl)oxy)methyl)phenyl)carbamate (14) 
 4-((tetrahydro-2H-pyran-2-yl)oxy)benzaldehyde (12) 
For the protection of HBDA with the tetrahydropyranyl group, a previously described 
method was followed.6 Briefly, to a vial containing HBDA (1 g, 8.2 mmol) and pyridine 
(0.065 g, 0.82 mmol), DCM was added (25 mL). Then, TsOH (0.14 g, 0.82 mmol) in the 
minimum amount of DCM was added. After that, 3,4-dihydropyran (1.12 mL, 12.3 mmol) 
in DCM (5 mL) was added dropwise and the mixture was stirred overnight at rt. After 
that, the solution was filtered through a short silica column and evaporated. The oily 
product was dissolved in ether, washed with NaCl and subsequently evaporated to yield 
an oil that was purified in a silica column (ethyl acetate/heptane, 1:9) leading to 
compound 12 as a colorless oil. 
 (4-((tetrahydro-2H-pyran-2-yl)oxy)phenyl)methanol (13) 
To a vial containing compound 12 (0.8 g, 3.87 mmol), dry THF (30 mL) was added. 
Then, NaBH4 (0.176 g, 4.64 mmol) in the minimum amount of dry THF was added 
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dropwise and the mixture was stirred overnight. After that, the solution was extracted in 
ethyl acetate, washed with NaCl and evaporated to yield compound 13 as an oily product.  
 4-((tetrahydro-2H-pyran-2-yl)oxy)benzyl (4-(((tert-butyldimethylsilyl)oxy)methyl)phenyl)carbamate 
(14) 
To a vial containing compound 6 (0.72 g, 2 mmol) and compound 13 (0.5 g, 2.4 mmol), 
toluene (10 mL) was added. Then, DBTL (20% mol) was added and the mixture was 
refluxed for 3 hours. After that the solvent was removed to yield an oily product that was 
dissolved in DCM, washed with water, dried over sodium sulfate and finally evaporated. 
The product degraded when introduced in the chromatography silica column for 
purification.   
2.5.2.2. Self-Immolative Polymer Sensitive to pH 6.8 
 (E)-4-(((4-(hydroxymethyl)phenyl)imino)methyl)benzoic acid (15) 
To a N2-purged flask containing ABA (0.25 g, 2.03 mmol) and molecular sieves, 
anhydrous ethanol (10 mL) was added. Then, 4-carboxybenzaldehyde (0.31 g, 2.03 
mmol) in anhydrous ethanol (5 mL) was added dropwise and the reaction was stirred 
overnight at rt in the dark. Then, the solvent was removed and the product was 
recrystallized in ethyl acetate and hexane, leading to compound 15 as a yellow solid.  
 Poly(phenyl (4-(hydroxymethyl)phenyl)carbamate) end-capped with compound 15 (16) 
The synthesis was adapted from a previously reported method.7 Briefly, to a N2-purged 
flask containing compound 1 (1 g, 4.12 mmol), dry DMSO (2.05 mL) and Et3N (0.57 mL, 
4.12 mmol) were added and the mixture was heated at 60ºC for 6 hours. Then, compound 
15 (0.71 g, 2.8 mmol) in dry DMSO (1 mL) was added at rt and the whole reaction mixture 
was stirred for either 3 or 24 hours. After that, the product was precipitated in an excess 
of cold methanol, centrifuged and washed with methanol to yield a whitish solid.  
2.5.2.3. Polymer Undergoing Conformational Changes at pH 6.8 
This polymer was synthesized following a previously reported method with some 
modifications.8 
 2-(piperidin-1-yl)ethyl methacrylate (17) 
To a N2-purged vial containing hydroquinone (0.12 g, 1.09 mmol), dry inhibitor-free 
THF (100 mL), 2-piperidinoethanol (15 mL, 112 mmol) and Et3N (15.7 mL, 112 mmol) 
were added. Then, methacryloyl chloride (11 mL, 112 mmol) in dry inhibitor-free THF 
(10 mL) was added dropwise over 20 minutes at rt. After that, the reaction was refluxed 
for 2 hours and subsequently filtered to remove the Et3N salts. Then, the solvent was 
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removed under reduced pressure to obtain a yellowish oil that was dissolved in 
chloroform and washed with water and saturated solutions of NaCl and sodium carbonate. 
Finally, the solution was dried over sodium sulfate and the solvent was removed under 
vacuum, leading to a dark green solid. Purification of compound 17 was attempted either 
through distillation at reduced pressure or through chromatography on a silica column 
(ethyl acetate/heptane, 1:1). 
 Poly(2-(piperidin-1-yl)ethyl methacrylate (18) 
To a N2-purged vial containing compound 17 (0.5 g, 2.5 mmol), dry dioxane (1.5 mL) 
was added and the mixture was deoxygenated. Then, 4,4’-azobis (4-cyanovaleric acid) 
(1% mol, 0.5% mol, 0.25% mol or 0.125% mol) in deoxygenated dioxane was added and 
the mixture was introduced in a bath at 80ºC and stirred overnight. Afterward, the mixture 
was precipitated in a (4:3) solution of methanol and 0.2 M NaOH, centrifuged and dried 
under vacuum to yield compound 18 as a reddish oily product.  
2.5.3. Results and Discussion 
2.5.3.1. Synthesis of a Self-Immolative Polymer Sensitive to pH 8 
In a first attempt, the general protocol described in Section 2.3 for the synthesis of pH 
5-responsive SIPs, i.e., formation of the polymeric chain and subsequent addition of the 
pH 5 trigger, were adapted for basic-responsive polymers. However, this approximation 
led to negligible trigger incorporation when using directly HBA instead of compound 2.  
In this sense, the synthesis of a triggering monomer analogous to compound 2 but 
sensitive to pH 8 (compound 5) was attempted. Three different strategies were explored 
(Scheme 2.12).  
 
Scheme 2.12. Different approximations for the synthesis of compound 5. Top: Target molecule. Bottom 
left corner: Protocol A, which was based on the formation of an isocyanate as intermediate of compound 5. 
Bottom center: Protocol B, which was based on the use of coupling agents for alcohols and amines. Bottom 
right corner: Protocol C, which was based on the protection of alcohol groups. 
Protocol B
(coupling agent) 
Protocol A
(isocyanate)
Protocol C
(phenol protection)
5
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Once synthesized, compound 5 would be used as end-cap for the preformed polymeric 
chain produced from compound 1. It should react with the self-immolative chain through 
the benzylic alcohol rather than the phenolic one, since it has been reported that a benzylic 
alcohol reacts preferentially over a phenolic one in the presence of DBTL.9 
The first approximation for the synthesis of compound 5 consisted in the formation of 
a carbamate between ABA and HBA. For that purpose, the amino group of ABA was 
converted to an isocyanate. Then, the benzyl alcohol of HBA would be added to yield 
compound 5 (Scheme 2.13). 
 
Scheme 2.13. Schematic representation of Protocol A. The amino group of ABA would be converted to an 
isocyanate group, to which HBA would be added to yield compound 5.  
The conversion was observed to be highly efficient. Indeed, (4-isocyanatophenyl) 
methanol underwent rapid self-polymerization and a white solid, which turned out to be 
a short SIP chain, precipitated out of the solution and prevented the subsequent addition 
of HBA.   
The second approximation consisted in the formation of the carbamate between ABA 
and HBA through a coupling agent to yield compound 5. CDI was used to mediate the 
carbamate formation from the alcohol and the amine.10,11 The idea was the formation of 
the CDI intermediate of HBA and the subsequent addition of ABA to create the carbamate 
(Scheme 2.14).  
 
Scheme 2.14. Schematic representation of Protocol B. A coupling agent would be used to initially create 
an CDI intermediate of HBA to which ABA would then be added, leading to compound 5.  
However, due to the similar reactivity of both alcohol groups of HBA, a mixture of 
benzyl-activated and phenol-activated CDI intermediates together with HBA-HBA 
carbonates were formed, leading to mixtures whose purification could not be performed. 
In consequence, this synthetic approximation was discarded.  
BOC2O
DMAP
Protocol A
5
Protocol B
5
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In view of the unsatisfactory previous results, it was concluded that the similar 
reactivity of the alcohol groups of HBA constituted the bottleneck of the synthesis. As an 
alternative, the previous activation of the benzylic alcohol of HBA with a base to enhance 
its reactivity was explored. However, the more acidic nature of the phenolic alcohol 
induced its activation over the benzylic one. This observation led to the third synthetic 
pathway, which consisted in the use of alcohol protecting groups. Three of these groups 
were explored (Scheme 2.15). 
 
Scheme 2.15. Different protecting groups for HBA. Left bottom corner: tert-butoxycarbonyl (BOC); 
Center: tert-butyldimethylsilyl ether (TBDMS); Right bottom corner: tetrahydropyranyl (THP). 
This third approximation was based on (1) the protection of the benzylic alcohol of 
compound 1 and (2) the protection of the phenolic alcohol of HBA. Then, these two 
molecules would be reacted using DBTL to activate the carbamate of compound 6. In a 
final step, the alcohol groups would be deprotected to yield compound 5 (Scheme 2.16).  
 
Scheme 2.16. Schematic representation of Protocol C. The benzylic alcohol of compound 1 was protected 
and then phenol-protected HBA was added. The final step would be the deprotection of the alcohol groups 
to yield compound 5. R: Protecting group for the phenolic alcohol. 
Compound 1 was synthesized using ABA as starting material and subsequently 
subjected to TBDMS protection to yield compound 6. This group was chosen for the mild 
BOC TBDMS THP
Deprotection
1 6
5
BOC (7)
TBDMS  (10)
THP (13)
R=
BOC (8)
TBDMS  (11)
THP (14)
R=
Protocol C
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conditions required for its deprotection (either fluoride or acid treatments at rt).12,13 The 
successful synthesis of compound 6 was characterized trough 1H-NMR (Figure 2.71). 
 
Figure 2.71. 1H-NMR of compound 6. (250 MHz, DMSO) δ 10.25 (s, 1H), 7.58–7.12 (m, 9H), 4.66 (s, 
2H), 0.90 (s, 9H), 0.07 (d, 6H). 
In a first approach, the phenolic alcohol of HBA was activated with a base a 
subsequently protected with BOC2O (Figure 2.72). 
 
Figure 2.72. 1H-NMR of compound 7. (250 MHz, DMSO) δ 7.24 (dd, 4H), 5.26 (t, 1H), 4.50 (d, 2H), 1.49 
(s, 9H). 
The precursor of compound 5 was synthesized reacting compound 6 and compound 7 
in the presence of DBTL (Figure 2.73). 
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Figure 2.73. 1H-NMR of compound 8. (250 MHz, DMSO) δ 9.78 (s, 1H), 7.58–7.17 (m, 9H), 5.15 (s, 2H), 
4.63 (s, 2H), 1.50 (s, 9H), 0.89 (s, 9H), 0.07 (s, 6H). 
Once synthesized the precursor of the trigger sensitive to pH 8, the next step was the 
deprotection of both alcohol groups. TFA in DCM was employed to remove both acid-
sensitive protecting groups. First, the cleavage was carried out at rt but the BOC group 
remained unaffected. The protocol was repeated at DCM reflux, leading to the 
deprotection of both groups but yielding a molecule where the expected signals could not 
be observed (Figure 2.74). 
 
Figure 2.74. Deprotection of compound 8. The application of TFA at DCM reflux led to a compound where 
the expected signals could not be observed.  
In view of these results, the TBDMS protecting group was employed to protect HBA. 
In a first attempt, the phenolic alcohol of HBA was activated with DIPEA but both 
alcohols were protected, regardless of the reactivity (Figure 2.75). 
Aromatics
1
1 3
3
2
2
4
4
5
5
6
6
DMSOWater
TFA
DCM reflux
181
Chapter 2: Stimuli-Responsive Drug Delivery 
Design of Self-Immolative Polymers Responsive to Alternative pH Values 
 
 
 
 
Figure 2.75. 1H-NMR of the protection of HBA with TBDMS. The magnified area represents the TBDMS 
signals. This protecting group indiscriminately protected both alcohol functionalities of HBA, as 
demonstrated by signals (1 and 2) and (3 and 4). 
In view of Figure 2.75, both alcohols were protected in almost the same proportion. 
Then, the yield after purification would be ca. 50% as much. For that reason, HBDA was 
chosen as starting material. Its alcohol would be protected and then the aldehyde reduced 
to yield a benzylic alcohol. The successful protection of HBDA was confirmed through 
1H-NMR (Figure 2.76).  
 
Figure 2.76. 1H-NMR of compound 9. (250 MHz, DMSO) δ 9.89 (s, 1H), 7.46 (dd, 4H), 0.97 (s, 9H), 0.26 
(s, 6H). 
Compound 9 was treated with NaBH4 to reduce the aldehyde, leading to compound 10 
(Figure 2.77). 
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Figure 2.77. 1H-NMR of compound 10. (250 MHz, DMSO) δ 7.00 (dd, 4H), 5.07 (t, 1H), 4.41 (d, 2H), 
0.95 (s, 9H), 0.18 (s, 6H). 
Finally, the TBDMS-protected analogue of HBA was added to compound 6 in the 
presence of DBTL to yield compound 11 (Figure 2.78).  
 
Figure 2.78. 1H-NMR of compound 11. (250 MHz, DMSO) δ 9.71 (s, 1H), 7.56–6.75 (m, 8H), 5.06 (s, 
2H), 4.63 (s, 2H), 0.96 (s, 9H), 0.89 (s, 9H), 0.19 (s, 6H), 0.06 (s, 6H). 
Once compound 6 was synthesized, the next step was the deprotection of both alcohol 
groups to yield compound 5. The different deprotection strategies are summarized in 
Table 2.10. 
Table 2.10. Deprotection protocols applied to compound 11. O.N.: Overnight; (1): Benzylic alcohol; (2): 
Phenolic alcohol; TBAF: Tetra-n-butylammonium fluoride. 
Deprotection protocol Effect 
TBAF in THF Self-immolation → molecule degraded 
TBAF in THF/Water (4:1), rt, O.N. 0% deprotected 
TBAF in THF/Water (4:1), 45oC, O.N. (1) ca. 40% deprotected; (2) unaffected 
TsOH in THF/Water (4:1), 45oC, O.N. (1) ca. 40% deprotected; (2) unaffected 
TsOH/TBAF in THF/Water (4:1), 45oC, O.N. (1) ca. 70% deprotected; (2) unaffected 
TsOH in MeOH/DCM (1:1), 45oC, O.N. (1) ca. 100% deprotected; (2) unaffected 
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The standard deprotection protocol for the TBDMS group, i.e., TBAF in THF was 
initially explored. However, it rapidly induced the self-immolation of compound 11. A 
possible explanation for this would be the need of an acidic work-up to transfer a proton 
to the just deprotected alcohol. In the case of compound 11, that deprotonated 
intermediate state would probably start the self-immolation, degrading the molecule.  
As an alternative, compound 11 was treated with an aqueous solution of TBAF in THF. 
In this way, there would be protons in the solution that might be transferred to the alcohol 
after its deprotection, avoiding self-immolation. However, neither the reaction at rt nor at 
45ºC deprotected the phenolic alcohol.   
Since the TBDMS protecting group is known to be cleaved under acidic conditions, 
compound 11 was treated with aqueous solutions of TsOH in THF. Nevertheless, none of 
the explored conditions yielded compound 5.  
Finally, it was found that the TBDMS group of a benzylic alcohol could be readily 
cleaved using a solution of TsOH in methanol and DCM. However, the phenolic alcohol 
remained unaffected.  
In view of the efficient removal of the TBDMS group of the benzylic alcohol, the next 
approximation was to use a protecting group able to be cleaved under that condition. In 
this sense, the THP group, which is known to be efficiently removed by TsOH in 
methanol,14,15 was employed.  
HBDA was used again as starting material to prevent double alcohol protection. Its 
protection with the THP protecting group was characterized through 1H-NMR (Figure 
2.79). 
 
Figure 2.79. 1H-NMR of compound 12. (250 MHz, DMSO) δ 9.89 (s, 1H), 7.55 (dd, 4H), 5.67 (t, 1H), 
3.81–3.50 (m, 2H), 1.99–1.35 (m, 6H). 
1
2
3
1
2
3
4
4
Aromatics
DMSOWater
184
Chapter 2: Stimuli-Responsive Drug Delivery 
Design of Self-Immolative Polymers Responsive to Alternative pH Values 
 
 
 
Then, compound 12 was treated with NaBH4 to reduce the aldehyde, leading to 
compound 13 (Figure 2.80).  
 
Figure 2.80. 1H-NMR of compound 13. (250 MHz, DMSO) δ 7.10 (dd, 4H), 5.44 (t, 1H), 5.08 (t, 1H), 4.42 
(d, 2H), 3.90–3.43 (m, 2H), 1.98–1.39 (m, 6H). 
Once synthesized the THP-protected HBA, the next step was its addition to compound 6 to 
produce the precursor of the trigger sensitive to pH 8. However, the compound degraded as it was 
introduced in the silica column and, consequently, compound 14 could not be effectively 
synthesized. The most feasible explanation might be that the slightly acidic nature of the silica 
employed in the column might have cleaved the protecting group, leading to the premature 
degradation of compound 13. 
 In summary, the three approximations here developed (formation of isocyanate, use of 
coupling agents and use of protecting groups) were ineffective in producing the desired compound 
5. In view of all these results, the consortium agreed to stop the production of a self-immolative 
polymer sensitive to pH 8.  
2.5.3.2. Synthesis of a Self-Immolative Polymer Sensitive to pH 6.8 
The self-immolative trigger sensitive to pH 6.8 (compound 15) was synthesized 
through the reaction of ABA with 4-carboxybenzaldehyde. At pH 6.8, this compound 
would be hydrolyzed, leading to a free electron pair that would start the self-immolation. 
The successful synthesis of compound 15 was confirmed through 1H-NMR (Figure 2.81). 
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Figure 2.81. 1H-NMR of compound 15. (250 MHz, DMSO) δ 8.75 (s, 1H), 8.17–7.95 (m, 4H), 7.35 (dd, 
4H), 5.25 (t, 1H), 4.53 (d, 2H). 
Compound 15 was subjected to the SIP synthesis conditions described in Section 
2.3.2.3 (85ºC, 2 hours) prior to any attempt to end-cap the self-immolative chains. The 
trigger was analyzed before and after the thermal treatment through 1H-NMR (Figure 
2.82).  
 
Figure 2.82. 1H-NMR of compound 15. a) Before thermal treatment; b) After thermal treatment. The 
application of the SIP synthesis conditions to compound 15 led to the appearance of the signal ascribed to 
the aldehyde of the precursor, indicating the degradation of the imine.  
The appearance of a signal associated to the aldehyde of 4-carboxybenzaldehyde 
confirmed the degradation of the imine. In consequence, if compound 15 were added as 
end-cap for the SIPs, the in situ hydrolysis of the imine bond would induce the self-
immolation of the polymeric chain, and no SIP would be obtained.  
There are some examples in the literature about self-immolative polymers synthesized 
using monomers similar to compound 1, at rt and under basic conditions. Those examples 
include the use of DMAP16 or Et3N and catalytic DMAP
17 in toluene. However, 
compound 1 was insoluble in toluene so a protocol using Et3N in DMSO was followed.
7   
The self-immolative chain was synthesized at 60ºC. Then, the reaction was cool down to 
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preserve the integrity of compound 15 and the mixture was reacted for either 3 or 24 hours 
(Figure 2.83). 
 
Figure 2.83. 1H-NMR of a base-mediated SIP polymerization. The SIP could be synthesized using Et3N as 
catalyst (left). However, the addition of compound 15 for either 3 or 24 hours (right) did not induce any 
changes in the spectrum, demonstrating that the trigger could not be introduced employing this 
methodology. 
As shown in Figure 2.83, the polymeric backbone could be formed using a base as 
catalyst, although the molecular weight was lower than that obtained using DBTL. 
However, the addition of the trigger for either 3 or 24 hours had no effect and the spectrum 
remained unchanged.  
In view of these results, and in agreement with the MOZART consortium, the synthesis 
of a self-immolative trigger sensitive to pH 6.8 was discarded and a contingency plan was 
activated, as it is described in the following section. 
2.5.3.3. Synthesis of a Polymer Undergoing Conformational Changes at pH 6.8 
Even though the proposal devised the use self-immolative polymers, a safety clause 
was included, meaning that if all the approximations for the synthesis of the pH-
responsive SIP failed, a totally different approximation might be applied. In this sense, 
the synthesis of a class of polymer able to undergo conformational changes at pH 6.8 
rather than self-immolation was explored.8 This polymer would be grafted to the particles 
and would be collapsed on the surface at physiological pH, closing the pore entrances. 
However, after a slight drop in pH, the polymer chains would adopt an extended 
conformation, opening the pores and triggering the drug release.   
3 hours
24 hours
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The monomer was synthesized using 2-piperidinoethanol as tertiary amine-source. 
Compound 17 was characterized through 1H-NMR (Figure 2.84).  
 
Figure 2.84. 1H-NMR of compound 17. (250 MHz, CDCl3) δ 6.13 (s, 1H), 5.59 (d, 1H), 4.31 (t, 2H), 2.69 
(t, 2H), 2.57–2.37 (m, 5H), 1.97 (s, 3H), 1.71–1.53 (m, 5H), 1.53–1.36 (m, 2H). 
The polymerization was initially attempted using the Reversible Addition-
Fragmentation chain-Transfer (RAFT) polymerization method, using the as-synthesized 
compound 17 as monomer. The mixture was stirred overnight but no precipitated polymer 
could be observed when the reaction mixture was poured in a (4:3) methanol:0.2 M NaOH 
solution. A possible explanation for this might be the presence of amine impurities that 
induced the aminolysis of the thiocarbonylthio chain transfer agents.18 
 In consequence, two purification methods were explored. In a first approach, a 
distillation of compound 17 was attempted. Only a small amount of compound 17 could 
be distilled, even though many conditions were used, including improvements in the 
distillation set-up. However, this distilled monomer was unable to polymerize, despite 
several conditions were attempted.  
The free radical polymerization, which is unaffected by amine impurities, was used as 
an alternative. The obtained polymer was characterized through 1H-NMR (Figure 2.85). 
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Figure 2.85. 1H-NMR of compound 18. The signals obtained in the spectrum were in agreement with those 
expected for polymer like this. Integrals are not depicted due to the lack of representative signals to 
normalize the integrals.  
According to the literature,8 polymers with a molecular weight of ca. 20,000 g/mol 
should have been obtained. However, after several attempts, the best result was a polymer 
with a molecular weight of ca. 1,000 g/mol, which was even lower than that of compound 
3 (3,300 g/mol) (Figure 2.86).   
 
Figure 2.86. Mass spectroscopy analysis of compound 18. The best synthesis led to polymers with a 
molecular weight of ca. 1,000 g/mol, which was even lower than that of compound 3. 
Distilling the monomer yielded poor results, even though some authors suggest this 
method in the literature. In a final attempt, compound 17 was purified by silica column 
chromatography. The target compound and the traces could be easily separated in the thin 
layer chromatography. However, after being eluted through the chromatography column 
the obtained compound rapidly became a gel that was impossible to dissolve in any 
solvent (Figure 2.87). 
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Figure 2.87. Demonstration of the gelification of compound 17 after attempting its purification on a silica 
chromatography column. 
The thin layer chromatography of the crude reaction mixture of synthesis of compound 
16 showed several spots. A possible explanation for the gelification might be that the 
radical inhibitors employed during the synthesis of compound 17 were separated from the 
target compound, leading to undesired polymerization in the tube.  
In consequence, the contingency plan had to be abandoned and idea of developing a 
polymeric coating sensitive to pH 6.8 was discarded by the MOZART consortium.   
2.5.4. Conclusions 
In view of the results derived from the in vivo measurements of the pH values in bone 
and wound healing, the efforts in this chapter were headed towards the development of 
alternative self-immolative polymers sensitive to either pH 6.8 or 8, rather than the SIP 
sensitive to pH 5 previously described in Sections 2.2 and 2.3.  
First, the direct incorporation of the molecule sensitive to pH 8, HBA, as end-cap for 
the self-immolative chains was attempted but no incorporation was observed. In 
consequence, the synthesis of a triggering monomer sensitive to pH 8 was explored. Three 
different approximations were developed during this work.  
In a first approach, the amino group of ABA was converted to an isocyanate, to which 
HBA would be added to form the trigger. However, ABA underwent self-polymerization 
as the amine was converted to the isocyanate and the protocol had to be discarded.  
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Then, the use of coupling agents between alcohol and amines was explored. The 
similar reactivity of both alcohol groups of HBA induced a mixture of CDI-activated 
compounds that could not be purified. In consequence, the protocol had to be abandoned. 
The use of protecting groups for the phenolic alcohol of HBA was then explored. First, 
the BOC protecting group was employed. The precursor of the trigger was effectively 
synthesized, although the deprotection was unsuccessful and compound 5 could not be 
obtained. Then, the TBDMS group was used to protect HBA, but both alcohols were 
protected. As an alternative, HBDA was selected as starting material. Initially the 
phenolic alcohol was protected and then the aldehyde was easily reduced to a benzylic 
alcohol. Again, the precursor was successfully synthesized and several deprotection 
approaches were explored. The best result was the complete deprotection of the benzylic 
alcohol, remaining the phenolic one unaffected. In consequence, this approximation had 
to be discarded. Finally, Finally, the THP group was employed to protect HBDA. The 
precursor of the trigger sensitive to pH 8 could be synthesized. However, the attempts to 
purify the precursor were ineffective and the molecule degraded when subjected to silica 
column chromatography. 
In view of the results and the several synthetic approximations employed, the 
MOZART consortium agreed to abandon the synthesis of a self-immolative polymeric 
coating sensitive to pH 8.  
The design of the self-immolative polymer sensitive to pH 6.8 was based on a trigger 
containing a benzoic imine bond, which is known to be hydrolyzed at pH 6.8. The trigger 
was successfully synthesized. However, it degraded when subjected to the standard SIP 
synthesis conditions. Instead, a base-mediated polymerization was attempted. The 
polymeric chain could be formed but the trigger could not be incorporated, despite various 
conditions were used.  
As an alternative, the MOZART consortium agreed to follow a contingency plan, and 
a new polymer able to change its conformation upon changes in pH was proposed. The 
monomer could not be properly purified, even though several purification methods were 
attempted. Two polymerization methods were employed. The polymer could not be 
synthesized through the RAFT method, probably due the presence of amine impurities. 
The free radical method allowed the synthesis of the polymeric chain but low molecular 
weights were obtained, despite several conditions were explored.  
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In view of the above-mentioned results, the MOZART consortium agreed to stop the 
design of a polymeric coating sensitive to pH 6.8. 
For the sake of clarity, the conclusions for the synthesis attempts of polymers sensitive 
to pH 6.8 or 8 are summarized in the Tables 2.11 and 2.12, respectively. 
Table 2.11. Summary of the synthetic approximations for the synthesis of the trigger sensitive to pH 6.8. 
 
Table 2.12. Summary of the synthetic approximations for the synthesis of the trigger sensitive to pH 8. 
 
 
 
 
Molecule Approximation Description Success 
  
Formation of a self-
immolative benzoic imine 
bond between 4-
aminobenzyl alcohol and 
4-carboxybenzaldehyde 
Synthesis: YES 
Incorporation in the 
polymer chain: NO 
(Degraded with 
temperature and did 
not end-cap the 
polymerization 
mediated by a base) 
 
 
Precursor of a 
poly(methacrylate) that 
changes its conformation 
at pH 6.8 
Synthesis: NO (Failed 
purification) 
Polymer synthesis: 
NO (Extremely low 
molecular weights) 
 
 
Molecule Precursors Description Success 
 
 
Formation of an isocyanate from 4-
aminobenzyl alcohol and 
subsequent addition of 4-
hydrobenzyl alcohol 
Synthesis: NO 
(Purification failed) 
 
Incorporation in the 
polymer chain: NO 
 
 
Use of a coupling agent to form a 
carbamate between 4-
hydroxybenzyl alcohol and 4-
aminobenzyl alcohol 
Synthesis: NO 
(Purification failed) 
Polymer synthesis: NO 
 
Protection of (a) benzylic alcohol 
of compound 1 and (b) phenolic 
alcohol of 4-hydrobenzyl alcohol 
Synthesis: NO 
(Deprotection of phenolic 
alcohol failed) 
Incorporation in the 
polymer chain: NO 
 
 
Synthesis: NO (Degraded 
during purification) 
Incorporation in the 
polymer chain: NO 
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2.6. Redox-Responsive Mesoporous Silica Nanoparticles 
2.6.1. Introduction 
Among the available internal triggers mentioned in Section 2.1, and after all the efforts 
made with pH in previous sections, exploiting the redox environment seemed to be an 
attractive approximation to tackle cancer treatment using stimuli-responsive drug 
delivery systems. The rationale behind using this stimulus is the overexpression of 
glutathione that is found in the cellular cytoplasm as a consequence of increased ROS 
levels, which is much higher than that found in the extracellular fluid.1,2 In consequence, 
that overexpression of glutathione constitutes a reliable trigger as it has been used to 
trigger the release from many drug delivery systems using several approximations.3–7 
As it has been extensively mentioned throughout this thesis, the main drawback of 
mesoporous materials is their open porosity. In this sense, this piece of research consisted 
in developing a nanocarrier based on MSNs and a stimuli-responsive diffusion barrier 
that could delay premature release from the mesopores. The design of this diffusion 
barrier was based on self-immolative chemistry, using similar technology as that 
developed in Sections 2.2, 2.3 and 2.5. In particular, a small molecule bearing a disulfide 
bond that could act at the same time as diffusion barrier and as linker for further 
functionalization was engineered. The structure of this linker was such that the cleavage 
of the disulfide bond by redox stimuli would lead to a self-immolative event. The 
hypothesized behavior of the system MSNs + Linker is depicted in Scheme 2.14. 
 
Scheme 2.14. Schematic representation of a self-immolative event through cyclization upon application of 
a redox stimulus to MSNs functionalized with the small molecule bearing a disulfide bond. The cleavage 
of this bond would lead to the self-immolation of the molecule and the subsequent opening of the 
mesopores. 
Redox stimulus
Cleavage of the disulfide bond
Cyclization and self-immolation
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The cleavage of the disulfide bond by a redox stimulus would lead to the cyclization 
and subsequent self-immolation of the grafted Linker, completely opening the pores 
entrances and triggering the drug release.8 
The synthesis of the linker as well as its subsequent grafting to MSNs involved a 
thorough optimization process, as described below. In addition, the hybrid nanoparticles 
were further functionalized with a PEG chain to endow the carrier with stealth properties 
and improved colloidal stability. The redox-responsiveness of the PEGylated and non-
PEGylated particles was evaluated through different methods using DTT as redox 
stimulus, which is a molecule widely employed to mimic the reductive environment 
found in the cytoplasm of cells.9,10 Finally, the ability of the self-immolative linker to 
delay the payload release from the mesopores in a preliminary release experiment in the 
presence or absence of DTT. 
A summary of the work carried out in this section is depicted in Scheme 2.15. 
 
Scheme 2.15. Schematic representation of the work developed in this section. The self-immolative linker 
was grafted to MSNs and further functionalized with a PEG chain. Then, the ability of the molecule to close 
the pore entrances and trigger the release upon application of a redox stimulus was evaluated. 
 
 
Loading
PEGylationGrafting of 
Self-Immolative Molecule
Hampered Release
Release
MSNs MSN-SS
MSN-SS-PEG
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2.6.2. Materials and Methods 
The following compounds were purchased from Sigma-Aldrich Inc.: TEOS, 
Ammonium nitrate; CTAB; FITC; APTES; ABA; Phenyl chloroformate; DBTL; 2-
Mercaptoethanol; 2,2’-Dipyridildisulfide; TBDMS-Cl; Ru; 3-(triethoxysilyl)propyl 
isocyanate; HS-PEG3500-NH2 (PEG-SH); Dithiothreitol (DTT);  DMF; THF; DCM, AcN. 
The rest of the chemicals (ethanol, heptane, etc) were of the best quality and were 
employed as received. 
2.6.2.1. Mesoporous Silica Nanoparticles 
MSNs were synthesized following the procedure described in Section 2.2.2.1 and 
characterized using the same techniques. Briefly, the particles were produced following 
a modification of the Stöber method.11 In particular, the sol-gel method under basic and 
very diluted conditions was employed, using TEOS as silica source and CTAB as 
template, which was removed by solvent extraction to obtain empty mesopores.  
2.6.2.2. Redox-Responsive Linker 
All compounds were characterized through 1H-NMR. 
 Phenyl(4-(hydroxymethyl) phenyl)carbamate (1) 
Compound 1 was synthesized as described in Section 2.3.2.3. Briefly, ABA was 
reacted with phenyl chloroformate to yield pure compound 1 after crystallization in 
chloroform. 
 Phenyl (4-(((tert-butyldimethylsilyl)oxy)methyl)phenyl)carbamate (6) 
Compound 6 was synthesized as described in Section 2.5.2.1. Briefly, compound 1 
was reacted with TBDMS-Cl to protect its benzylic alcohol. The crude reaction mixture 
was purified in a silica column using DCM as mobile phase, leading to compound 6.   
 2-(pyridin-2-yldisulfaneyl)ethan-1-ol (19) 
Compound 19 was synthesized using a previously reported protocol.12 Briefly, to a 
vial containing 2,2’-dipyridyldisulfide (2.42 g, 10.98 mmol), methanol (40 mL) and acetic 
acid (0.26 mL, 4.55 mmol) were added. Then, 2-mercaptoethanol (0.6 mL, 8.52 mmol) 
in methanol (10 mL) was added dropwise over 30 minutes and the mixture was stirred for 
48 hours at rt. Afterward, the solution was evaporated under reduced pressure to yield a 
dark yellow oil that was chromatographed in a silica column (ethyl acetate/heptane, 1:1) 
leading to compound 19 as a light yellow oil. 
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 2-(pyridin-2-yldisulfaneyl)ethyl (4-(((tert-butyldimethylsilyl)oxy)methyl)phenyl)carbamate (20) 
To a vial containing compound 6 (1.9 g, 5.3 mmol), toluene (25 mL) and compound 
19 (1.1 g, 5.9 mmol) in toluene (15 mL) were added. Then, DBTL (20% mol) was added 
and the mixture was refluxed for 4 hours. After that, the solvent was evaporated to yield 
a dark orange oil that was chromatographed in a silica column (ethyl acetate/heptane, 1:4) 
to lead to compound 20 as a pale orange oil.  
 2-(pyridin-2-yldisulfaneyl)ethyl (4-(hydroxymethyl)phenyl)carbamate (21) 
Compound 20 (2 g, 4.44 mmol) was dissolved in a 1:1 mixture of methanol and DCM 
(50 mL). Then, TsOH (10% mol) in a 1:1 mixture of methanol and DCM (15 mL) was 
added to compound 20 and the whole reaction mixture was refluxed overnight. After that, 
the solvent was removed under reduce pressure to yield an oil that was subsequently 
chromatographed in a silica column (ethyl acetate/heptane, 2:1) to yield compound 21 as 
a colorless oil.  
2.6.2.3. PEGylated MSNs Functionalized with the Redox-Responsive Linker   
 MSN-SS 
To a N2-purged vial containing 3-(triethoxysilyl)propyl isocyanate (148.5 µL, 0.60 
mmol), dry DCM (0.5 mL) was added (vial 1). A second N2-purged vial containing 
compound 21 (0.24 g, 0.72 mmol) and dry DCM (1.2 mL) was prepared (vial 2). Then, 
the content of vial 2 was slowly added over vial 1 and the final mixture was refluxed 
overnight. Afterward, to a vial containing MSNs (50 mg), AcN (5 mL) was added and the 
particles were sonicated to disperse the particles. Then, the content of the previously 
reacted mixture was added in three times (two hours between additions) and the mixture 
was refluxed overnight. Finally, the particles were centrifuged and washed twice with 
AcN and twice with methanol to yield MSNs functionalized with the redox-responsive 
linker, which will be denote hereafter as MSN-SS. The particles were characterized by 
means of TGA, FTIR spectroscopy, DLS and Zeta potential.  
 MSN-SS-PEG 
To a flask containing MSN-SS (45 mg), methanol (15 mL) was added and the particles 
were dispersed with the aid of an ultrasonicator. Then, PEG-SH (15 mg, 0.004 mmol) in 
methanol (1 mL) was slowly added to the particles and the mixture was stirred at rt 
overnight. Then, the particles were centrifuged and washed twice with methanol, leading 
to MSN-SS-PEG. The PEGylated nanoparticles were characterized in terms of TGA, 
FTIR spectroscopy, TEM, DLS and Zeta Potential. 
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2.6.2.4. Preliminary Release Experiments from MSN-SS-PEG 
 MSN-SS-PEG Loaded with Ru (MSN-SS-PEG-Ru) 
To a vial containing MSN-SS-PEG, a saturated solution of Ru in methanol was added. 
The mixture was stirred overnight and subsequently centrifuged and washed several times 
until the Ru dye could not be observed in the media. 
 Release Experiment 
The release experiment was carried out following the protocol described in Section 
2.2.2.4. To test the redox-responsiveness of the carrier, PBS 1x solutions with and without 
DTT (10 mM) were used instead of those at pH 7.4 and pH 5 employed in the previous 
cases. Briefly, the particles were dispersed in the corresponding PBS solution and placed 
in Transwell® at 37ºC with orbital stirring. The media were removed every time point 
and analyzed in a fluorimeter to quantify the amount of Ru released. Fresh medium was 
added every time point after the old media were removed. 
2.6.3. Results and Discussion 
2.6.3.1. Synthesis of Mesoporous Silica Nanoparticles  
The synthesis of MSNs was accomplished following the procedure described in 
Section 2.2.2.1. Briefly, MSNs were synthesized following a modification of a Stöber 
method using CTAB as structure directing agent and TEOS as silica precursor, yielding 
homogenous particles with an array of hexagonally distributed cylindrical mesopores.   
2.6.3.2. Synthesis of the Redox-Responsive Linker  
The synthesis of the self-immolative molecule sensitive to the overexpression of GSH 
(compound 21) was based on the synthetic pathway developed for the synthesis of the 
different precursors of compound 5 (Scheme 2.14).  
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Scheme 2.14. Schematic pathway for the synthesis of the redox-responsive self-immolative molecule. The 
disulfide bond that would start the self-immolation was introduced using 2-mercaptoethanol and a thiol 
coupling agent. Then, compound 19 was added to compound 6 as it was described in Section 2.5. Finally, 
the TBDMS protecting group was removed to yield compound 21. 
The synthesis of compound 19 was accomplished straightforwardly using 2-
mercaptoethanol and 2,2’-dipyridyldisulfide. The correct synthesis was confirmed 
through the signals observed in the 1H-NMR spectrum (Figure 2.88). 
 
Figure 2.88. 1H-NMR of compound 19. (250 MHz, DMSO) δ 8.46 (d, 1H), 7.91–7.72 (m, 2H), 7.38–7.15 
(m, 1H), 5.02 (t, 1H), 3.63 (q, 2H), 2.93 (t, 2H). 
Compound 20 was synthesized reacting compound 6 and compound 19, using DBTL 
as catalyst. The final product was characterized with 1H-NMR, where the expected signals 
could be observed (Figure 2.89). 
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Figure 2.89. 1H-NMR of compound 20. (250 MHz, DMSO) δ 9.75 (s, 1H), 8.47 (dt, 1H), 7.81 (dd, 2H), 
7.42 (d, 2H), 7.31–7.15 (m, 4H), 4.64 (s, 2H), 4.31 (t, 2H), 3.17 (t, 2H), 0.90 (s, 9H), 0.07 (s, 6H). 
The TBDMS protecting group of compound 20 was efficiently cleaved using TsOH, 
leading to compound 21 that was characterized with 1H-NMR, were the expected signals 
were found (Figure 2.90).  
 
Figure 2.90. 1H-NMR of compound 21. (250 MHz, DMSO) δ 9.73 (s, 1H), 8.47 (dt, 1H), 7.81 (dd, 2H), 
7.41 (d, 2H), 7.34–7.15 (m, 4H), 5.10 (t, 1H), 4.42 (d, 2H), 4.31 (t, 2H), 3.17 (t, 2H). 
The efficient deprotection was confirmed through the disappearance of the signals 8 
and 9 from Figure 2.89 associated to the TBDMS group and the appearance of signal 2 
in Figure 2.90 associated to the expected alcohol.  
2.6.3.3. Synthesis of MSN-SS and MSN-SS-PEG 
The first step was to find out a convenient solvent to attempt the coupling between 
compound 21 and the organosilane. Two solvents, namely THF and DCM, were explored. 
The efficiency of the silylation of compound 21 was determined through 1H-NMR (Figure 
2.91). 
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Figure 2.91. Determination of the best solvent for the coupling between compound 21 and the alkoxysilane. 
The appearance of signal 4 and the disappearance of signal 2 were unequivocally ascribed to the addition 
of the alcohol to the isocyanate. The highest conversion was obtained using DCM. 
The efficiency of the coupling between both compounds was determined through 
comparison of the different signals in Figure 2.91. The appearance of signal 4 and the 
decrease of signal 1 were unequivocally ascribed to the proper addition of compound 21 
to the isocyanate. The comparison of the relative intensities among signals 1, 2 and 3 of 
each spectrum provided an estimation of the rate of conversion. In this sense, Figure 2.91 
clearly showed that the highest conversion into the final molecule was obtained for the 
reaction carried out in DCM. 
A general protocol for grafting alkoxysilanes to MSNs consists in refluxing the 
mixture in toluene (110ºC) under magnetic stirring under inert conditions. However, the 
redox-responsive linker was insoluble in this solvent. The initial idea was to attempt the 
grating of this molecule in DCM. In this sense, the reflux temperature of DCM, ca. 40ºC, 
might be insufficient to maximize the degree of functionalization. For that reason, the 
grafting was performed in a mixture of solvents. The reactions were carried out using a 
ratio MSNs:Linker 1:1. The silylation of compound 21 was carried out in DCM and then 
the mixture was added to MSNs dispersed either in DMF or AcN. The efficiency of the 
grafting was determined through the amount of organic matter incorporated in the MSNs, 
which was determined by TGA analysis (Figure 2.92). 
Compound 19
Compound 19 + NCO (DCM)
Compound 19 + NCO (THF)
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Figure 2.92. TGA analysis of the grafting of the linker in different solvents using a ratio MSN:Linker 1:1. 
The reaction in DMF led to ca. 3% of additional % weight loss while that in AcN led to ca. 7.5% of 
incorporated organic matter, confirming its suitability as solvent for the functionalization.  
As shown in Figure 2.92, the use of DMF as co-solvent introduced ca. 3% of additional 
organic matter. The best results were obtained using AcN as co-solvent. In this case, the 
functionalization led to ca. 7.5% of additional organic matter, compared to bare MSNs, 
demonstrating its suitability for the reaction. The reason for that behavior might be that, 
unlike AcN, DMF presents an unshielded oxygen with high electron density able to form 
hydrogen bonds with the silanol groups of the particles. Then, these groups are more 
shielded and the rate of condensation reactions between the organosilane and the surface 
of the particles is retarded because of the steric hindrance. In consequence, more 
condensations events would take place when using AcN instead of DMF, for the same 
reaction time.13 
The presence of the functional groups of the silylated compound 21 on the 
functionalized samples was confirmed by FTIR spectroscopy (Figure 2.93). 
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Figure 2.93. FTIR spectroscopy of MSNs and MSN-SS synthesized either in DMF or AcN. The addition 
of the linker led to the appearance of vibration bands ascribed to the carbamate of molecule 20 in both 
cases, confirming the presence of the compound. 
The addition of the silylated compound 21 induced the appearance of vibration bands 
ascribed to the carbamate of the molecule, regardless of the solvent employed (Figure 
2.93), which confirmed the completion of the reaction. The appearance of C-H vibration 
bands in both spectra also confirmed the presence of the molecule, although the TGA 
analysis (Figure 2.92) clearly indicated that AcN performed better.  
Once the best solvents for the silylation of compound 21 and its subsequent grafting 
to the surface were determined, the next step in the optimization process was to maximize 
the amount of organic matter in the sample. Various ratios MSNs:Linker were explored. 
The output of the different conditions was studied by TGA analysis (Figure 2.94). 
 
Figure 2.94. TGA analysis of the different MSNs:Linker ratios employed for the synthesis of MSN-SS. 
The best results were obtained for a ratio 1:7, which led to increase of ca. 24% of weight loss. 
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The ratios 1:1 and 1:3 led to an increase of ca. 7.5% and ca. 10% in the weight loss, 
respectively. The best results were obtained for the ratio 1:7, which enabled to incorporate 
ca. 24% of additional organic matter in the sample.  
Once the MSNs:Linker ratio was optimized (1:7), MSN-SS was partially PEGylated 
to improve its colloidal stability and endow it with stealth properties. A PEG chain of 
3,500 g/mol was employed. MSN-SS-PEG was synthesized introducing a PEG chain via 
thiol exchange with the grafted compound 21. The overall success of the different 
functionalization steps was evaluated different characterization techniques. The 
efficiency of the coupling was initially determined through TGA analysis (Figure 2.95). 
 
Figure 2.95. TGA analysis of the MSNs, MSN-SS and MSN-SS-PEG. The grafting of the linker led to 
24% of addition weight loss. The addition of PEG-SH introduced ca. 2.5 % of additional weight loss. 
As shown in Figure 2.95, the correct PEGylation was confirmed through the increase 
of ca. 2.5% in the weight loss, compared to MSN-SS. It should be mentioned that the 
effective grafting of each PEG chain entailed the loss of the pyridyl moiety of compound 
21 and, consequently, the exact amount of PEG in MSN-SS-PEG was, indeed, higher 
than the mentioned 2.5%. 
The presence of functional groups characteristic of compound 21 in the particles was 
evaluated using FTIR spectroscopy (2.96). 
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Figure 2.96. FTIR spectroscopy of MSN, MSN-SS and MSN-SS-PEG. The vibration bands ascribed to the 
carbamate of compound 21 further confirmed the correct synthesis of MSN-SS using the ratio 1:7. The 
higher intensity of the C-H vibration bands confirmed the presence of the PEG chain.   
As shown in Figure 2.96, the appearance of vibration bands associated to the 
carbamate functionality of compound 21 conformed the successful synthesis of MSN-SS. 
In addition, the spectrum of MSN-SS-PEG showed much deeper C-H vibration bands, 
which confirmed the correct PEG anchoring. 
The effect of the successive functionalization steps on the ordered mesostructure was 
evaluated through XRD measurements (Figure 2.97). 
 
Figure 2.97. XRD diffractogram of MSNs, MSN-SS and MSN-SS-PEG. The diffraction pattern of MSNs 
was preserved after the functionalization steps, indicating that the pore structure was unaffected after both 
processes.   
Overall, the maxima depicted in Figure 2.97 showed the diffraction pattern typical of 
MCM-41 mesoporous silica materials, confirming that the mesostructure was unaffected 
by the successive synthetic steps. The lower intensity observed in MSN-SS and MSN-
SS-PEG was ascribed to the presence of organic matter around or partially within the 
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mesopores, leading to slightly lower periodicity, and confirming again the correct 
grafting.  
The effect of the functionalization of MSNs with the redox-responsive self-immolative 
linker and the PEG chains on the textural properties of the samples was determined with 
N2 adsorption (Figure 2.98). 
 
Figure 2.98. N2 adsorption analysis of MSNs, MSN-SS and MSN-SS-PEG. The successive 
functionalization steps of MSNs induced a marked reduction in the specific surface area, especially after 
the grafting of the self-immolative linker. 
As shown in Figure 2.98, the shape of the type-IV isotherm of MSNs confirmed the 
presence of cylindrical mesopores.14,15 The values obtained from the N2 adsorption 
analysis are summarized in Table 2.12. 
Table 2.12. Summary of the values obtained from the N2 adsorption analysis of MSNs, MSN-SS and MSN-
SS-PEG. The significant variations of MSN-SS with respect to MSNs verified the correct functionalization 
of MSNs with the self-immolative linker. 
 MSNs MSN-SS MSN-SS-PEG 
Surface area (m2/g) 1102 259 117 
Pore volume (cm3/g) 1.02 0.17 0.11 
Pore diameter (nm) 3.73 3.27 2.64 
The variations in the specific surface area after the successive modifications confirmed 
the success of the functionalization. The addition of the silylated compound 21 induced a 
significant reduction of the specific surface area (ca. 75%). The changes in the pore 
volume and pore diameter were ascribed to the presence of molecules within or around 
the pores, in agreement with the XRD pattern (Figure 2.97).  
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The morphology of the particles as well as the presence of organic matter on the 
surface of MSN-SS-PEG was evaluated using TEM microscopy. For that purpose, MSNs 
and MSN-SS-PEG were stained with phosphotungstic acid prior to observation to observe 
organic matter (Figure 2.99). 
 
Figure 2.99. TEM micrographs of samples stained with phosphotungstic acid. a) MSNs. b) MSN-SS-PEG. 
The presence of a blurrier surface in MSN-SS-PEG was ascribed to the presence of organic matter in the 
sample. 
The observation of the particles through the TEM microscope confirmed the almost 
spherical and homogeneous shape of the particles. The blurrier surface observed in MSN-
SS-PEG (Figure 2.99b) was ascribed to the presence of organic matter to which 
phosphotungstic acid bounded. 
The colloidal stability and the size distribution of the samples in aqueous solution was 
analyzed through DLS measurements (Figure 2.100). 
a) b)
MSNs MSN-SS-PEG
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Figure 2.100. DLS measurements of MSN, MSN-SS and MSN-SS-PEG (PDI width indicates the width at 
medium height of the distribution). The size distribution was centered at ca. 190-200 nm for all the cases. 
The successive modifications improved the colloidal stability of the samples, as indicated by the 
progressively lower value of PDI width. 
As observed in Figure 2.100, the distribution was centered at ca. 190-200 nm for the 
three samples synthesized here. The functionalization of MSNs with compound 21 clearly 
improved the colloidal stability of the samples, as demonstrated by the decrease in the 
PDI width, which was indicative of better dispersion in the solution. The PEGylation of 
MSN-SS led to a narrower distribution, which was indicative of improved colloidal 
stability, confirming its suitability for potential biomedical applications. In addition, the 
analysis of the changes in the zeta potential further confirmed the correct synthesis of 
MSN-SS and MSN-SS-PEG (-34.3 mV for MSNs vs -30.5 mV for MSN-SS vs -24.0 mV 
for MSN-SS-PEG). 
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Once all materials were characterized, the next step was to evaluate the redox-
responsiveness of here produced materials. For that purpose, the particles were soaked in 
a solution of DTT (10 mM) in PBS (1x). The sample produced using the ratio 1:3 was 
initially employed to find out if the self-immolation was actually taking place. The 
samples were analyzed with elemental analysis (Table 2.14).  
Table 2.14. Elemental analysis of MSNs, MSN-SS and MSN-SS soaked in DTT. The decrease of all values 
for MSN-SS (DTT) confirmed the effective cleavage of the disulfide bond.  
 C (%) N (%) S (%) 
MSNs 4.26 0.13 0.03 
MSN-SS 11.82 1.73 1.88 
MSN-SS (DTT) 6.68 1.32 0.08 
The addition of compound 21 increased the amount of organic matter, in agreement 
with the TGA analysis in Figure 2.95. The presence of sulfur in MSN-SS further 
confirmed the presence of compound 21. However, the application of DTT to MSN-SS 
led to significant changes. The decrease of the amount of carbon and nitrogen meant that, 
at least, the pyridyl moiety of compound 21 was cleaved. Besides, the sample treated with 
the redox agent contained negligible amount of sulfur, which would account for the self-
immolation process actually taking place through cyclization.  
In view of a subsequent release experiment, the sample produced using the ratio 1:7 
was also subjected to a redox stimulus. In this case the result was evaluated by FTIR 
spectroscopy (Figure 2.101). 
 
Figure 2.101. FTIR spectroscopy of MSN-SS-PEG before and after the exposure to DTT. The application 
of a redox stimulus led to the disappearance of the vibration bands ascribed to compound 21 and the 
decrease of the intensity of the C-H vibration bands.  
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The application of DTT to MSN-SS-PEG led to appreciable changes in the FTIR 
spectra of the samples (Figure 2.101). The redox-responsiveness of the carrier was 
confirmed through the disappearance of the vibration bands ascribed to the redox-
responsive linker. The decrease of the intensity of C-H vibration bands was ascribed to 
the cleavage of the PEG chains and the loss of compound 21, in agreement with Table 
2.14.  
2.6.3.4. Preliminary Release Experiments 
The effectiveness of compound 21 to delay the payload release from the mesopores 
was evaluated loading the PEGylated particles with Ru and performing an in vial release 
experiment using PBS (1x). Two MSNs:Linker ratios were explored, namely 1:3 and 1:7, 
to evaluate the influence of the amount grafted linker (Figure 2.102). 
 
Figure 2.102. % Dye released in PBS (1x) at 24 hours for MSNs, MSN-SS-PEG (1:3) and MSN-SS-PEG 
(1:7). The experiment showed that the ratio 1:7 could hamper the release by ca. 50%, compared to the ratio 
1:3. 
As shown in Figure 2.102, the ratio 1:3 was ineffective in hampering the cargo release 
and almost 100% of dye was released within 24 hours. The results were much promising 
when using the ratio 1:7. This condition released ca. 50% less amount of dye than the 
former ratio, indicating a more effective sealing of the mesopores and, consequently, 
delaying premature drug release.  
The next step was to evaluate whether the drug release could be triggered by a redox 
stimulus. For that purpose, MSN-SS-PEG produced using a ratio 1:7 was loaded with Ru 
and a release experiment using a 10 mM DTT solution in PBS (1x) was employed as 
redox stimulus. A control group with just PBS (1x) was also included (Figure 2.103). 
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Figure 2.103. Release experiment from MSN-SS-PEG using a 10 mM solution of DTT in PBS (1x) (in 
red) or PBS (1x) as control (in black). The group containing the DTT released more dye, demonstrating 
that the self-immolative linker could hamper the payload release.  
As shown in Figure 2.103, the group receiving the 10 mM DTT solution released ca. 
50% more dye than the control group after 24 hours, demonstrating that compound 21 
could act as a diffusion barrier to delay premature release in absence of a redox stimulus. 
After 24 hours, the PBS solution of the control group was replaced by the 10 mM DTT 
solution and the particles were incubated for 6 further hours to provide additional 
evidence of the redox-responsiveness (Figure 2.104). 
 
Figure 2.104. Release experiment from MSN-SS-PEG initially using a control solution (in red) and 
changing it to a 10 mM solution of DTT in PBS (1x) after 24 hours (in black). The addition of the redox 
stimulus led to an increase in the dye release. 
As observed in Figure 2.104, the control group only released ca. 19% of the dye from 
10 to 24 hours of experiment (14 hours). However, the addition of DTT led to the release 
of ca. 21% of the dye in just 6 hours (in black). This enhanced release confirmed that the 
DTT solution triggered the drug release as a consequence of the cleavage of the disulfide 
bond of compound 21 and the subsequent self-immolation. 
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2.6.4. Conclusions 
The objective of this work was to develop a stimuli-responsive nanocarrier with 
potential applicability in cancer therapy. The much higher concentration of glutathione in 
the cytoplasm, compared to the extracellular fluids, was selected as stimulus to trigger 
the drug release. In this sense, a carrier based on mesoporous silica nanoparticles and a 
redox-responsive self-immolative molecule was devised. This molecule would act, at the 
same time, as diffusion barrier and as linker for further functionalization. 
The self-immolative molecule was engineered so that it could undergo cyclization and 
subsequent self-immolation upon application of a redox stimulus. The functionalization 
of MSNs with this compound involved 2 different optimizations. First, the silylation of 
this compound was explored and it was concluded that DCM was provided the best 
results. Then, the efficiency of the grafting to MSNs was evaluated in different solvents 
and it was shown that a mixture of DCM and AcN yielded the highest amount of grafted 
linker. Once the best solvents were determined, the next step was to maximize the amount 
of grafted linker so that premature release could be hampered. Different MSNs:Linker 
ratios were explored and it was concluded that a ratio 1:7 led to the greatest degree of 
functionalization. Finally, the particles were PEGylated and it was observed that their 
colloidal stability increased as a consequence of the presence of this polymer.  
The redox-responsiveness of the particles was evaluated for MSN-SS and MSN-SS-
PEG using DTT as redox stimulus. The FTIR spectrum showed that the vibration bands 
ascribed to the linker disappeared after the application of DTT. In addition, the elemental 
analysis showed that ca. 100% of sulfur disappeared from the sample after applying the 
stimulus, unequivocally demonstrating that the linker underwent cyclization and 
subsequent self-immolation. 
The PEGylated particles were loaded with a model fluorophore and soaked in PBS 
(1x) to find out if the self-immolative molecule could hamper premature drug release. 
Different ratios were explored and it was shown that the ratio 1:7 released 50% less dye 
than the other conditions. After that, a preliminary release experiment using DTT as redox 
stimulus was carried out and it was shown that the triggered group released ca. 50% after 
24 hours. Besides, the medium of the control group was replaced by the DTT solution 
after 24 hours and significant drug release could be observed in a short period of time, 
showing further confirmation of the redox-responsiveness of the system.   
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Chapter 3 
Overcoming Biological Barriers 
El científico encuentra su recompensa en lo que Henri Poincaré llama el 
placer de la comprensión, y no en las posibilidades de aplicación que 
cualquier descubrimiento pueda conllevar. 
Albert Einstein 
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3.1. Introduction 
3.1.1. Aims 
One of the major concerns of current chemotherapeutics is their lack of selectivity for 
cancer tissues. A smart approximation to reduce the nonspecific distribution of the drugs 
could be the design of stimuli-responsive nanoparticles able to achieve on-demand drug 
release, as it has been thoroughly discussed in Chapter 2 of this thesis.  
Ideally, drug-loaded nanocarriers should preferentially accumulate in the tumor tissues 
and, once there, their payload should be selectively delivered only to cancer cells. 
However, nanoparticles may have to face several biological barriers when administered 
to the bloodstream, including (1) opsonization and subsequent clearance of the particles 
by the macrophages, (2) nonspecific particle distribution throughout the organism, i.e., 
lack of selectivity towards cancer tissues, (3) a dense collagen tumoral matrix with high 
intracellular pressure that hampers nanoparticle penetration into the tumoral mass, (4) 
lack of selectivity towards cancer cells over normal cells and (5) endo-lysosomal 
entrapment so that the effective payload release may be compromised.  
The implementation of a nanomedicine able to effectively overcome all the above-
mentioned biological barriers with a unique nanocarrier remains a chimera. In this sense, 
the overall objective of this chapter was to engineer a system based on mesoporous silica 
nanoparticles which were able to address some of these biological barriers, namely (1) 
the lack of selectivity towards cancer tissues, (2) the lack of selectivity towards cancer 
cells and (3) the entrapment of the particles within the endo-lysosomal pathway.  
In this sense, the first objective of this chapter was to engineer a smart solution to 
tackle the lack of particle selectivity towards cancer cells over normal cells. In this way, 
the drug-loaded particles here designed would be preferentially internalized by tumoral 
cells and the cytotoxics would only affect malignant cells.  
The endo-lysosomal entrapment of the particles constitutes a serious drawback. These 
subcellular organelles, which are acid in nature, may degrade the cargo or even lead to 
multidrug resistance. In this sense, the second objective of this chapter was to design a 
solution able to avoid the particle sequestration in the endo-lysosomal pathway. The first 
and second objectives were addressed via the design of a polyvalent peptidic molecule, 
whose combination with MSNs was thoroughly studied in different biological scenarios 
219
Chapter 3: Overcoming Biological Barriers 
Introduction 
 
 
 
as a result of a research stay carried out during this PhD in the Institute for Integrated 
Cell-Material Sciences (iCeMS) at Kyoto University, Japan. 
The third objective of this chapter was to evaluate whether those engineered particles 
could preferentially accumulate in the tumoral mass rather than being distributed 
throughout the organism. This last objective was accomplished using a standardized 
pseudo-in vivo model in the iCeMS. 
In summary, this chapter will provide an introduction to the state-of-the-art on the 
accumulation of nanoparticles in tumors, their selective uptake by cancer cells and the 
strategies to bypass endosomal entrapment of these nanomatrices. Then, the methodology 
and results derived from the use of a targeted stimuli-responsive material against tumoral 
cells will be thoroughly discussed.  
 
Scheme 3.1. Schematic representation of the aims of Chapter 3. 
  
Aims Chapter 3
1
2
3
Redox-responsive MSNs with
endosomal escape capabilites
Cellular evaluation in 2D and 
3D systems
Preliminary in vivo study of 
biodistribution and cytotoxicity
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3.1.2. Passive and Active Targeting of Solid Tumor Tissues 
The encapsulation of cytotoxic compounds in stimuli-responsive nanoparticles 
constitutes a smart approximation to achieve on-demand drug delivery under certain 
conditions. Yet achieving preferential cellular internalization in cancer cells is of major 
importance, the specific accumulation of the particles in the tumoral tissues still needs to 
be addressed. In other words, before trying to maximize the cellular uptake, it is more 
important the delivery of as much particles as possible to the tumoral mass. In this sense, 
passive and active targeting strategies to tumor tissues have been explored, constituting 
promising tools for the effective delivery of cytotoxics to the tumoral cells.   
3.1.2.1. Passive Accumulation in Solid Tumors: The EPR effect.  
In 1984, Maeda and coworkers were investigating the biological activity of a polymer-
drug conjugate when they discovered in tumor-bearing mice that the conjugate showed 
much higher accumulation in the tumors than the free drug.1 Based on that discovery, 
they labelled proteins of different molecular weights (from 12 to 160 kDa) and observed 
that only those above 68 kDa were retained in the tumor for longer periods of time (less 
than 1 hour vs more than 30 hours).2 Later experiments set the lower limit in 40 kDa.3 
They proposed that this tumor-tropic behavior was a result of the hypervasculature, the 
enhanced permeability and the poor lymphatic drainage found in many tumors, and called 
it the Enhanced Permeability and Retention effect (EPR effect).  
Subsequent research demonstrated that most solid tumors exhibit enhanced vascular 
permeability to ensure enough supply of nutrients and oxygen for their rapid growth. The 
rapid growth of these vessels is known as tumor angiogenesis, and is mediated by the 
secretion of vascular endothelial growth factors by the tumors. Owing to this uncontrolled 
growth, the newly formed tumor blood vessels present an abnormal architecture, 
including wide fenestrations (200-2000 nm endothelial cell-cell gaps), irregular vascular 
alignment or lack of smooth muscle layer, among others. As a result, molecules larger 
than 40 kDa leak out from them and accumulate in the extravascular tissues. On the 
contrary, healthy tissues do not show this abnormal development and no accumulation is 
observed, thus creating a differential selectivity for cancer tissues.4 In addition, unlike 
normal tissues where the extracellular fluid is constantly removed, tumors present 
defective lymphatic drainage and the accumulated macromolecules tend to remain in the 
tumoral mass for longer periods of time (Figure 3.1).5 
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Figure 3.1. Schematic representation of the EPR effect. Nanoparticles accumulate in the tumor due to the 
fenestrations in the blood vessels, and remain there due to the poor lymphatic drainage. Reproduced from 
Ref 6 with permission of Taylor & Francis Online. 
These two phenomena are responsible for the effective accumulation of nanoparticles 
in tumors and provide a first targeting approximation. This effect is highly marked in 
several animal models although its magnitude in human patients highly depends on the 
particularities of the patient and the tumor.7 However, the EPR effect do constitute a 
reliable approximation as some commercialized nanomedicines rely on this principle.8  
3.1.2.2. Active Accumulation in Solid Tumors  
The non-universality of the EPR effect has fueled the exploration of alternative 
strategies to enhance the accumulation of nanoparticles in the tumoral mass. Examples of 
this active vectorization to tumor tissues include the use of tumor-tropic cyclic peptides 
and tumor-tropic cells, among others.   
The use of cyclic peptides has been observed to promote the preferential accumulation 
of nanoparticles in tumors. In addition, it has been shown that nanoparticles bearing this 
peptide are able to internalize deeper in the tumoral mass. This phenomenon is based on 
the existence of an endocytic transcytosis pathway in tumor endothelial cells that can be 
activated by tumor-penetrating iRGD-like cyclic peptides. In particular, the iRGD peptide 
consists of the integrin-binding RGD motif and the neuropilin-1 binding motif. First, the 
RGD motif binds αβ integrin present in the membrane of tumor endothelial cells. Then, 
there is a proteolytic cleavage and the neuropilin-1 motif (previously inactive) is exposed, 
interacting with the NRP-1 receptor and triggering a trans-tissue transport pathway. The 
RGD motif can be tuned so that other receptors can be exploited. Interestingly, this 
preferential pathway exists regardless of whether the peptide is covalently bonded to the 
surface or co-administered with the particles.9,10 
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On the other hand, there are some types of cells with migratory properties, including 
different bacteria and mesenchymal stem cells, among others.11,12 Particle-carrying 
bacteria are interesting because they can be specifically selected so that they move 
towards hypoxic areas, as tumors are, enhancing both the extravasation and the 
penetration through deeper areas of the tumor.13,14 The main advantage of mesenchymal 
stems cells over bacteria is their low or non-immune response. These type of cells are 
interesting because they can carry drug-loaded nanoparticles. In this way, it is possible to 
transport nanoparticles to the tumor without caring about their undesired interactions with 
the organism and only triggering the drug release in the tumor.15–18 
3.1.3. Journey Inside the Cells 
Once the nanoparticles have reached the tumoral tissues, whether through active or 
passive strategies, the next step should be to maximize their cellular uptake and achieve 
effective intracellular drug release. In this sense, cellular internalization of nanoparticles 
includes complicated machinery that can be affected by different situations, as described 
below.  
3.1.3.1. Cellular Uptake Mechanisms 
The cell membrane is mostly permeable to small and non-polar molecules, which enter 
the cells through passive mechanisms. In contrast, polar or charged biomolecules that 
cannot pass through the hydrophobic membrane are internalized by means of active 
transport processes, also known as endocytosis. This general process can be classified 
into phagocytosis and pinocytosis (Figure 3.2). In addition, the latter can be divided into 
(1) clathrin-mediated endocytosis, (2) caveolae-mediated endocytosis, (3) clathrin- and 
caveolae-independent endocytosis and (4) macropinocytosis.19 
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Figure 3.2. Different endocytic pathways for nanoparticle uptake. a) Phagocytosis (inherent to 
macrophages and triggers immune response against foreign materials) and Macropinocytosis (form of 
endocytosis in which a larger of fluid is internalized in a vesicle) (b) Clathrin-mediated endocytosis and 
caveolae-mediated endocytosis (internalization mechanism found in cells having clathrin and caveolin 
proteins in the membrane, respectively); and clathrin and caveolae independent endocytosis (internalization 
mechanism found in cells lacking in clathrin and caveolin proteins). Reproduced from Ref 19 with 
permission of Springer. 
 Nanoparticle Uptake by Macrophages 
The first biological barrier that nanoparticles have to face when administered in vivo 
is their potential clearance from the bloodstream, which is accomplished by the 
macrophages.20 In this way, large materials can be internalized by these cells and removed 
from the bloodstream. To do so, a membrane-bound vesicle is formed around the 
materials, forming a phagosome that finally fuses with the lysosomes for cargo 
degradation.  
Nanoparticle clearance is mediated by the phenomenon of opsonization, which 
consists in the deposition of proteins on the surface of the particles, leading to the 
formation of a protein corona. The protein corona provides a biological identity to the 
particles that the immune system can detect, triggering their removal from the 
bloodstream.21 Examples of strategies to minimize opsonization include the PEGylation 
of the nanocarriers or the use of zwitterionic moieties. PEGylation reduces the amount of 
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proteins adsorbed on the surface by creating a hydration layer around the particles.22 
Zwitterionic surfaces reduce the protein corona creating a neutral surface to which 
proteins are less prone to attach.23,24 
 Nanoparticle Uptake by the Rest of Cells 
Cells internalize plasma membrane components and nutrients via clathrin-mediated 
endocytosis. It can take place either via receptor-specific uptake (formation of a ligand-
receptor complex) or by non-specific adsorptive uptake (non-specific hydrophobic or 
electrostatic interactions that trigger the uptake). There is a formation of clathrin-coated 
vesicles that normally end up in the endo-lysosomal pathway and can be exploited for the 
design of pH-responsive nanocarriers.19,25 Caveolae-mediated endocytosis is found in 
epithelial and non-epithelial (adipocytes, smooth muscle, etc) cells. It is characterized by 
the formation of flask-shaped membrane invaginations composed of caveolin proteins, 
called caveolae. These vesicles fuse with a cell compartment called caveosome and are 
able to bypass the endo-lysosomal pathway, preventing degradation. This process can 
mediate transcytosis processes through the endothelial tumor cells, enhancing nanocarrier 
penetration in the tumor.19,25 Clathrin- and caveolae-independent endocytosis occur in 
cells deprived of clathrin and caveolin proteins. It is the pathway used by growth 
hormones, extracellular fluid or some proteins, among others.19 Macropinocytosis, which 
is found in all cells except brain microvessel endothelial cells, is the mechanism by which 
cells internalize high amounts of fluids. It is used for the uptake of micron-sized 
nanoparticles that are not internalized by other mechanisms.19  
3.1.3.2. Factors Affecting the Fate of Nanoparticles 
Nanoparticles are engineered to maximize their half-life in the bloodstream, enhance 
their extravasation in the tumors and achieve as much cellular internalization as possible. 
It is generally accepted that the size of a nanoparticle must be at least 10 nm in diameter 
to avoid renal clearance and not bigger than 400 nm, so it can diffuse properly through 
the tumor interstitium. The best results in terms of cellular uptake are obtained for 
nanoparticles smaller than 100 nm. However, the appropriate size to balance enhanced 
circulation time, extravasation and cellular uptake is controversial. In this sense, some 
authors propose a size of ca. 300 nm26 while others propose a size of ca. 100 nm or 
below.27 
In addition to size, the shape also affects both the biodistribution and the interaction 
with cells. It has been shown that rod-like nanoparticles remain longer in the bloodstream 
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at the same time that are more prone to diverge closer to the blood vessel walls, increasing 
extravasation, compared to their spherical counterparts.28,29 However, there is growing 
controversy regarding whether non-spherical particles show better cellular internalization 
than their spherical counterparts.25,30   
Nanoparticles primarily interact with the organism through their surface and, 
consequently, the surface charge is of major importance. Since the cell membrane is 
negatively charged, positive nanoparticles show better uptake. However, it has also been 
shown that positively charged nanoparticles are more prone to undergo opsonization, 
showing lower circulation time than neutral or negative nanocarriers.31,32 In addition, 
there is evidence that cationic nanoparticles tend to accumulate around the tumor mass, 
while negatively charged particles penetrate deeper in the tumoral mass due to the 
repulsion between their surface and the negative cell membrane.33  
3.1.3.3. Enhanced Cellular Uptake of Mesoporous Silica Nanoparticles: Active 
Targeting of Cancer Cells 
The size, shape and surface charge affect nanoparticle internalization in cancer cells. 
In addition, these nanocarriers can be engineered so they selectively recognize cancer 
cells. In particular, MSNs have been extensively decorated with chemical moieties able 
to selectively bind receptors that are only overexpressed in cancer cells (Figure 3.3). The 
targeted nanoparticles interact with the tumoral cells through the formation of ligand-
receptor complexes that facilitate their uptake. In consequence, this approximation 
provides a powerful tool to distinguish between healthy and tumoral cells, improving the 
efficiency of the delivery.6,34,35  
 
Figure 3.3. Most employed targeting agents in combination with MSNs. Clockwise: Antibodies, proteins, 
saccharides, small molecules, aptamers and peptides. Nanoparticles bearing these agents are able to 
internalize in cancer cells through the specific interaction with their complementary and overexpressed. 
Reproduced from Ref 6 with permission of Taylor & Francis Online. 
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As shown in Figure 3.3, some examples of targeting agents are antibodies, proteins, 
saccharides, small molecules, aptamers and peptides. Antibodies can target specific 
antigens present on the membrane of many tumoral cells with high specificity. For 
instance, the anti-EGFR (EGFR: epidermal growth factor receptor) has been used to target 
nanoparticles to this receptor, because it is overexpressed in many solid tumors.36,37 Their 
high production cost has fueled the research of alternative strategies. In this sense, the use 
of peptides has attracted much attention because of the ease of their production. In fact, 
they can be synthesized from well-stablished standard techniques in small 
laboratories.38,39 Some examples are the surface modification with RGD (binds 
overexpressed αβ-integrin in endothelial and many cancer cells),40–42 NAPamide (binds 
overexpressed melanocortin-1 receptor in melanoma)43 or more complex cell-penetrating 
peptides.44,45 Aptamers are single-stranded RNA, DNA or unnatural oligonucleotides that 
can adopt tertiary conformations able to recognize various types of targets with high 
affinity. Aptamers show comparable specificity compared to antibodies. In addition, they 
are non-immunogenic and easy to synthesize. Examples are the modification of 
nanoparticles with the thrombin-binding aptamer46 or the AS1411,47 which indeed was 
the first aptamer to enter clinical trials.   
Proteins have also been used as targeting agents. For instance, transferrin mediates 
iron cellular uptake, and its receptor is highly overexpressed in cancer cells. For such 
reason, the surface modification of nanoparticles with this protein enhances their cellular 
internalization in tumoral cells.48,49 Another example is concanavalin A, which can 
interact with the overexpressed sialic acid on some tumor cells to enhance the uptake, at 
the same time that induces cytotoxicity.50 The use of carbohydrates as targeting agents 
has also been widely explored owing to their specific recognition by lectin proteins on 
the cell membrane. Examples are the coating of nanoparticles with lactobionic acid51 or 
hyaluronic acid.52  
The use of small molecules is particularly interesting because many of them are 
commercially available or can be relatively easy synthesized. For instance, cancer cells 
require high amounts of vitamins and, as a consequence, present many overexpressed 
receptors. Widely used examples are folic acid (vitamin B9) or biotin (vitamin H), whose 
conjugation with nanoparticles enhances their cellular uptake.53–57 It is also possible to 
design small synthetic molecules with high affinity for a very specific receptor. For 
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example, the norepinephrine transporter is highly overexpressed in neuroblastoma cells 
and can be specifically targeted using benzylguanidine analogues.58,59  
3.1.4. Towards Efficient Cytosolic Delivery: Endosomal Escape 
In general, nanoparticles are internalized through the endocytic pathway. In this way, 
nanocarriers are internalized into an endocytic vesicle that fuses into the early endosomal 
compartment and matures later into a late endosome, finally leading to the accumulation 
in the lysosome (Figure 3.4). This process involves the progressive acidification of the 
different compartments for proteolysis and recycling of unneeded cellular components. 
In particular, pH drops from 6.5 (early endosomes) to 6 (late endosomes) and finally 4.5-
5 (lysosomes).60–62  
 
Figure 3.4. The endo-lysosomal pathway involves the internalization of the biological in a vesicle that fuse 
and matures into the early and late endosomes respectively. The content can be delivered in the cytoplasm 
or degraded in the lysosomes if the endosomal entrapment occurs. Adapted from Ref 63 with permission 
of Elsevier. 
Achieving the endosomal escape before reaching the lysosomes is a major issue since 
the acid pH may degrade the therapeutics entrapped within this compartment, reducing 
the efficacy of the treatment.64 In addition, it has been shown that the accumulation of 
anticancer drugs which are hydrophobic weak bases in the lysosomes may trigger a 
mechanism of multidrug resistance, leading to the exocytosis of these drugs.65 
Furthermore, there is growing evidence that endo-lysosomal entrapment may reduce 
transcytosis events, leading to poor distribution of nanoparticles in the target tissue.66–68 
Cytoplasm
Early Endosome
Late Endosome
Lysosome
Nucleus
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The approximations that have been explored so far to overcome endosomal entrapment 
can be classified into viral and nonviral. The most efficient approximation for the delivery 
of nucleic acids is the use of virus, although there are concerns about their 
immunogenicity that limit their use. For such reason, research on nonviral vectors has 
attracted growing attention. Not all these approximations are based on the same principles 
and several mechanisms for the endosomal escape have been proposed (Figure 3.5).60 
Figure 3.5. Endosomal escape mechanisms. a) Membrane fusion between the nanoparticle and the 
endosomal membrane induces content delivery in the cytosol. b) Entrapment of species with buffering 
capacity induces an influx of chloride ions, together with fluid that finally disrupt the membrane. c) The 
swelling of pH-responsive nanogels leads to the destabilization of the membrane due to the increased 
mechanical strain. d) pH-mediated disassembly of nanoparticles may lead to destabilization of the 
membrane. Reproduced from Ref 60 with permission of ACS. 
Some viruses and liposomal systems induce the endosomal escape through the 
membrane fusion mechanism, leading to the cytosolic delivery of the content.69,70 In 
addition, it is possible to engineer the nanocarriers so that fusion only takes place with 
the endo-lysosomal membrane, as a consequence of the acid pH, and not with other 
targets.71,72 When the entrapped nanoparticles contain protonable functionalities, the 
endosomal escape can be mediated by the proton sponge effect. The presence of species 
with buffering capacity induces an influx of protons and chloride counterions and water, 
increasing the pressure and eventually lysing the membrane.60,73 It is also possible to 
design nanoparticles able to swell upon changes in pH and disrupt the membrane. The 
mechanism is still not completely clear but the disruption is thought to be mediated by 
the mechanical strain created by the swelling.74,75 In fact, the contribution of this 
mechanism along with the proton sponge effect has also been proposed.76 An additional 
mechanism of endosomal escape is through membrane destabilization. In this way, 
polymer nanoparticles are designed so that they undergo disassembling below 
physiological pH, and that mediates membrane destabilization. Nanoparticles can be 
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engineered so that the disassembling only takes places at endo-lysosomal pH, avoiding 
disruption of the cell membrane, which would lead to cytotoxicity.60  
In conclusion, the magic bullet, i.e., a nanomedicine able (1) to significantly 
accumulate in the tumor tissues, (2) to be preferentially internalized by cancer cells and 
(3) to effectively deliver its payload within the cells still constitutes a chimera.
Nonetheless, there are several promising strategies that should be implemented in every 
upcoming cutting-edge nanomedicine to overcome those issues and facilitate the clinic 
translation. 
Examples of these strategies are (1) the passive accumulation of nanoparticles via EPR 
effect, which constitutes a reliable approximation in EPR effect-positive patients to 
selectively address the particles to tumors, (2) the use of readily available small molecules 
able to specifically recognize cancer cells over normal cells and (3) the implementation 
of different approximations to bypass the endosomal entrapment of nanoparticles and 
achieve effective intracellular drug release. In this sense, the main objective of the next 
section will be to develop a nanocarrier able to merge all these approximations in a single 
polyvalent nanocarrier with potential applicability in cancer therapy.  
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3.2. Targeted Mesoporous Silica Nanoparticles with 
Enhanced Endosomal Escape Capabilities 
3.2.1. Introduction 
The effective translation of nanomedicines to the clinic remains challenging owing to 
the several biological barriers that nanoparticles encounter when administered in vivo, as 
it was mentioned in Section 3.1. Relevant examples of such biological barriers are (1) the 
lack of particle selectivity for tumoral cells so that drug-loaded particles may be 
internalized by normal cells, increasing undesired side effects; (2) the potential 
sequestration of the particles within the endo-lysosomal pathway, which may lead to 
cargo degradation or multidrug resistance; and (3) the lack of preferential particle 
accumulation in the tumoral mass, which may lead to nonspecific particle distribution 
throughout the organism rather than just to the tumor.1 In this sense, this last piece of 
research involved the design of a smart nanocarrier based on MSNs able to overcome 
these biological barriers. 
The idea was to design a molecule that could be grafted to MSNs, leading to a carrier 
with excellent physical-chemical properties that could address the first and second above-
mentioned biological barriers. In this context, a multifunctional peptidic molecule was 
devised and its synthesis was accomplished using solid phase peptide synthesis. (Scheme 
3.2). 
 
Scheme 3.2. Schematic representation of the designed peptidic molecule (compound 22, HAVAB). The 
biotin molecule allows preferential accumulation in tumor cells overexpressing its receptor. The histidine 
motif provides buffering capacity to mediate endosomal escape.  
 
As shown in Scheme 3.2, HAVAB was composed of a cell membrane targeting moiety 
and a fragment with potential endosomal escape capabilities. Biotin was selected as model 
Active Targeting
(Biotin)
Endosomal Escape
(Histidine)
22
(HAVAB)
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targeting agent because its receptor is overexpressed in a wide variety of tumoral cells 
and can mediate the internalization of drug delivery systems. Examples of cell lines 
overexpressing this receptor include HeLa, A549 and human ovarian cancer.2,3 Histidine 
was included because its imidazole ring presents buffering capacity at the acid pH of 
endosomes and can induce endosomal escape via the proton sponge effect.4–6 This 
phenomenon is based on the presence of species with buffering capacity trapped in the 
endo-lysosomes. These species can capture protons present in these organelles, which is 
counteracted by influxing protons, chloride counterions and water in the endosomes and 
lysosomes, increasing the pressure and eventually lysing the membrane.7,8 
The peptidic fragment was grafted to the redox-responsive system engineered in 
Section 2.6 and its biological performance was evaluated in vitro and in ovo. The in vitro 
studies comprised the use of 2D and 3D models. The effect of nanoparticles on 2D cell 
cultures have been widely studied due to the ease of the experimental methods. This 
model constitutes a valuable starting point for the study of the cell-material interactions. 
However, 2D monolayers lack the complex physiology and microenvironment of real 
tumors and, consequently, the results obtained there, yet provide essential information, 
are only partially translatable. For that reason, the performance of the biotinylated 
particles was also evaluated using 3D spheroids, which show several in vivo tumor 
features such as cell-cell interaction, hypoxia and production of extracellular matrix, 
among others.9 Spheroids are formed using non-adherent plates were cells self-aggregate 
rather than attach to the bottom, as it happens with 2D cell cultures.  
In particular, the biological studies involved the evaluation of the cellular uptake of 
the targeted carrier, its ability to inhibit cell proliferation and the detection of endosomal 
escape. The effect of the peptidic fragment on the cellular uptake was quantitatively 
studied using 2D HeLa cell cultures. The uptake was also qualitatively evaluated using 
A549 and OVCAR8 2D cell cultures. The accumulation and distribution of the particles 
were further analyzed in A549 and OVCAR8 spheroids to evaluate the performance of 
the particles in a more complex scenario. Besides, the particles were loaded with different 
drugs and their cytotoxic effect was evaluated in 2D and 3D scenarios. Finally, the ability 
of the carrier bypass endosomal entrapment was evaluated using calcein in 2D and 3D 
cell cultures (Scheme 3.3). 
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Scheme 3.3. Schematic representation of the evaluation of endosomal escape using calcein. Its fluorescence 
self-quenches when entrapped in the endosomes and can barely be detected. However, when calcein leaves 
the endosomes self-quenching disappears and a strong fluorescence can be detected. Reproduced from Ref 
10 with permission of ACS. 
Calcein is a membrane impermeable dye which useful for the detection of endosomal 
escape. If particles remain in the endo-lysosomes, calcein fluorescence self-quenches and 
it is undetectable. However, if the escape takes place a strong green fluorescence can be 
observed. 
Finally, the biodistribution of the targeted system as well as a preliminary tumor 
inhibition experiment were evaluated in ovo using chicken embryos bearing A549 tumors. 
The chicken embryo model constitutes a pseudo-in vivo tumoral model that provides 
useful information about the systemic administration of a nanomedicine reducing the 
number of animals employed (Scheme 3.4).  
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Scheme 3.4. Schematic representation of experiments using the chicken embryo model. The freshly 
fertilized eggs are pre-incubated for 10 days. Then, cancer cells are deposited on the chorioallantoic 
membrane (CAM) for tumor growth. After that, the particles are administered and the experiments conclude 
sacrificing the embryos before hatching. Adapted from Ref 11 with permission of Springer Nature 
Publishing AG. 
The freshly fertilized eggs are incubated for 10 days. Then, a small window is opened 
and tumoral cells are deposited on the chorioallantoic membrane (CAM) for tumor 
growth. The particles are administered via syringe injection in a vein after tumor 
formation and the embryos are incubated until the experiment finishes, when they are 
sacrificed. The tumor formed resembles actual cancer patient tumors and contains a 
highly irrigated extracellular matrix.11,12  
The main advantages of this model are that (1) the tumor grows within 3-4 days, (2) 
the results are available 2-3 days after the administration of the particles, (3) the costs are 
reduced in comparison with animal models and (4) it allows the optimization of 
nanomedicine so that the in vivo experiments can be restricted to the optimized 
conditions.   
A summary of the biological experiments carried out during this work is depicted in 
Scheme 3.5. 
Particles
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Scheme 3.5. Summary of the biological experiments carried out in this work. The engineered nanoparticles 
were tested in 2D and 3D in vitro models to evaluate their cellular uptake, their cytotoxicity when loaded 
with a drug and their ability to bypass endosomal entrapment. In addition, the biodistribution and 
cytotoxicity of the particles were tested in ovo using the chicken embryo model. 
3.2.2. Materials and Methods 
The following compounds were purchased from Sigma-Aldrich Inc.: TEOS, 
Ammonium nitrate; CTAB; FITC; APTES; ABA; Phenyl chloroformate; DBTL; 2-
Mercaptoethanol; 2,2’-Dipyridildisulfide; TBDMS-Cl; 3-(triethoxysilyl)propyl 
isocyanate; HS-PEG3500-NH2 (PEG-SH); 2-Chlorotrityl chloride resin; Fmoc-His(Trt)-
OH (His); Fmoc-5-Ava-OH (Ava); N,N,N′,N′-Tetramethyl-O-(1H-benzotriazol-1-
yl)uronium hexafluorophosphate (HBTU), 1-Hydroxybenzotriazole hydrate (HOBt); 
DIPEA; Biotin N-hydroxysuccinimide Ester (NHS-Biotin); TFA; Triisopropylsilane 
(TIPS); DCC; Topotecan (TOP); DMF; THF; DCM, AcN. The rest of the chemicals 
(ethanol, heptane, etc) were of the best quality and were employed as received. 
3.2.2.1. Redox-Responsive Mesoporous Silica Nanoparticles (MSN-SS-PEG) 
MSNs were synthesized following the procedure described in Section 2.2.2.1. 
Compound 21 was synthesized following the protocols described in Section 2.6.2.2. The 
grafting of compound 21 to the MSNs and the subsequent addition of PEG-SH to yield 
MSN-SS-PEG were carried out following the protocols described in Sections 2.6.2.3 and 
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Biodistribution
Cytotoxicity
Cellular Uptake
Cytotoxicity
Endosomal Escape
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2.6.2.4, respectively. All materials were characterized using the same techniques, 
including 1H-NMR, TGA analysis, FTIR spectroscopy, DLS and Zeta potential.  
3.2.2.2. Biotinylated Histidine-Rich Peptide  
The biotinylated peptide (22) was synthesized using standard solid phase peptide 
synthesis techniques and Fmoc-protected amino acids. The amide bond formation was 
carried out adding a solution of HOBt (107.06 mg, 0.792 mmol), HBTU (300 mg, 0.792 
mmol) and the corresponding amino acid (327.54 mg, 0.528 mmol for His, 179.2 mg, 
0.528 mmol for Ava) in DMF (3.5 mL) and DIPEA (0.275 mL, 1.58 mmol) to the resin 
(200 mg, 0.264 mmol). Then, the mixture was shaken in a reactor with a wrist-shaker 
overnight. Afterward, the resin was thoroughly washed with DMF to remove unbounded 
amino acids and by-products. Then, a solution of piperidine (20%) in DMF (2 mL) was 
added to the resin to cleave the Fmoc-protecting group. After that, the resin was 
extensively washed with DMF and the next amino acid was added following the same 
procedure. Once the last amino acid was added, NHS-Biotin (270 mg, 0.792 mmol) in 
DMF (6.5 mL) and DIPEA (0.275 mL, 1.58 mmol) were added to the resin and wrist-
shaken overnight in a reactor.  
Once the biotinylation of the peptidic chain was accomplished, the resin was 
thoroughly washed with DMF and DCM. Then, 1.2 mL of a cocktail containing TFA 
(95%), TIPS (2.5%) and water (2.5%) was added dropwise to the resin, which was gently 
shaken for 2 hours to accomplish the peptide release from the resin. After that, the solution 
was filtered and the resin was washed with a small amount of the cleavage cocktail. Both 
solutions were mixed. The peptide-containing solution was added dropwise to cold ether, 
leading to a precipitate that was isolated by centrifugation. Finally, the precipitate was 
purified by molecular exclusion chromatography, using Sephadex® G-25 as stationary 
phase and water as mobile phase. The collected phases were lyophilized and characterized 
by 1H-NMR and mass spectrometry. This compound will be denoted hereafter either as 
compound 22 or HAVAB. 
3.2.2.3. Targeted Mesoporous Silica Nanoparticles 
To a N2-purged flask containing compound 22 (30 mg, 0.04 mmol) in dry DMF (0.6 
mL), DCC (21.7 mg, 0.11 mmol) and NHS (12.1 mg, 0.11 mmol) in dry DMF (0.6 mL) 
were added. The solution was stirred for 1 hours at rt for acid activation. After that, the 
mixture was added dropwise to N2-purged flask containing MSN-SS-PEG (35 mg) in dry 
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DMF (3.5 mL) and the whole reaction mixture was stirred at rt for 24 hours. Then, the 
nanoparticles were thoroughly washed with DMF, ethanol, water and methanol to remove 
unbounded reagents, dicyclohexylurea by-products, residual DMF and water, 
respectively. Finally, the particles were dried under vacuum to yield MSN-PEPT. The 
particles were characterized in terms of TGA analysis, FTIR spectroscopy, DLS and Zeta 
potential. 
3.2.2.4. 2D cellular experiments 
 2D Cell Cultures 
Cell culture tests were performed using HeLa, A549 and MC3T3-E1 cells. HeLa or 
A549 cells were plated at a density of 20,000 cells cm2 in 1 mL DMEM containing 10% 
of FBS and 1% penicillin–streptomycin at 37ºC in a humidified atmosphere of 5% CO2. 
MC3T3-E1 cells were plated using the same conditions but in 1 mL of α-minimum 
essential medium. OVCAR8 cells were plated using the same conditions but in 1 mL of 
Roswell Park Memorial Institute (RPMI) medium. Then, nanoparticles were placed at 
different concentrations and incubated for different periods of time.  
 Cell Viability  
HeLa or A549 cell proliferation was determined by addition of Alamar Blue solution 
following the protocol described in Section 2.2.2.5.  
 Internalization studies 
For the fluorescence microscopy studies, cells were seeded following the protocol 
described in Section 2.2.2.5. The studies were carried out with Rhodamine B-labelled 
nanoparticles to detect the internalization capability. The endosomal escape was studied 
using calcein-loaded nanoparticles. 
For the flow cytometry studies, HeLa or MC3T3-E1 cells were cultured in each well 
of a 6-well plate. After 24 hours, the cells were incubated with different concentrations 
of the fluorescein-labelled nanoparticles. After 2 hours, cells were washed twice with 
PBS and incubated at 37ºC with trypsin–EDTA solution for cell detachment. The reaction 
was stopped with culture medium after 5 minutes and cells were centrifuged at 1,500 rpm 
for 10 minutes and re-suspended in fresh medium. Then, the surface fluorescence of the 
cells was quenched with trypan blue (0.4%) to confirm the presence of an intracellular, 
and therefore internalized, fluorescent signal. Flow cytometry was performed at an 
excitation wavelength of 488 nm, green fluorescence was measured at 530 nm. The 
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trigger was set for the green fluorescence channel. The conditions for the data acquisition 
and analysis were established using negative and positive controls with the CellQuest 
Program of Becton–Dickinson and these conditions were maintained during all the 
experiments. Each experiment was carried out three. For statistical significance, at least 
10,000 cells of each sample were analyzed. 
For confocal laser scanning microscopy, A549 or OVCAR8 cells were incubated with 
different concentrations of Rhodamine B-labelled nanoparticles. Each well was 
thoroughly washed with cold PBS three more times to wash out the non-internalized 
nanoparticles, and then fixed with ethanol (75%) (kept at −20°C) for 10 min. Then, 
ethanol was removed and the wells were washed with PBS. After that, the nuclei of cells 
were stained with DAPI for 5 min, respectively, and then washed three times with cold 
PBS. Cellular uptake of MSNs was recorded by confocal laser scanning microscopy with 
an excitation wavelength at λ = 488 nm. The emission was detected using a 610 nm long 
pass filter.  
3.2.2.5. 3D cellular experiments 
 3D Cell Cultures 
Cells were grown in a 96 U-shaped-well plate for spheroid formation. For that purpose, 
10,000 A549 or OVCAR8 cells were inoculated in 200 µL of DMEM or RPMI medium, 
respectively. Cells were cultured for 7 days at 37ºC in a humidified CO2 atmosphere. 
Then, nanoparticles were placed at different concentrations. 
 Spheroid viability 
The viability was evaluated using A549 spheroids. Nanoparticles were added at 
different concentrations and incubated for 24 hours. Then, the particles were removed 
and each well was washed three times with PBS 1x and 200 µL of the corresponding 
medium were added. The spheroids were maintained for 7 days at 37ºC in a humidified 
atmosphere. The spheroids were imaged at different time points. The viability was 
evaluated in terms of volume variation following the formula:13 
V=0.5 *(short ϕ)2*long ϕ 
Equation 3.1. Formula for the calculation of the spheroid volume. ϕ denotes the diameter.  
 Internalization studies 
The internalization studies were carried out using A549 and OVCAR8 spheroids. 
Rhodamine B-labelled Nanoparticles were incubated with the spheroids for 24 hours. 
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Then, spheroids were thoroughly washed with PBS 1x and placed in an Eppendorf tube. 
The samples were fixed using a paraformaldehyde solution (4%) at 4ºC overnight. Then, 
spheroids were washed with cold PBS 1x and treated with methanol (99.8%) at -80ºC for 
30 minutes. After that, the nuclei of the spheroids were stained with Hoechst 33258 
solution for 30 minutes for confocal microscopy.  
3.2.2.6. Chicken eggs experiments 
 Tumor Formation 
Freshly fertilized chicken eggs were incubated at 37ºC in a humid atmosphere (60%) 
for 10 days. On day 10, a window was made on the eggshell and a Teflon ring was placed 
on the CAM membrane. Then 100,000 A549 cells were placed into the ring and the 
window was sealed for tumor growth.  
 Biodistribution Studies 
Once the tumor was formed, normally after 3 days, a small window was opened and 
Rhodamine B-labelled particles were administered via syringe injection in a vein. 
Afterward, the window was closed and the chicken embryos were incubated for further 2 
days. Then, the eggs were imaged in a fluorescence stereomicroscope and subsequently 
dissected for organ observation.  
 Tumor Reduction 
Once the tumor was formed, DOX-loaded Rhodamine B-labelled particles were 
administered via syringe injection in a vein following the above-mentioned protocol. The 
chicken embryos were incubated for 3 days and subsequently dissected to weight the 
tumors.  
3.2.3. Results and Discussion 
3.2.3.1. Synthesis of Redox-Responsive Mesoporous Silica Nanoparticles 
The redox-responsive nanoparticles were synthesized following the methodology 
described in Section 2.6 and characterized through the same techniques. Briefly, MSNs 
were synthesized following a modification of a Stöber method, yielding homogenous 
particles with an array of hexagonally distributed cylindrical mesopores. The carrier was 
endowed with stimuli-responsiveness through the surface functionalization of the 
particles with a redox-responsive self-immolative molecule. Its stimuli-responsive 
behavior was evaluated using DTT as redox agent and their ability to hamper premature 
release from the particles was analyzed in a preliminary release experiment. 
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3.2.3.2. Synthesis of Biotinylated Histidine-Rich Peptide  
The biotinylated peptide was synthesized using standard solid phase peptide synthesis 
techniques and Fmoc-protected amino acids (Scheme 3.6).  
 
Scheme 3.6. Schematic synthesis of HAVAB. The amino acids and the acid activators were sequentially 
added to the resin. After each amide coupling, the Fmoc group was removed using piperidine (20%) in 
DMF. Once the last amino acid was added and deprotected, NHS-Biotin was added. After that, the peptide 
was released from the resin using a cleavage cocktail containing TFA, TIPS and water and purified in a G-
25 column. 
As shown in Scheme 3.6, the procedure consisted in the formation of an amide bond 
between the free amino group of the amino acid on the resin and the activated carboxylic 
acid of the Fmoc-protected amino acid freshly added to the resin. Once the coupling was 
accomplished, the Fmoc of the latter amino acid was removed and the coupling protocol 
was carried out again. After the addition of all amino acids, biotin was added, leading to 
a multifunctional peptide composed of a fragment able to induce endosomal escape and 
a fragment able to recognize cancer cells over healthy cells. The correct synthesis was 
evaluated by 1H-NMR and mass spectrometry. 
Fmoc-His(Trt)-OH
Fmoc-5-Ava-OH
NHS-Biotin
22
(HAVAB)
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Figure 3.6. 1H-NMR of HAVAB. (250 MHz, D2O) δ 8.50 (t, 3H), 7.16 (s, 3H), 4.59–4.43 (m, 5H), 3.25–
2.90 (m, 12H), 2.11 (t, 6H), 1.65–1.15 (m, 15H). 
The spectrum shown in Figure 3.6 confirmed the presence of the endosomal escape 
fragment (signals 4, 5, 11 and 12) and the targeting agent (signals 1, 2, 3, 7, 8, 9 and 10). 
The peptide was further analyzed by mass spectrometry to confirm the presence of all 
peptide components (3 His, 2 Ava and 1 biotin) (Figure 3.7). 
 
Figure 3.7. Mass spectrometry of HAVAB. The concordance between the expected molecular weight and 
the found molecular weight confirmed the correct synthesis of the peptide.   
The calculated molecular weight for the peptidic fragment was 854 g/mol. As shown 
in Figure 3.7, the analysis of HAVAB by mass spectrometry yielded a value of 854.47 
g/mol, in agreement with the expected value. This confirmed the correct synthesis of the 
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biotinylated peptide and the convenience of using solid phase peptide synthesis to 
accomplish its synthesis.  
3.2.3.3. Synthesis of Targeted Mesoporous Silica Nanoparticles  
The coupling of the peptidic fragment to the nanoparticles was carried out using 
carbodiimide chemistry between the amino groups present in the PEG chain and the C-
terminal of the peptide. The system containing [MSNs + self-immolative linker + PEG + 
HAVAB] was denoted as MSN-PEPT. The presence of additional organic matter on the 
latter material was evaluated using TGA analysis (Figure 3.8). 
 
Figure 3.8. TGA analysis of all materials synthesized in this chapter. The addition of the peptide induced 
1.5% of additional weight loss.  
As shown in Figure 3.8, the functionalization of MSN-SS-PEG with HAVAB 
increased the weight loss ca. 1.5%, confirming the correct grafting of the peptide. 
However, such small additional amount of organic was undetectable in the FTIR 
spectroscopy (Figure 3.9). 
 
Figure 3.9. FTIR spectroscopy of MSN-SS-PEG and MSN-PEPT. No appreciable changes could be 
observed after the grafting of HAVAB.  
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The effect of the peptidic fragment on the colloidal stability of MSN-PEPT in aqueous 
solution was analyzed through DLS measurements (Figure 3.10). 
 
Figure 3.10. DLS measurements of MSN-SS-PEG and MSN-PEPT (PDI width indicates the width at 
medium height of the distribution). The addition of the peptidic fragment improved the colloidal stability, 
as indicated by the lower value of PDI width. 
As observed in Figure 3.10, the colloidal stability of MSN-PEPT improved as a 
consequence of the introduction of HAVAB, as demonstrated by PDI width values. This 
result highlights the suitability of MSN-PEPT to be systemically administered as drug 
delivery system, since this carrier would circulate in the bloodstream without forming 
aggregates owing to its excellent colloidal stability. Finally, the correct grafting of the 
peptide was confirmed through the variations in the zeta potential of the samples (-24 mV 
for MSN-SS-PEG vs -37. 5 mV for MSN-PEPT). Those values were in agreement with 
those expected for the peptide presence, which confirmed the success of the synthetic 
approach here proposed.  
3.2.3.4. 2D cellular experiments 
 2D cellular internalization studies 
Once the complete system was synthesized and characterized, the next step was to find 
out if the peptidic fragment improved the cellular internalization of the particles. For that 
purpose, MSN-SS and MSN-PEPT were incubated with HeLa cells. In addition, a group 
of particles composed of [MSNs + self-immolative linker + PEG + Biotin] was included 
MSN-SS-PEG PDI width: 97,2 nm
MSN-PEPT PDI width: 53,8 nm
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as control to further evaluate the effect of HAVAB. This control group was denoted as 
MSN-PEG-Biotin. The cellular uptake was analyzed by flow cytometry (Figure 3.11). 
 
Figure 3.11. Flow cytometry of MSN-SS, MSN-PEPT and MSN-PEG-Biotin incubated with HeLa cells. 
The group containing the complete system (MSN-PEPT) showed better internalization for all the 
concentrations studied. The graph represents 2 independent experiments: (1)75 and 37.5 µg/mL and (2) 18 
and 9 µg/mL, which confirmed the effect of the peptidic fragment on the cellular uptake. * p<0.05 vs MSN-
SS; # p<0.05 vs MSN-PEPT-Biotin; ǂ p<0.01 vs MSN-SS; § p<0.05 vs MSN-PEPT-Biotin. 
As shown in Figure 3.11, the groups MSN-SS and MSN-PEG-Biotin showed 
comparable cellular uptake. The unexpectedly high values obtained for MSN-SS might 
be ascribed to a thiol exchange with some proteins present in the cell membranes of some 
cellular lines, such as HeLa cells, which has been reported to mediate the internalization 
of nanoparticles.14,15  
The best results were obtained for the complete system (MSN-PEPT), which showed 
higher cellular uptake for all the concentrations studied. Figure 3.11 represents 2 
independent experiments, one at concentrations of 75 and 37.5 µg/mL and another one at 
concentrations of 18 and 9 µg/mL. This fact highlighted the lack of serendipity in the 
results and confirmed the positive effect of the biotinylated peptidic fragment. The 
marked differences between the groups MSN-PEPT and MSN-PEG-Biotin might be 
explained as a consequence of two possible contributions, which might act alone or in 
combination.  
On the one hand, the pKa of histidine is ca. 6.5.16,17 The molecule progressively 
protonates as pH acidifies, appearing as a combination of its protonated and neutral 
conformations until pH 4.5, where only the protonated state is observed.18 Indeed, 
histidine protonation can be observed at values slightly lower than physiological pH, such 
as pH 7.2.19 In addition, cancer cells can slightly acidify culture medium by secretion of 
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lactic acid.20 This can be experimentally observed through the subtle color changes of the 
red phenol indicator included in the medium. In view of these evidences, the higher 
internalization observed for MSN-PEPT compared to MSN-PEG-Biotin might be 
explained by the partial protonation of the histidine residues as a consequence of the slight 
medium acidification. This partial protonation would translate into local positive charge 
effects that would interact more tightly with the negatively charged cellular membrane. 
This local charge effect would show a collaborative effect with the active targeting 
activity of the biotin motif, thus leading to enhanced cellular uptake.  
On the other hand, some cell-penetrating peptides internalize through membrane 
fusion.21 Besides, it has been shown that proteins or peptides that contain histidine motifs 
within their structure may lead to membrane fusion upon protonation.22–25 In 
consequence, another possible explanation for the results observed in Figure 3.11 might 
be a collaborative behavior between the biotin active binding and some fusion events that 
would lead to the observed enhanced internalization. Interestingly, as it was mentioned 
in Section 2.1.2.1, the pH of the extracellular tumor matrix has been quantified to be 
within the range 6.5-7, which is a pH lower than the slight deviations than can occur in 
culture medium. In consequence, the effect observed in vitro should be observed in vivo, 
leading to the appearance of local positive charge effects that should enhance the cellular 
uptake in a more relevant in vivo scenario.   
Once the effect of HAVAB was validated, the next step was to evaluate whether the 
complete system could distinguish between healthy and tumoral cells. For that purpose, 
MSN-PEPT was incubated with HeLa and healthy MC3T3-E1 preosteoblastic cells 
(Figure 3.12). MSN-SS-PEG was used as control to eliminate the different positive effects 
observed for MSN-SS (thiol-mediated internalization) and MSN-PEG-Biotin (active 
targeting through biotin receptors).  
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Figure 3.12. Flow cytometry of MSN-SS-PEG and MSN-PEPT incubated with MC3T3-E1 and HeLa cells. 
The group containing the peptide (MSN-PEPT) showed significantly higher cellular uptake in HeLa cells 
due to the overexpressed biotin receptors. The differences between both groups were imperceptible for the 
healthy cells. * p<0.01 vs MSN-SS-PEPT. 
  As shown in Figure 3.12, the differences in the cellular uptake between the targeted 
and non-targeted groups were negligible in the case of healthy cells, as expected for cells 
lacking overexpressed biotin receptors. The low internalization observed for MSN-SS-
PEG was ascribed to the hydration layer created by the PEG chains that hindered the 
interaction with the cell membrane.26 On the contrary, only the group containing the 
peptidic fragment was able to be selectively and greatly internalized by the tumoral cells, 
as expected for cells overexpressing the biotin receptor. In this sense, a significant 
difference between the targeted and non-targeted material could be observed, highlighting 
again the positive effect of the peptidic fragment.  
In view of subsequent experiments using A549 and OVCAR8 spheroids, the cellular 
uptake of MSN-PEPT in these two cell lines was qualitatively evaluated using confocal 
microscopy (Figure 3.13). 
 
Figure 3.13. Evaluation of MSN-PEPT internalization using confocal microscopy. a) A549 cells. b) 
OVCAR8 cells. The particles (in red) could be internalized by both cells lines, in agreement with the 
presence of overexpressed biotin receptors.  
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As shown in Figure 3.13, the biotinylated particles could be effectively internalized in 
both cell lines, as expected, due to overexpressed biotin receptors in both cells lines. 
These experiments further confirmed the initial hypothesis of using specific targeting 
moieties to enhance to efficacy of the particle internalization. 
 Endosomal Escape in 2D Cell Cultures  
The endosomal escape capability of MSN-PEPT was first evaluated in 2D cell cultures 
using A549 cells. For that purpose, the particles were loaded with calcein, which is known 
to be membrane impermeable. MSNs were also loaded with calcein and used as control. 
The samples were analyzed using fluorescence microscopy (Figure 3.14). 
 
Figure 3.14. Evaluation of the endosomal escape in A540 2D cell cultures. Free calcein (right) could not 
be incorporated in the cells. MSNs (left) remained inside the endo-lysosomes, calcein fluorescence was 
self-quenched and could barely be observed. MSN-PEPT (center) could escape the endo-lysosomes and 
calcein fluorescence could be observed more intense and showing slight diffusion. 
As shown in Figure 3.14, free calcein could not be internalized by the cells, as it was 
expected owing to their membrane impermeable nature. Calcein-loaded MSNs showed 
low green fluorescence. This would be consequence of the endosomal entrapment of the 
particles, where calcein fluorescence was self-quenched and could barely be detected.27–
29 On the contrary, cells incubated with calcein-loaded MSN-PEPT showed strong green 
fluorescence with a slight diffusion pattern, which was ascribed to effective endosomal 
escape.10 The explanation to this could be based on MSN-PEPT disrupting the 
endosomes, probably through proton sponge effect.30 Therefore, calcein would be no 
longer self-quenched, showing strong green fluorescence and confirming the endosomal 
escape capabilities of the here designed nanocarrier.  
 Evaluation of cytotoxicity in 2D cell cultures 
The cytotoxicity was first evaluated in 2D HeLa cell cultures. For that purpose, MSNs 
and MSN-PEPT were loaded with TOP and incubated with the cells at a concentration of 
25 µg/mL (Figure 3.15). 
MSNs MSN-PEPT Free calcein
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Figure 3.15. Evaluation of HeLa cell viability using unloaded and TOP-loaded MSNs and MSN-PEPT. 
The group MSN-PEPT loaded with the drug was able to induced significant cell death compared to rest of 
the groups. ǁ p<0.01 vs MSNs and control; * p<0.01 vs MSNs (TOP); # p<0.01 vs MSN-PEPT and control; 
ǂ p<0.05 vs MSNs (TOP). 
As shown in Figure 3.15, the viability of cells incubated with MSNs was unaffected, 
demonstrating the suitability of using this type of particles as platform for drug delivery. 
The cytotoxicity of TOP-loaded MSNs was expected to be lower than that observed in 
Figure 3.15 owing to the lack of targeting agents. However, it should be mentioned that 
MSNs had no gatekeepers closing the pore entrances and, consequently, the drug could 
freely diffuse out of the pores. As a result, TOP located outside the cells could passively 
diffuse inside the cells, leading to higher cytotoxic effect than expected. This observation 
highlighted the need of a diffusion barrier at the pore entrances. 
The viability of the cells incubated with MSN-PEPT remained unaffected during the 
whole experiment, demonstrating the biocompatibility of the here engineered carrier per 
se. On the other hand, TOP-loaded MSN-PEPT exerted significant toxicity on the cells, 
highlighting the ability of the system to internalize cytotoxic compounds. Compared to 
its unloaded counterpart, the drug-loaded group was able to eliminate up to 60% of the 
cells after 48 hours of experiment. In addition, TOP-loaded MSN-PEPT induced 
significantly higher cytotoxicity than TOP-loaded MSNs for all the time points studied.  
The ability of MSN-PEPT to inhibit cellular proliferation was further evaluated using 
A549 2D cell cultures. For that purpose, MSNs and MSN-PEPT were loaded with DOX 
and incubated with the cells at a concentration of 50 µg/mL (Figure 3.16). 
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Figure 3.16. Evaluation of A549 cell viability using unloaded and DOX-loaded MSNs and MSN-PEPT. 
The group MSN-PEPT loaded with the drug was able to induced significant cell death compared to rest of 
the groups. ǁ p<0.01 vs control * p<0.01 vs MSNs and control; # p<0.01 vs MSN-PEPT, MSNs (DOX) and 
control. 
As shown in Figure 3.16, the viability of the cells incubated with MSNs was 
unchanged, demonstrating the biocompatibility of mesoporous silica nanoparticles, 
regardless of the cell line employed. In this case, DOX-loaded MSNs led to reduced cell 
viability. The experimental evidence is that DOX strongly interacts with the silanol 
groups of MSNs. In this sense, DOX premature release would be lower than that observed 
for TOP and, consequently, the amount of free DOX in the medium would be lower, 
leading to less inhibition of the cell viability. Besides, MSNs lacked of biotin targeting so 
the total amount of particles in the cells was lower.  
MSN-PEPT had a statistically significant positive effect on the viability of A549 cells, 
indicating again its high biocompatibility, independently of the cell line studied. On the 
other hand, DOX-loaded MSN-PEPT dramatically reduced the cell viability within the 
first 24 hours by ca. 60% and ca. 70% at 48 hours. Interestingly, the cytotoxic effect of 
DOX-loaded MSN-PEPT was much higher than that of DOX-loaded. This was a direct 
consequence of the enhanced uptake of the particles bearing the peptidic fragment, 
confirming the suitability of using active targeting moieties in combination with 
nanoparticles. 
3.2.3.5. 3D cellular experiments 
 Endosomal escape in 3D cell cultures 
The endosomal escape capability of MSN-PEPT was further evaluated using A549 3D 
cell cultures. For that purpose, MSNs and MSN-PEPT were loaded with calcein and 
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incubated with the spheroids. The outcome of the experiment was evaluated by confocal 
microscopy (Figure 3.17). 
 
Figure 3.17. Evaluation of the endosomal escape of MSNs and MSN-PEPT in A549 spheroids. The MSNs 
(left) remained trapped within the endo-lysosomes and, consequently, calcein was undetectable. White dots 
indicate residual areas where endosomal escape took place for MSNs. On the contrary, MSN-PEPT (center) 
could escape and a strong signal could be detected. Free calcein (right) could not be incorporated owing to 
its membrane impermeable nature.  
As observed in Figure 3.17, free calcein could not be internalized by the cells, in 
agreement with Figure 3.14. The degree of endosomal escape for MSNs was almost 
negligible. The particles remained inside the endo-lysosomes and, consequently, calcein 
fluorescence was self-quenched and its intensity was too low to be detected. Only a 
residual amount of particles could escape the endosomes and showed strong green 
fluorescence. On the contrary, strong green fluorescence could be observed in the 
spheroid treated with MSN-PEPT. This fluorescent signal confirmed that this group of 
particles was no longer trapped within the endo-lysosomes. In consequence, self-
quenching did not take place and calcein could be detected.  
The combination of the results shown in Figures 3.14 and 3.17 confirmed the ability 
of MSN-PEPT to induce endosomal escape. In addition, MSN-PEPT could internalize 
and release a membrane impermeable cargo. This might be useful to encapsulate 
membrane impermeable drugs with high biological activity that otherwise would be 
discarded and would not reach the clinic. Besides, it would be useful to avoid the 
degradation that some therapeutics compounds might undergo when trapped in the endo-
lysosomal pathway, thus increasing the efficacy of the treatment. 
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 Accumulation of Nanoparticles in 3D Cell Cultures 
The performance of Rhodamine B-labelled MSN-PEPT in 3D cellular spheroids was 
evaluated using confocal microscopy. MSNs were used as control. First, both groups of 
particles were incubated with A549 spheroids (Figure 3.18). 
 
Figure 3.18. Confocal microscopy of MSN and MSN-PEPT incubated with A549 3D cellular spheroids. 
Higher accumulation of particles could be observed for MSN-PEPT, as expected owing to the 
overexpressed biotin receptors in these cells.  
As observed in Figure 3.18, the group MSN-PEPT (right) led to the greater 
accumulation of nanoparticles, confirming the active targeting of the compound 22. The 
depth reached by the particles in the spheroid was analyzed using ImageJ software (Figure 
3.19). This software allows the measurement of the red intensity of each layer generated 
by the confocal microscope, obtaining the distribution of the particles through the 
spheroids.  
 
Figure 3.19. Depth analysis of MSN and MSN-PEPT using the ImageJ software. The particles containing 
the biotinylated peptide were able to reach deeper depth (250 µm vs 200 µm). 
The depth analysis (Figure 3.19) demonstrated that the majority of the MSN-PEPT 
particles (right) could locate deeper in the 3D cellular spheroids (ca. 250 µm) compared 
to MSNs (left), which could only penetrate ca. 200 µm. 
MSNs MSN-PEPT
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Both groups of particles were also incubated with OVCAR8 spheroids and the results 
were analyzed by confocal microscopy (Figure 3.20). 
 
Figure 3.20. Confocal microscopy of MSN and MSN-PEPT incubated with OVCAR8 3D cellular 
spheroids. The group MSN-PEPT yielded a higher accumulation of particles in the spheroids, as expected 
for cells overexpressing biotin receptors.  
Analogous results were obtained when MSN-PEPT were used with OVCAR8 
spheroids. As observed in Figure 3.20, the biotinylated particles (right) showed higher 
accumulation of particles in the spheroid, in agreement with the presence of biotin 
receptors in these cells. This was a demonstration of the targeting ability of the system 
here designed and developed, independently of the tumoral cell type evaluated as long as 
biotin receptors are overexpressed.  
 The penetration of the particles in the spheroid was analyzed using the ImageJ 
software (Figure 3.21). 
 
Figure 3.21. Depth analysis of MSN and MSN-PEPT using the ImageJ software. MSN-PEPT could reach 
deeper depth in the OVCAR8 spheroids, compared to pristine MSNs (100 µm vs 70 µm). 
The depth analysis of the OVCAR8 spheroids (Figure 3.21) showed analogous results 
as those observed for A549 spheroids (Figure 3.19). In this case, the majority of the MSN-
PEPT particles (right) could penetrate ca. 100 µm. On the contrary, bare MSNs (left) 
MSNs MSN-PEPT
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could reach only ca. 70 µm. The reason for the lower values obtained in the case of the 
OVCAR8 spheroids (70 and 100 µm vs 200 and 250 µm) was the smaller size of these 
spheroids compared to the A549 ones. The experimental evidence was that A549 cells 
were objectively bigger than OVCAR8 and, consequently, the former led to bigger 
spheroids every time both types of spheroids were grown.   
Overall, the general trend observed in both types of cellular spheroids was that the 
particles containing the biotinylated peptide could penetrate deeper than MSNs. The 
rationale behind these results might rely on the endosomal escape capability demonstrated 
by MSN-PEPT. In this sense, it has been shown that endo-lysosomal entrapment limits 
the exocytosis of nanoparticles.31,32 Besides, it has been demonstrated that the rate of 
transcytosis decreases when the nanoparticles remain trapped in the lysosomes.33 
Furthermore, it has been reported that nanoparticles that achieve exocytosis lead to higher 
penetration in spheroids through transcytosis.34  
In view of the results shown in Figures 3.19 and 3.21 and the just-mentioned reported 
evidences, the higher penetration observed for MSN-PEPT might be ascribed to 
transcytosis events. The endosomal escape would lead to the exocytosis of the particles 
through inner areas of the spheroids and, consequently, these particles would be 
internalized again by inner cell layers, achieving effective transcellular transport and 
improving the penetration ability of the system containing the biotinylated peptide.  
 Evaluation of cytotoxicity in 3D cellular models  
The cytotoxicity was further studied using A549 3D cellular spheroids. For that 
purpose, MSNs and MSN-PEPT were loaded with DOX and incubated with the spheroids 
using 2 different concentrations. A control group without particles was also included. The 
cytotoxic effect exerted by the particles was evaluated measuring the volume of the 
spheroids at different time points, according to a previously reported work.13 Figure 3.22 
shows the results obtained at a particle concentration of 35 µg/mL. 
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Figure 3.22. Evaluation of the spheroid viability in terms of % volume using unloaded and DOX-loaded 
MSNs and MSN-PEPT at a concentration of 35 µg/mL. The group MSN-PEPT loaded with the drug was 
able to significantly reduced the volume, compared to rest of the groups. * p<0.01 vs MSN-PEPT; ¦ p<0.05 
vs MSN-PEPT; # p<0.01 vs MSN (DOX); ǁ p<0.05 vs MSN (DOX); Ꙅ p<0.05 vs MSN; ǂ p<0.01 vs Control; 
§ p<0.05 vs Control. 
As shown in Figure 3.22, the volume of the spheroids incubated with MSNs followed 
the trend observed for the control group without particles, demonstrating the 
biocompatibility of this type of particles in more complex biological scenarios. Only a 
slight volume decrease could be observed for DOX-loaded MSNs after 7 days, as it was 
expected owing to the lack of active targeting. 
The growth of the spheroids incubated with unloaded MSN-PEPT was comparable to 
that of the control group, indicating the biocompatibility of the here designed carrier and 
confirming the results obtained in Section 3.2.3.6. The best results were obtained for 
DOX-loaded MSN-PEPT, which was able to reduce the volume by ca. 20% after 7 days. 
Indeed, this group induced significant reduction after only 48 hours compared to all 
groups. This could be explained taking into account that MSN-PEPT and consequently, 
DOX, accumulated more and deeper in the spheroids, compared to bare MSNs, leading 
to higher cytotoxic effects. The results obtained at a concentration of 70 µg/mL are shown 
in Figure 3.23. 
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Figure 3.23. Evaluation of the spheroid viability in terms of % volume using unloaded and DOX-loaded 
MSNs and MSN-PEPT at a concentration of 70 µg/mL. The group MSN-PEPT loaded with the drug was 
able to significantly reduced the volume, compared to rest of the groups. MSN (DOX) was also able to 
reduce the volume at this concentration. * p<0.01 vs MSN-PEPT; ¦ p<0.05 vs MSN-PEPT; # p<0.01 vs 
MSN (DOX); ǁ p<0.05 vs MSN (DOX); Ꙅ p<0.05 vs MSN; ǂ p<0.01 vs Control; § p<0.05 vs Control. 
The incubation of MSNs with spheroids at a higher concentration had no effect on the 
spheroid volume. In this case, the effect of DOX-loaded MSNs at 7 days was much higher 
than that observed at a concentration of 35 µg/mL (Figure 3.22), although only a slight 
reduction could be observed at 48 hours. This might be explained as follows. From the 
results shown in Figures 3.18 and 3.19, (1) the amount of MSNs in A549 spheroids was 
lower than that of MSN-PEPT and (2) MSN-PEPT reached deeper areas. For such reason, 
the amount of DOX in the spheroids incubated with DOX-loaded MSNs would be lower 
and would penetrate less than that of DOX-loaded MSN-PEPT and, consequently, DOX-
loaded MSNs would require longer periods of time to exert appreciable cytotoxicity. 
The growth of the spheroids was also unaffected when a higher concentration of 
unloaded MSN-PEPT (70 µg/mL) was employed, confirming again its highly 
biocompatible nature and paving the way for future in vivo studies of the here engineered 
carrier. As shown in Figure 3.23, the spheroids incubated with DOX-loaded MSN-PEPT 
reduced their volume by ca. 30% after only 48 hours and ca. 40% after 7 days, confirming 
their ability to penetrate in the spheroid and deliver the drug to the tumoral cells.  
3.2.3.6. Chicken Embryo Model 
Once the behavior of MSN-PEPT was evaluated in 2D and 3D in vitro models, the 
next step was to evaluate its performance in a preliminary in ovo model. For that purpose, 
A549 cells were grown on the CAM membrane of chicken embryos until a tumoral mass 
could be clearly observed. Then, Rhodamine B-labelled MSN-PEPT was administered 
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via vein injection and allowed to circulate in the bloodstream for 48 hours. The 
biodistribution was evaluated through fluorescence microscopy (Figure 3.24). 
 
Figure 3.24. Analysis of the biodistribution of MSN-PEPT by fluorescence microscopy. a) Bright field. b) 
Red fluorescence. 48 hours after the injection the red fluorescence of particles could be observed in the 
tumor, confirming the passive accumulation of the particles.  
The red fluorescence of the particles could be detected in the tumor 48 hours after the 
administration of MSN-PEPT, confirming that the carrier could passively target the tumor 
via EPR effect, as it happens with many commercialized nanomedicines.35 Then, the 
animals were dissected and imaged to find out if the particles accumulated preferentially 
in the tumor (Figure 3.25).  
 
Figure 3.25. Imaging of the organs and tumor of dissected chicken embryo. a) Bright field. b) Red 
fluorescence. The particles preferentially accumulated in the tumor, showing only minor accumulation in 
the liver and kidneys.  
Overall, the particles were undetectable in the organs and only minor accumulation 
could be observed in the liver and kidneys. On the other hand, the bright red fluorescence 
in the tumor confirmed the preferential accumulation of MSN-PEPT in the tumor tissue, 
in agreement with Figure 3.24. These observations confirmed that the here engineered 
nanocarrier was colloidally stable, since it could circulate for long periods of time in the 
chicken egg without forming aggregates (otherwise a thrombus would form and the 
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chicken embryo would dye), leading to its passive accumulation in the tumoral mass via 
the EPR effect. In addition, the preferential accumulation of the particles in the tumor was 
consequence of their low clearance from the bloodstream, highlighting again the 
biocompatibility of the here synthesized nanocarrier. 
Once the ability of MSN-PEPT to preferentially accumulate in the tumor was 
confirmed, the next step was to evaluate whether these particles could inhibit tumor 
growth. For that purpose, a preliminary cytotoxicity study using DOX-loaded MSN-
PEPT was carried out. The particles were administered via vein injection to tumor-bearing 
chicken embryos and subsequently imaged after 48 hours (Figure 3.25). 
 
Figure 3.25. Analysis of the biodistribution of DOX-loaded MSN-PEPT by fluorescence microscopy. a) 
Bright field. b) Red fluorescence. The strong red fluorescence confirmed that the encapsulated DOX 
accumulated in the tumor. 
As shown in Figure 3.25, the cytotoxics were accumulated preferentially in the tumor 
as a consequence of the passive accumulation in the tumor via EPR effect of DOX-loaded 
MSN-PEPT, confirming the suitability of mesoporous carriers to reduce typical side 
effects originated by the non-specific distributions of the drugs. After 3 days, the chicken 
embryos were sacrificed and the effect of DOX-loaded MSN-PEPT on the tumor growth 
was evaluated in terms of tumor weight reduction (Figure 3.26). 
 
Figure 3.26. Inhibition of the tumor growth by DOX-loaded MSN-PEPT. In this preliminary study (n=3 
for the control and n=2 for MSN-PEPT (DOX)) the carrier demonstrated its ability to reduce the tumor 
weight by ca. 30% after 3 days.  
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As shown in Figure 3.26, the DOX-loaded nanocarrier could reduce the tumor weight 
by ca. 30% after only 3 days of treatment, indicating the suitability of MSN-PEPT as drug 
delivery system with potential applicability to the treatment of solid tumors. 
3.2.4. Conclusions 
The objective of this last work was to develop a system able to overcome some of the 
biological barriers that nanoparticles have to face when interacting with living organisms. 
In particular, the accumulation of the particles in the tumoral mass, the preferential 
targeting of tumoral cells and the avoidance of endo-lysosomal entrapment were studied.  
The macromolecule able to target cancer cells and induce endosomal escape was 
designed using biotin as model binding motif and histidine as buffering agent. That 
macromolecule was successfully synthesized using standard solid phase peptide synthesis 
and effectively grafted to the redox-responsive nanoparticles previously developed in this 
thesis. 
The performance of the system with living organisms was thoroughly studied using 
2D and 3D cellular models and a preliminary in ovo model using chicken embryos. The 
targeting ability of the peptidic fragment was quantitatively validated using 2D cell 
cultures. These tests demonstrated the outstanding targeting capacity of the system, 
probably due to collaborative effects ascribed to the appearance of local positive charges. 
In addition, the cellular uptake of the system was qualitatively analyzed in alternative 
cells overexpressing biotin receptors, showing significant particle accumulation within 
the cells and paving the way for the use of 3D cell cultures. 
The endosomal escape was evaluated using calcein as model membrane impermeable 
dye in 2D and 3D cell cultures. The results here obtained demonstrated that only MSN-
PEPT could achieve effective endosomal escape, as demonstrated by the strong green 
fluorescence observed. However, MSNs remained entrapped in the endo-lysosomes and 
calcein could barely be detected as a consequence of self-quenching.  
The evaluation of particle accumulation in cellular spheroids revealed that MSN-PEPT 
presented greater and deeper accumulation in the spheroids than pristine MSNs. These 
results were ascribed to the achievement of effective endosomal escape which, according 
to the literature, would be related to enhanced transcytosis events. 
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The biocompatibility of the carrier was evaluated in vitro, using 2D and 3D cell 
cultures, and in ovo using the chicken embryo model. To validate the versatility of the 
carrier, MSN-PEPT was loaded with different drugs and incubated various cell lines. The 
obtained results demonstrated that only the targeted material could significantly reduce 
the cell viability. The biocompatibility was further evaluated using spheroids and drug-
loaded MSN-PEPT, demonstrating that the highest inhibition of spheroid volume was 
obtained for the here engineered material.  
Finally, the performance of the designed nanocarrier in a more complex system was 
evaluated using tumor-bearing chicken embryos. The results demonstrated that MSN-
PEPT preferentially accumulated in the tumors, probably via EPR effect, without 
aggregating in the bloodstream nor inducing embryo death, demonstrating its colloidal 
stability and biocompatibility. In addition, a preliminary efficacy study was carried out 
using drug-loaded MSN-PEPT. The particles showed preferential accumulation in the 
tumor and could significantly reduce the tumor weight in only 3 days, paving the way for 
future in vivo experiments and for its potential use in cancer treatment. 
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Chapter 4 
Conclusions / Conclusiones 
Investigar es ver lo que todo el mundo ha visto, y pensar lo que nadie 
más ha pensado. 
Albert Szent-Györgyi 

Conclusions 
Conclusions 
The overall objective of this doctoral thesis has consisted in the design and evaluation 
of engineered mesoporous nanoparticles for biomedical applications. In particular, this 
thesis has comprised the development of smart approximations for the treatment of 
complex diseases, such as bone and wound healing and cancer. The general conclusions 
that can be derived from the results here presented and discussed are the following. 
1) The design of a pH-responsive nanocarrier based on MSNs and self-immolative 
polymers as gatekeepers was successful. The particles were successfully 
synthesized using the sol-gel method, yielding mesoporous and homogeneous 
nanoparticles. The synthesis of the polymer involved several optimizations of a 
previously reported method that provided a polyurethane with adequate molecular 
weight. Additionally, the pH-responsiveness of the here produced polymer was 
validated. The grafting protocol was optimized and the pH-responsive behavior 
of the SIP-coated MSNs was confirmed in vial. In addition, a preliminary in vitro 
study was conducted, demonstrating that these particles were biocompatible and 
could be internalized by tumoral cells.  
2) The translation of the pH-responsive self-immolative technology to different 
mesoporous carbon matrices was completely successful. Prior to the 
functionalization with the pH-responsive polymers, it was shown that both types 
of carbon particles provided greater loading capacity than MSNs. Then, a grafting 
protocol was developed and the pH-responsiveness of the carriers was evaluated 
in vial, in vitro and in vivo, demonstrating that the release could be triggered at 
acid pH. In addition, it was shown in vitro that the presence of the pH-responsive 
trigger was essential for the self-immolation to occur. The biocompatibility of the 
SIP-coated carbons was evaluated in vitro and in vivo, showing excellent results. 
In addition, the carbons were loaded with a cytotoxic and their ability to inhibit 
the viability of cancer cells was successfully validated.  
3) The translation of the pH-responsive self-immolative technology to the different 
mesoporous silica-based MOZART nanomatrices involved the development of 2 
alternative grafting protocols to minimize the potential leakage of therapeutic 
ions. Using a carboxylic acid linker provided the best results, although the 
presence of a model fluorophore in the medium highly affected the final output of 
the functionalization. The SIP-coated MOZART particles were subjected to 
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release experiments to evaluate whether the self-immolative polymer could seal 
the mesopores. The results were, in general, not fully satisfactory, although 
promising results were obtained for one of the samples. The most feasible 
explanation for the here obtained results could be that the pores were too large to 
be sealed with this polyurethane. In this sense, the synthesis of bigger polymers 
was attempted with relatively low success. The functionalization of labelled 
matrices for future in vivo experiments was, in general, successful demonstrating 
that the polymer could still be grafted, regardless of presence of a covalently 
attached fluorophore. 
4) Several in vitro and in vivo experiments carried out by members of the consortium 
demonstrated that the pH values found in chronic wound healing and delayed bone 
healing were 8 and 6.8, respectively. In consequence, the previously self-
immolative polymer responsive to pH 5 was modified and the synthesis of 
alternative self-immolative triggers sensitive to pH 8 and 6.8 was attempted. The 
synthesis of a trigger sensitive to pH 8 involved the development of 3 protocols. 
In particular, the one based on using protecting groups involve 3 subprotocols. 
Unfortunately, all the attempts were unsuccessful and the trigger could not be 
synthesized. After exposing the results in a project meeting the consortium agreed 
to discard the synthesis of a trigger responsive to pH 8. With regard to pH 6.8, the 
trigger was successfully synthesized, although it could not be incorporated as 
endcap for the self-immolative polyurethane, despite different approaches were 
employed. In view of these results, the consortium activated a contingency plan 
and the synthesis of a polymer showing a totally different behavior was attempted. 
Unfortunately, the polymerization of the monomer was unsuccessful despite 
different approaches were follow. The consortium finally agreed to discard the 
synthesis of a polymer responsive to pH 6.8. 
5) The use of redox species overexpressed in the cytoplasm of cells was explored as 
alternative stimulus to trigger the release from a carrier with potential application 
in cancer treatment. A small redox-responsive self-immolative molecule was 
synthesized and further grafted to MSNs to hamper premature release. This 
process initially involved the optimization of the silylation of the self-immolative 
molecule. Then, its grafting to the surface of mesoporous silica was also 
optimized. The particles were PEGylated to improve their colloidal stability and 
endow them with stealth properties. The redox-responsive behavior was validated 
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soaking the particles in a solution containing a redox agent, and it was shown that 
the self-immolative molecule was no longer grafted to the particles, probably 
because it suffered cyclization and subsequent self-immolation. Finally, the 
ability of the molecule to delay premature release was evaluated in vial, 
demonstrating that a higher amount of dye could be released when a redox agent 
was present in the medium.  
6) The last part of this thesis involved the development of a system able to overcome 
relevant biological barriers. For that purpose, the redox-responsive system 
previously engineered was employed as starting material. A peptidic molecule 
containing a cancer-specific binding motif and a fragment with endosomal escape 
capabilities was synthesized and further grafted to the redox-responsive MSNs. 
The biological performance was evaluated in 2D and 3D cell cultures. The here 
designed nanocarrier could be preferentially internalized by cancer cells rather 
than normal cells. Besides, this system shown higher internalization than the rest 
of the controls, indicating the positive effect of the peptidic fragment. In addition, 
it was shown that the particles bearing the peptidic molecule could internalize 
deeper in cellular spheroids, probably thanks to transcytosis events. The targeted 
redox-responsive nanoparticles were shown to be totally biocompatible in 2D and 
3D in vitro models. Furthermore, the drug-loaded particles could significantly 
inhibit cellular growth in cell monolayers and cellular spheroids, indicating its 
potential applicability as drug delivery systems. The accumulation of the particles 
in the tumoral mass was validated using tumor-bearing chicken embryos, where 
it could be observed that the particles preferentially accumulated in the tumoral 
mass rather than in the rest of the organs, highlighting the excellent 
biocompatibility of the here designed nanocarrier. Finally, a preliminary tumor 
elimination experiment was conducted, showing that the drug-loaded particles 
could significantly inhibit the tumor weight in a short period of time.  
In summary, the work carried out during this doctoral thesis reinforces the suitability 
of using mesoporous nanocarriers as drug delivery systems. In addition, the usefulness of 
using self-immolative chemistry to endow mesoporous nanocarriers with stimuli-
responsiveness has been validated, and might pave the way for future cutting-edge smart 
gatekeepers. Finally, a simple but effective peptide-like fragment able to overcome 
relevant biological barriers has been reported, whose main feature is the possibility of 
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tuning the membrane binding motif so that different types of cancer cells can be targeted 
on-demand. 
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El objetivo general de esta tesis doctoral ha consistido en el diseño y evaluación de 
nanopartículas mesoporosas funcionalizadas para aplicaciones biomédicas. En particular, 
esta tesis ha comprendido el desarrollo de aproximaciones inteligentes para el tratamiento 
de enfermedades complejas como las de hueso y piel o el cáncer. Las conclusiones 
generales que pueden derivarse de los resultados aquí presentados y discutidos son las 
siguientes.  
1) El diseño de un nanotransportador sensible al pH basado en MSNs y polímeros 
autoinmolativos como compuertas fue satisfactorio. Las partículas fueron 
correctamente funcionalizadas utilizando el método sol-gel, dando lugar a 
nanopartículas homogéneas y mesoporosas. La síntesis del polímero implicó 
varias optimizaciones de un método previamente reportado, el cual finalmente dio 
lugar a un poliuretano con un peso molecular adecuado. Adicionalmente, la 
respuesta al pH del polímero fue validada. El protocolo de anclaje fue optimizado 
y la respuesta al pH de las partículas funcionalizadas con el SIP fue confirmada 
in vial. Además, un estudio preliminar in vitro fue llevado a cabo, demostrando 
que las partículas eran biocompatibles y que podían ser internalizadas por las 
células tumorales.  
2) La traslación de la tecnología autoinmolativa sensible al pH a las diferentes 
matrices mesoporosas de carbono fue exitosa. Antes de proceder a dicha 
funcionalización, se demostró que ambos tipos de partículas de carbono 
proporcionaban mayor capacidad de carga que las MSNs. Tras ello, se desarrolló 
un protocolo de anclaje y la respuesta al pH de las matrices funcionalizadas fue 
evaluado in vial¸ in vitro e in vivo, demostrando que la liberación podía ser 
iniciada a pH ácido. Además, se demostró in vitro que la presencia del fragmento 
iniciador de la autoinmolación sensible al pH era vital para que este proceso 
ocurriera. La biocompatibilidad de las partículas de carbono funcionalizadas fue 
evaluada in vitro e in vivo, mostrando resultados excelentes. Además, las 
partículas fueron cargadas con un citotóxico y su habilidad para inhibir la 
viabilidad de células tumores fue demostrada con éxito.  
3) La traslación de la tecnología autoinmolativa sensible al pH a las diferentes 
nanomatrices mesoporosas basadas en sílice proporcionadas por el consorcio 
MOZART implicó el desarrollo de 2 métodos de anclaje alternativos con el fin de 
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minimizar la potencial pérdida de iones terapéuticos durante los pasos de síntesis 
y lavado. El uso de un linker que contenía un ácido carboxílico proporcionó los 
mejores resultados, aunque la presencia del fluoróforo en el medio afectó el 
rendimiento final de la funcionalización. Las partículas funcionalizadas con el 
polímero fueron sometidas a experimentos de liberación para evaluar si el 
polímero autoinmolativo podía cerrar los poros. Los resultados fueron, en general, 
no satisfactorios, aunque se obtuvieron algunos resultados prometedores para una 
de las muestras. La explicación más probable para estos resultados podría ser que 
los poros eran demasiado grandes para ser tapados por un polímero como el 
empleado. En este sentido, se intentó sintetizar polímeros más grandes, aunque 
con bajo éxito. La funcionalización de las matrices marcadas para futuros 
experimentos in vivo fue, en general, satisfactoria demostrando que el polímero 
se podía seguir anclando a la superficie independientemente de la presencia de un 
fluoróforo previamente anclado de forma covalente.  
4) Varios experimentos in vitro e in vivo llevados a cabo por miembros del consorcio 
demostraron que los valores de pH encontrados en ambientes de reparación de 
heridas en hueso y piel eran, en realidad, 8 y 6.8, respectivamente. En 
consecuencia, el polímero autoinmolativo sensible a pH 5 anteriormente 
empleado fue modificado y la síntesis de iniciadores de la autoinmolación 
alternativos sensibles a pH 8 y 6.8 fue explorada. La síntesis del fragmento 
sensible a pH 8 involucró el desarrollo de 3 protocolos. En particular, aquel basado 
en el uso de grupos protectores involucró 3 subprotocolos adicionales. 
Desafortunadamente, todos los intentos fueron insatisfactorios y la molécula no 
pudo ser sintetizada. Tras exponer los resultados en una reunión del proyecto, el 
consorcio acordó descartar la síntesis de la molécula sensible a pH 8. Con respecto 
al pH 6.8, la molécula iniciadora de la autoinmolación fue sintetizada con éxito, 
aunque no se pudo incorporar como finalizador del polímero autoinmolativo a 
pesar de usar diferentes aproximaciones. En vista de estos resultados, el consorcio 
activó un plan de contingencia y como consecuencia se activó la síntesis de un 
polímero con un comportamiento diferente, no autoinmolativo. 
Desafortunadamente la polimerización del monómero fue insatisfactoria a pesar 
de los diferentes métodos empleados. Finalmente, el consorcio descartó la síntesis 
del polímero autoinmolativo sensible a pH 6.8.  
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5) El uso de especies redox sobreexpresadas en el citoplasma de las células fue 
explorado con estímulo alternativo para iniciar la liberación desde el 
transportador. Una pequeña molécula autoinmolativa sensible a redox se sintetizó 
y ancló a las MSNs para retardar la liberación prematura. Este proceso implicó 
inicialmente la optimización del proceso de sililado la molécula autoinmolativa. 
Tras ello, su anclaje a la superficie de la sílice mesoporosa fue también 
optimizado. Las partículas fueron PEGiladas para mejorar su estabilidad coloidal 
y proporcionar propiedades furtivas. El comportamiento sensible a especies redox 
fue validado sometiendo a las partículas a una solución que contenía un agente 
reductor, y se demostró que la molécula autoinmolativa ya no se encontraba en 
las partículas tras la aplicación de dicha solución. Finalmente, la habilidad de la 
molécula para retardar la liberación prematura de la carga fue evaluada in vial, 
demostrando que mayor cantidad de fluoróforo era liberado cuando el agente 
redox estaba presente en el medio.  
6) La última parte consistió en el desarrollo de un sistema capaz de superar barreras 
biológicas relevantes. Para ello, el sistema sensible a redox fue empleado como 
material de partida. Tras ello, se diseñó una molécula peptídica que contenía una 
parte capaz de reconocer células tumorales y otra capaz de inducir el escape 
endosomal. La molécula fue anclada a las partículas y su desempeño biológico 
fue evaluado en cultivos celulares 2D y 3D. El sistema aquí diseñado pudo ser 
preferencialmente internalizado por las células tumorales frente a las normales. 
Además, el sistema mostró mayor internalización que el resto de controles, 
indicando el efecto positivo del fragmento peptídico. Además, se demostró que 
las partículas con el fragmento peptídico pudieron internalizar más 
profundamente en esferoides celulares, probablemente a través de eventos de 
transcitosis. El sistema aquí diseñado demostró ser totalmente biocompatible en 
modelos in vitro 2D y 3D. Más aún, el sistema cargado con un fármaco pudo 
inhibir significativamente la viabilidad celular en ambos tipos de modelos 
celulares, indicando su idoneidad para ser potencialmente aplicado como sistema 
de transporte de fármacos. La acumulación de las partículas en la masa tumoral 
fue estudiada usando embriones de pollo en los que se crecieron tumores. Se pudo 
observar que las partículas se acumularon preferencialmente en la masa tumoral 
en lugar de en el resto de órganos, indicando la excelente biocompatibilidad del 
sistema aquí diseñado. Finalmente, un estudio preliminar de eliminación tumoral 
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fue llevado a cabo, mostrando que las partículas cargadas con un fármaco 
pudieron reducir significativamente el peso del tumor en un corto periodo de 
tiempo.  
En resumen, el trabajo realizado durante esta tesis doctoral reafirma la idoneidad de 
usar nanotransportadores mesoporosos como sistemas de transporte de fármacos. 
Además, la utilidad de usar química autoinmolativa para controlar la liberación prematura 
de fármacos con sistemas estímulo-respuesta ha sido validada, y podría sentar las bases 
para futuras compuertas inteligentes. Finalmente, se desarrolló un sistema peptídico muy 
simple pero efectivo capaz de superar barreras biológicas relevantes, cuya principal 
característica es la capacidad de modificar fácilmente el fragmento de reconocimiento de 
células tumorales, de modo que diferentes tipos de estas células pueden ser reconocidas 
a voluntad.  
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Appendix I. Characterization techniques  
The objective of this appendix is to provide a brief introduction to the different 
techniques employed to characterize the performance of the materials produced during 
this doctoral thesis. The information here presented is a summary of the instructions 
manuals as well as different online information from the different manufacturers. Table 
A1.1 summarizes the essential information provided by each technique. 
Table A1.1. Summary of the techniques employed to characterize the performance of the materials here 
produced and the information that can be obtained from them.  
Characterization technique Sample Information 
Thermogravimetric Analysis (TGA) Quantification of the amount of organic matter 
Fourier Transformed Infrared (FTIR) spectroscopy Presence or absence of functional groups 
X-Ray Diffraction (XRD) Mesostructure periodicity 
Nitrogen porosimetry Textural properties 
Scanning Electron Microscopy (SEM) Morphology and size 
Transmission Electron Microscopy (TEM) Morphology, porosity and size 
Dynamic Light Scattering (DLS) Colloidal stability and hydrodynamic size 
Zeta potential Surface charge 
1H-Nuclear Magnetic Resonance (1H-NMR) Identification of 1H atoms in an organic compound 
X-ray Photoelectron Spectroscopy (XPS) Functional groups and composition of a surface 
MALDI-TOF mass spectrometry Molecular weight of an organic compound 
Elemental analysis Content of C, H, N, S 
Confocal microscopy Quantitative cellular uptake of the particles 
Flow cytometry Qualitative cellular uptake of the particles 
Thermogravimetric Analysis 
This technique provides a quantitative analysis of the sample composition as a function 
of temperature. It allows to quantify the variations in the sample weight upon application 
of a heating ramp under a controlled atmosphere. In particular, this technique has been 
employed during this thesis to evaluate the correct surfactant removal and the amount of 
organic matter incorporated in the different mesoporous nanomatrices after each 
functionalization step. 
Fourier Transformed Infrared spectroscopy 
This technique allows the determination of the presence or absence of functional 
groups in a sample upon irradiation with infrared light (4,000-400 cm1). The irradiation 
of a sample provides a FTIR spectrum, which is composed of vibration bands that are 
unique for a particular sample. The origin of those bands is the various types of vibrations 
283
Appendix I 
that can be detected for the different bonds of the molecule upon infrared irradiation. 
FTIR spectroscopy finds wide application because it is possible to analyze liquids, gels, 
fibers, surfaces…In particular, this technique has been employed during this PhD to 
evaluate the proper surfactant elimination as well as the success of the different grafting 
steps. 
X-Ray Diffraction  
This technique provides information about the structural periodicity of a material upon 
irradiation with x-rays. The x-ray beams are elastically dispersed after interacting with 
the sample and, consequently, they preserve the initial wavelenght. The beams can only 
be dispersed in certain directions, which are characteristic of a particular periodic system 
and are determined by the Bragg law (Equation A1.1). 
𝑛𝜆 = 2𝑑ℎ𝑘𝑙 sinΘ 
Equation A1.1. The Bragg law provides the directions in which the x-ray beams are diffracted. n: 
diffraction order, λ: wavelength, dhkl: distance between planes and ϴ: irradiation angle. 
In the case of the mesoporous materials here studied, the small angle XRD allows the 
determination of the periodicity of the corresponding mesostructure, although they are 
amorphous at the atomic scale.  
Nitrogen porosimetry 
This technique provides information about the textural properties of a sample based 
on the interaction between the nitrogen gas (adsorbate) and the solid to be analyzed 
(adsorbent). In general, adsorption processes can be classified either as chemisorption 
(existence of chemical bond between adsorbate and adsorbent) or physisorption (the 
interaction is labile and take place through Van der Waals interactions). The results of the 
nitrogen porosimetry, which is based on physisorption processes, are expressed as 
adsorption-desorption isotherms. These curves provide the volume of gas adsorbed by the 
surface as a function of the pressure conditions. The raw data obtained by the apparatus 
is treated using different mathematical models to provide the textural properties. In our 
case, the textural properties that have been measured are the specific surface area, the 
pore volume and the pore size: 
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 Specific surface area: It provides the surface of the solid per unit of mass. The value 
has been determined using the B.E.T. (Brunauer-Emmett-Teller) mathematical 
model.  
 Pore volume: Nitrogen porosimetry provides the volume occupied by the adsorbate 
within the adsorbent at a p/p0 close to 1. In this case, the value is the direct volume 
filled by the gas molecules and no mathematical models are employed. 
 Pore size: This parameter can be elucidated using different mathematical models. 
The BJH (Barret-Joyner-Halenda) model, which allows to calculate the pore size in 
the range 2-50 nm, has been employed during this thesis.  
This technique has been initially employed during this PhD thesis to determine the 
textural properties of the different as-produced mesoporous materials. In addition, the 
variations in the above-mentioned parameters after the different functionalization steps 
verify the success those synthetic steps.  
Scanning Electron Microscopy 
This technique provides high resolution images of surface based on the interactions 
between the electron beam and the surface of the sample. These microscopes present high 
depth of field so a large area of the sample can be focused at the same time. The samples 
are required to be conductor for SEM observation. For that purpose, they are usually 
covered with a carbon or gold layer. The image is formed from the detection of secondary 
and backscattered electrons by electromagnetic lenses. Finally, the image is formed from 
the amount and intensity of the electrons detected.  
This technique has been employed during this doctoral thesis to evaluate the correct 
synthesis of the different nanomatrices here produced, in terms of morphology, size or 
state of aggregation.  
Transmission Electron Microscopy 
This technique allows the observation of materials, even at the atomic scale (HRTEM), 
when a high energy electron beam is focused on a thin sample. The beam interacts with 
the atoms of the sample and consequently, some electrons go directly through the sample 
while others are scattered.  All electrons are then collected and a grayscale image is 
generated from the different degree of dispersion of the electrons. This technique provides 
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information about the crystallinity of a material or whether it shows porosity, among 
others.  
This electron microscopy technique has been employed during this thesis to evaluate 
the presence of porosity in the as-produced mesoporous samples. In addition, the presence 
of organic matter in the samples can be evaluated if materials are stained with 
phosphotungstic acid. 
Dynamic Light Scattering 
This technique allows the determination of the size distribution of particles or 
emulsions, among others. It is based on the Brownian motion of the particles or molecules 
present in the solution. As a consequence of this motion, light is dispersed showing 
different intensities, whose analysis permits the determination of the speed of the 
Brownian motion. In our case, that speed provides the size of the particles through the 
Stokes-Einstein equation (Equation A1.2). 
𝐷 =
𝑘𝑇
3𝜋𝜂𝑟
 
Equation A1.2. The Stokes-Einstein equations provides the diffusion coefficient D, which is related to the 
hydrodynamic size of the particle. k: Boltzmann constant, T: Temperature, η: liquid viscosity  
In the case of the materials produced during this PhD thesis, this technique has been 
used to evaluate the correct synthesis of MSNs (indicated by the absence of big 
aggregates) as well as the colloidal stability of the particles after the different 
functionalization steps.  
Zeta potential 
This technique provides information about the surface charge of the particles through 
the application of an electric field between two electrodes. The magnitude of the zeta 
potential, which can be positive, negative or neutral, indicates the degree of electrostatic 
repulsion between adjacent as similarly charge particles in a dispersion. In particular, this 
technique has been employed during this thesis to evaluate the success of the different 
functionalization steps as a function of the variations in the surface charge of the particles.  
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1H-Nuclear Magnetic Resonance 
This technique is mainly used to elucidate molecular structures of organic compounds, 
although it can also be applied to thermodynamic and kinetic studies. 1H has magnetic 
spin, which moves around a rotation axis as if it were a small magnet. The spins are 
randomly oriented in absence of magnetic field. However, the field is applied the nuclei 
can absorb the energy of the spins are promoted to a state of different energy. Nuclei emit 
signals when they go back to the ground state. That signal depends on the energy gap 
between the two spin states and can be detected by the apparatus. The magnetic field 
sensed by each atom and, consequently, the resonance frequency depend on the 
surrounding environment of each atom. This technique has been thoroughly applied 
during this doctoral thesis to evaluate the correct synthesis of the different organic 
molecules grafted to the mesoporous matrices.  
MALDI-TOF mass spectrometry 
The acronym stands for Matrix-Assisted Laser Desorption/Ionization - Time-Of-
Flight. This technique allows the analysis of biomolecules (proteins, peptides, lipids, 
sugars) and other organic molecules (small molecules, polymers, dendrimers…) that tend 
to be fragile and would be fragmented using other ionization techniques. The sample is 
initially mixed with a suitable matrix material and applied to a metal plate. Then, a pulsed 
laser irradiates the sample, leading to the ablation and desorption of the sample and the 
matrix. Finally, the molecules are ionized and the gaseous state obtained is subsequently 
accelerated into the mass spectrometer.  
This technique has been employed during this PhD thesis to evaluate the molecular 
weight of particular organic macromolecules, providing additional information to the 1H-
NMR.  
X-ray Photoelectron Spectroscopy 
This technique provides quantitative information about the elemental composition of 
the surface of a material. XPS spectra are obtained by irradiating the material with an x-
ray beam and, at the same time, measuring the kinetic energy and the amount of electrons 
that escape from the material under high vacuum conditions. 
This characterization technique has been employed during this thesis to evaluate the 
chemical groups present on the surface of the carbon materials and the subsequent 
changes upon functionalization with the polymeric coating.  
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Elemental analysis 
This technique provides the amount of carbon, hydrogen, nitrogen and sulfur in a 
material. Samples are burnt at 1,000ºC under an oxygen atmosphere so that organic 
molecules are converted into simple gases, such as CO2, N2, H2O…that are separated 
using a chromatography column. The total amount of each one is measured thanks to their 
thermal conductivity. This technique has been employed during this doctoral thesis to 
evaluate the success of different functionalization steps as a function of particular atoms. 
In addition, the analysis of sulfur content was employed to evaluate the redox-
responsiveness of one of the materials here produced.  
Confocal microscopy 
This technique allows the observation of discrete layers of a sample by using a pinhole 
that discards light that is out of focus. It is possible to generate 3D images from the 
stacking of individual layers. It is widely employed in biosciences because it allows the 
detection of light with different wavelengths. In this way, it is possible to stain different 
parts of the cells and the particles to observe them and to evaluate whether particles and 
cells are in the same plane, i.e., if particles are inside the cells. 
This technique has been employed during this PhD thesis to evaluate the effective 
internalization of the particles in different cellular models.  
Flow cytometry 
This technique provides qualitative information about the physical and chemical 
characteristics of a population of cell. The cells are suspended in a fluid and subsequently 
injected in the cytometer. Ideally, only one cell flow at a time through the laser beam and 
the scattered light is characteristic to the particular cell and its components. It allows the 
detection of fluorescent markers. 
This technique has been employed during this thesis to evaluate the amount of particles 
incorporated in the cells, providing a value of its ability to be internalized by different 
type of cells.  
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This doctoral thesis is focused on the design, synthesis and physical-chemical and biological
evaluation of stimuli-responsive mesoporous nanomatrices with potential applicability for the
treatment of bone and wound healing or cancer.
The first of part of this doctoral thesis comprises (1) the development of internal stimuli-responsive
self-immolative moieties responsive to either pH changes or redox species, (2) the development of
synthetic approaches to graft those molecules to the surface of the particles and (3) the evaluation of
the pore capping capability of these structures. In addition, the biological performance has been
evaluated, showing outstanding biocompatibility and efficiency.
The second part of this doctoral thesis is focused on the development of a simple but unique
strategy to bypass some of the biological barriers that nanoparticles have to face when
administered in the body. For that purpose, a multifunctional molecule able to (1) selectively
recognize cancer cells over normal cells and (2) induce endosomal escape has been synthesized
and grafted to mesoporous silica nanoparticles. In addition, (3) a pseudo-in vivo model has been
employed to validate that these particles are able to preferentially accumulate in the tumoral mass.
Esta tesis doctoral se centra en el diseño, síntesis y caracterización fisicoquímica y biológica de
nanomatrices mesoporosas estímulo-respuesta con potencial aplicabilidad en el tratamiento de
enfermedades de hueso y piel o cáncer.
La primera parte de la presente tesis doctoral se ha centrado en (1) el desarrollo de estructuras
autoinmolativas sensibles a estímulos internos (variaciones de pH y sobreexpresión de especies
reductoras), (2) el desarrollo de métodos de anclaje de dichas moléculas a la superficie de las
partículas y (3) la evaluación de la eficiencia de estas estructuras para cerrar los poros. Además, se
ha evaluado el desempeño biológico de estos sistemas, demostrando su alta biocompatibilidad y
eficiencia.
La segunda parte de esta tesis doctoral se ha centrado en el desarrollo de una aproximación capaz
de superar algunas barreras biológicas que las nanopartículas tienen que afrontar al ser aplicadas
al tratamiento del cáncer. Para ello, se ha desarrollado y anclado a nanopartículas mesoporosas de
sílice una molécula capaz, al mismo tiempo, (1) de reconocer selectivamente células tumorales y
(2) de inducir el escape endosomal. Además, (3) se ha comprobado en un modelo pseudo-in vivo
que las partículas son capaces de acumularse preferencialmente en la masa tumoral.
